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ABSTRACT 
 
ABSTRACT 
 
Background:  Health care workers are at increased risk of acquiring latent 
tuberculosis infection (LTBI). The emergence of interferon-gamma release assays 
(IGRAs) for the diagnosis of LTBI, presents an opportunity for improved estimation 
of TB infection prevalence and incidence. Their utility in settings with high 
background prevalence TB and HIV infection is unknown. Major aims of the study 
were to: 
• Evaluate the prevalence and factors associated with TB infection using both 
tuberculin skin test (TST) and IGRA assays in a sample of health care 
workers.  
• Evaluate change in interval test response over one year to determine annual 
risk of infection and determinants associated with test conversion. 
 
Methods:Participants completed a questionnaire on occupational and 
environmental characteristics including a TB symptom screen and underwent chest 
radiograph and rapid HIV test. Three tests for latent TB infection were administered: 
TST, QuantiFERON-TB Gold In-Tube (QFT-GIT) and a T-SPOT.TB test. All tests 
were repeated one year later. 
 
Results: The prevalence of TB infection at baseline was 84%, 65% and 60% as 
measured by TST, QFT-GIT and T-SPOT.TB. There was only fair agreement 
between TST and IGRAs.  HIV positive status was significantly associated with 
having a TST negative / T-SPOT.TB positive discordant test response (OR=4.72). 
TST had superior sensitivity than IGRAs for the diagnosis of LTBI.  
In primary level staff a positive TST outcome, was negatively associated with HIV 
positive status (0R=0.41). Long employment duration was positively associated with 
TST (OR=4.17) and QFT-GIT (OR= 2.42) positivity. 
Involvement in sputum collection (OR=3.25) and home-based care of TB patients 
(OR= 4.14) was associated with a positive IGRA test.  
The conversion rate for TST and IGRAs was 38% and 22%, respectively. Reversion 
rates ranged from 1% - 16 % and was lowest for TST. Factors associated with 
conversion (for IGRAs) included employment sector, counselling of TB patients and 
a baseline positive TST.  
 
Conclusion:The annual rate of TB infection was very high pointing to occupational 
exposure as a contributory factor. TST had superior sensitivity than IGRAs for LTBI 
diagnosis but poor uptake on serial testing. IGRAs had excellent uptake but its 
clinical utility was negatively influenced by high rates of reversion.  
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INTRODUCTION 
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 CHAPTER 1 
 
1.1 INTRODUCTION 
 
Tuberculosis as a public health problem in South Africa and globally 
 
Tuberculosis (TB) is an important public health problem globally with 8.8 
million (range, 8.5–9.2 million) incident cases of TB and 1.1 million (range, 
0.9–1.2 million) TB related deaths reported among HIV-negative people. 
HIV-associated TB contributes an additional 0.35 million (range0.32–0.39 
million) deaths.(World Health Organization, 2011:13) TB is the second 
leading cause of death from an infectious disease worldwide (after HIV, 
which caused an estimated 1.8 million deaths in 2008). Whilst the Millennium 
Development Goal of halting and reversing the TB epidemic may already 
have been reached as manifested in a slowly declining incidence rate it is 
unlikely that the more important long term elimination target set for 2050 will 
be met (Lonnroth et al., 2010; Dye & Williams, 2010). Reasons for the 
continued global burden of tuberculosis may in part be attributed to a rise in 
the world population. Contributing factors to the epidemic may be broadly 
categorized into a failure to reduce transmission or an increase in host 
susceptibility to infection and disease. Low- and middle-income countries 
shoulder most of the global tuberculosis burden as a result of the synergy 
between these two factors which are highly prevalent in such countries.  
 
In South Africa despite a relatively well-funded and functioning National 
Control Programme, TB has remained a pressing public health problem. The 
disease burden posed by TB in South Africa is considerable and the 
epidemic continues unabated, much of it fuelled by the high HIV prevalence 
in the region. South Africa is currently ranked third among high burden 
countries with an estimated 0.40 million–0.59 million incident cases in 2010, 
outranked by only India and China (World Health Organization, 2011).Whilst 
all of the high burden countries have demonstrated declines or stabilization 
2
 in their incident rates, South Africa has shown  an increasing trend in incident 
rate with the latest annual incidence estimated to be 1170 per 100 000 
persons. The importance of HIV infection as a risk factor is underscored by 
the latest estimate of a 60% HIV prevalence among incident TB cases in 
South Africa, relative to a general population HIV prevalence of 9.6 
(Statistics South Africa, 2013). 
 
Tuberculosis as an occupational risk of health workers 
 
It is well established that health care workers (HCWs) globally have an 
increased risk of tuberculosis infection and disease due to occupational 
exposure (Baussano et al., 2011; Joshi et al., 2006). In recognition of this 
risk, the World Health Organization (WHO) has advocated a more proactive 
approach than currently is the case towards protecting the health of HCWs. 
This includes improving infection control in health care facilities and the 
implementation of isoniazid prophylaxis for those highest risk of progression 
to TB disease (WHO, UNAIDS & ILO, 2010; World Health Organization, 
2010; World Health Organization, 2009). 
 
In many low and intermediate TB incidence settings, screening programmes 
for latent TB infection in HCWs are routinely implemented (Menzies, Joshi & 
Pai, 2007). This is coupled with targeted prophylactic treatment of those with 
latent TB infection (LTBI) to prevent progression to TB disease. This is not 
the case in many high TB incidence settings, including South Africa, where 
the focus until recently has been on the diagnosis and treatment of TB 
disease (Kasprowicz et al., 2011). Whilst the main reason for this 
discrepancy is the extent of the TB burden in such settings, another reason 
is the absence of highly sensitive and specific tests for the diagnosis of LTBI.  
The tuberculin skin test (TST) until recently has been the only test utilised for 
the diagnosis of LTBI. It has poor specificity for LTBI diagnosis as test 
outcome may be affected by immunosuppression, confounding due to prior 
Bacille Calmette Guerin (BCG) vaccination or exposure to environmental 
3
 mycobacteria and boosting when used in serial testing. These factors 
adversely influence the specificity of TST test response (Lalvani & Pareek, 
2010). Furthermore the lack of a gold standard for LTBI diagnosis has 
resulted in the use of active TB as a surrogate measure to evaluate test 
sensitivity and specificity. This adversely influences TST test performance as 
cellular immunity is likely to be compromised in the setting of severe infection 
or immunosuppression. 
 
This past decade has seen the introduction of interferon-gamma release 
assays (IGRAs), novel diagnostic assays for the diagnosis of LTBI, which 
have shown promise on account of superior specificity and equivalent 
sensitivity to that of TST. These features would allow for more targeted 
implementation of isoniazid prophylactic treatment (IPT) (Pai, Zwerling & 
Menzies, 2008; Menzies, Pai & Comstock, 2007). Several studies have 
confirmed that IGRAs have superior sensitivity for LTBI diagnosis in 
immunocompromised individuals, and improved sensitivity in the setting of 
active TB, when used as a proxy measure for latent TB infection. IGRAs are 
also not subject to boosting when used on their own (i.e. without preceding 
administration of TST) and are thought to be better correlated with recent TB 
exposure. This has resulted in them being proposed as ideal tests for serial 
screening of LTBI in HCWs and in outbreak investigations.  
 
Based on the emerging evidence, IGRAs have been incorporated into 
screening protocols for HCWs in countries such as the USA and the UK 
(Mazurek et al., 2005; National Collaborating Centre for Chronic Conditions 
(UK) & Centre for Clinical Practice at NICE (UK), 2011). Other countries, 
such as Canada, have adopted a more cautious approach as more recent 
evidence emerging from systematic reviews and mature screening 
programmes has raised questions about the utility and performance of 
IGRAs for serial screening of HCWs in low and intermediate TB incidence 
settings(Dorman et al., 2014; Slater et al., 2013; Zwerling et al., 2013).These 
doubts are in the main about the interpretation of conversion and reversion 
4
 patterns, the use of standard cut-offs to denote test positivity and the variable 
associations with LTBI prevalence and incidence as well as with TB 
exposure.  This lack of consistency in IGRA test results has resulted in calls 
for a better understanding of IGRA test response and the use of additional 
risk factor analysis in clinical decision making to inform the targeted 
implementation of both LTBI screening and IPT in low TB incidence 
settings(Pai, 2012). 
 
The evidence base for the performance and utility of IGRAs has in the main 
come from low and intermediate TB incidence setting. Several authors have 
pointed to the limited research on the utility of IGRAs for the diagnosis of 
LTBI in HCWs in high TB incidence settings (Zwerling et al., 2013; Zwerling 
et al., 2012; Joshi et al., 2006; Pai et al., 2005). This is precisely the setting 
where HCWs could benefit most from targeted IPT and a resultant reduction 
in risk of contracting TB disease. A few studies conducted among select 
groups of HCWs in South Africa have illustrated an increased risk of TB 
disease and LTBI (Claassens et al., 2010; Claassens et al., 2013; Kranzer et 
al., 2010; Naidoo & Jinabhai, 2006; O'Donnell et al., 2010; van Rie et al., 
2013). This is to be expected as HCWs in South Africa are exposed to high 
background population TB incidence, have an HIV prevalence which mirrors 
that of the population, and have additional occupational exposure with 
relatively poor implementation of infection control practices where they work, 
adding to their TB risk (Adams et al., 2012; Farley et al., 2012; Naidoo, 
Seevnarain & Nordstrom, 2012; Zungu & Malotle, 2011). This makes them 
an ideal population for targeted implementation of IPT.  
 
The evidence base from high TB incidence countries for the use of IGRA 
assays in screening of HCWs is, however, sparse. A recent systematic 
review includes results from only five studies which have evaluated LTBI in 
HCWs from high TB incidence settings (Zwerling et al., 2012). Only two 
studies involved a head-to-head comparison between TST and IGRAs at 
baseline, whilst two studies had a prospective design and evaluated IGRA 
5
 test conversion over time. Pai et al (2005) in a study of HCWs in India found 
a stronger association between occupational exposure and IGRA test 
positivity than for TST, but this difference in association was not statistically 
significant. Neither longitudinal study reported data that showed IGRA 
conversion to be more strongly associated with TB exposure than TST 
conversion.  
 
The one-year prospective study on which this thesis is based, was therefore 
undertaken to evaluate the use of IGRAs for LTBI screening in HCWs in a 
high TB incidence settings, against a background of high HIV prevalence.  
 
1.2 STUDY AIM 
 
The aim of this study was to evaluate the use of interferon gamma release 
assays for the diagnosis of latent tuberculosis infection in a population of 
health care workers engaged in providing health care services to 
communities where high rates of tuberculosis (TB) and Human 
immunodeficiency virus (HIV) infection prevail.  
 
1.3 OBJECTIVES OF THE STUDY 
 
1.  Determine the prevalence of latent TB infection using tuberculin skin 
 test (TST) and interferon gamma release assays (IGRAs) and 
 evaluate the occupational  and host factors associated with the 
 occurrence of LTBI, as measured by the different tests. 
2.  Determine the baseline prevalence of TB disease in this population 
3.  Determine the level of agreement between the different tests and 
 the factors associated with concordant and discordant test 
 outcomes at baseline. 
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 4.  Perform a direct comparison between test performance of the 
 different tests, using latent class analysis, in measuring sensitivity and 
 specificity in this population. 
5.  Estimate the annual incidence of infection (based on test conversion) 
 through the employment of a serial testing strategy and explore 
 the occupational and host factors associated with risk of conversion.   
 
1.4 STRUCTUREOF THE THESIS 
 
Chapter 2 is a comprehensive literature review of the problem of 
tuberculosis infection and disease in health care workers with a focus on 
determinants associated with such infection in this occupational group. 
Included in the review is a focus on studies which use both tuberculin skin 
tests and interferon gamma release assays as outcome measures of LTBI 
and which measure agreement between these two testing modalities. 
Research findings from studies which report results from serial screening are 
also included to evaluate changes in test response over time and the factors 
associated with test conversion and reversion.  The aim of this chapter is to 
provide a context for the study and the questions asked. 
 
Chapter 3 provides a detailed description of the methods employed in the 
execution of the study. This includes a detailed description of the study 
setting and the population to develop a basis for comparison with results 
from similar studies conducted among different HCW populations. 
 
Chapter 4 presents the results of the baseline phase of the study. Findings 
with regard to the prevalence and determinants of LTBI using different test 
modalities are presented. This is only the second South African study which 
has evaluated the prevalence of LTBI (using both TST and IGRAs) among 
HCWs and the first to evaluate the relationship with LTBI occurrence and 
occupational factors in a HCW population.  
7
  
Chapter 5 evaluates agreement between TST and IGRAs for the diagnosis 
of LTBI. It includes an exploration of factors associated with concordant 
versus discordant test results using a multinomial regression model. A direct 
comparison between test performance is also done using latent class 
statistical modelling techniques. 
 
Chapter 6 evaluates change in LTBI test response over a one year interval. 
Estimates of annual incidence of infection (based on test conversion) are 
reported.  Factors associated with risk of conversion are explored with a view 
to identifying consistent predictors of conversion across all test modalities. 
Potentially modifiable occupational risk factors influencing conversion are 
also evaluated.  
 
Chapter 7 concludes with a discussion of the implications of the main 
findings and limitations of the study. The implications for research and public 
health policy and occupational health programmes are outlined and 
recommendations are made in this regard. 
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 1.5 DEFINITIONS 
 
Health care worker 
In the South African context and for the purpose of this study, a health care 
worker was defined as any person directly engaged in providing a service at, 
or on behalf of the health care facility. This included those in direct 
employment by the health department and those employed by non-
governmental organizations such as community based health care workers 
who provide support for health programmes e.g. TB adherence supporters. 
In addition, those employees who provide support services such as 
administrative, security, or cleaning services were also classified as health 
care workers and were considered eligible to participate in the study. This is 
in line with the approach adopted by the World Health Organization that 
proposes the inclusion of all those involved in the provision of health 
services, as well as management and support workers in such a definition. It 
furthermore includes subsectors of workers engaged in community-based 
and home-based care(WHO, UNAIDS & ILO, 2010; Oxlade et al., 2009). 
 
Low, medium and high tuberculosis- incidence country 
The World Health Organization characterizes countries based on their 
annual TB incidence rate. Low TB incidence countries have a<50/100 000 
annual incidence of TB; intermediate-incidence 50-99/100 000 and high 
incidence ≥100/100 000. 
 
Low, middle and high- income countries 
This refers to a definition employed by the World Bank to characterize a 
country by its economic status (The World Bank Group, 2014).For the 
current 2015 fiscal year, low-income economies are defined as those with a 
gross national income (GNI) per capita, calculated using the World Bank 
Atlas method, of $1,045 or less in 2013; middle-income economies are those 
with a GNI per capita of more than $1,045 but less than $12,746; high-
income economies are those with a GNI per capita of $12,746 or more.  
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 Latent TB infection 
LTBI is defined by the presence of an M. tuberculosis specific immune 
response in the absence of clinical and radiological disease (Chee et al., 
2013). 
 
Tuberculosis disease 
For the purpose of this study TB disease was defined as bacteriologically 
confirmed tuberculosis on either sputum smear microscopy or culture. 
 
TST conversion  
This was defined as a negative baseline TST (induration of <10mm), and 
follow-up positive TST (induration ≥ 10mm), with an increase of at least 
10mm, as per American Thoracic Society (ATS) and Centres for Disease 
Control (CDC) standards(American Thoracic Society, 2000). 
 
TST reversion 
 A positive TST at baseline (≥10 mm) which becomes negative upon 
retesting (< 10 mm induration) 1 year later. 
 
QuantiFERON Gold-in-tube (QFT-GIT) conversion 
A QFT-GIT conversion was represented by a baseline interferon-gamma 
(IFN-γ)<0.35 IU/ml and follow-up IFN-γ>0.35 IU/ml.  
 
 
TSPOT.TB conversion 
A conversion was represented by a negative test (<6 spots increment in 
Panels A and B) at baseline changing to a positive test (>6 spots increment 
in either Panel A or B) on follow-up testing. 
 
IGRA reversion 
A change from a positive IGRA at baseline to a negative IGRA at follow-up. 
 
10
 Employment sector 
This refers to the employer group who is responsible for delivery of health 
care and support services and provides employment to health care workers. 
Employees were categorized as belonging to four employment sectors viz. 
the Provincial health department, the local authority health department, non-
governmental organizations or other (usually support services such as 
security which is outsourced)  
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CHAPTER 2 
 
2.1 BACKGROUND AND REVIEW OF THE LITERATURE ON 
TUBERCULOSIS IN HEALTH CARE WORKERS IN HIGH BURDEN 
COUNTRIES 
 
In reviewing the literature on TB infection and disease risk in HCWs, a 
distinction has been made between estimates from low incidence TB settings 
(< 50 / 100 000 cases per year), intermediate setting (50 - 100 / 
100 000cases per year) and high TB incidence settings (≥ 100 / 100 000 
cases per year)(Zwerling et al., 2012; Baussano et al., 2011). Estimates from 
high TB burden countries  usually refer to the 22 countries identified by the 
World Health Organization as contributing the greatest caseloads to the 
global TB burden, accounting for 81% of cases in 2010(World Health 
Organization, 2011). Others have evaluated HCW TB risk by the socio-
economic status of their countries (using criteria defined by the World Bank), 
referring to low and middle income countries (LMICs) and high-income 
countries (HICs)(Menzies, Joshi & Pai, 2007; Joshi et al., 2006). These 
authors report that 90% of the global TB burden affects populations residing 
in LMICs and that HCW in high income countries generally have a very low 
occupational risk of TB. There is some overlap of these classifications as the 
high burden countries and LMICs include countries with either high or 
intermediate TB incidence rates. In reporting on these estimates in this 
thesis, as far as possible a distinction has been made between low and high 
TB incidence settings, as TB caseload is likely to differ considerably from 
setting to setting influencing the TB infection risk faced by HCWs. 
 
For the purpose of this review, a broad definition of health care worker is 
employed to include all those engaged in the support and delivery of health 
services at a selected health facility. This is in line with the approach adopted 
by the World Health Organization that proposes the inclusion of all those 
involved in the provision of health services, as well as management and 
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support workers, in such a definition. It furthermore includes subsectors of 
workers engaged in community-based and home-based care(WHO, UNAIDS 
& ILO, 2010; Oxlade et al., 2009). 
 
Whilst the primary focus of the thesis is on latent TB infection (LTBI), it is 
important to distinguish between LTBI and TB disease. In clinical practice 
LTBI is defined by the presence of an immunological sensitization to 
mycobacterial antigens in the absence of clinical signs and symptoms of 
active disease (Barry et al., 2009). As a consequence of this definition TB is 
commonly viewed as having a binary distribution – latent versus active 
disease.  TB disease or active TB would require a course of chemotherapy 
with standard treatment regimens in accordance with a country-specific 
national TB control programme. Individuals with LTBI who are considered at 
high risk of progression to active TB would be offered isoniazid prophylaxis. 
This simplistic view of TB, whilst useful in the clinical setting, does not 
accurately reflect the diverse range of clinical phenotypes which represents 
the spectrum of LTBI. These may include individuals who have completely 
“cleared the infection to those who are actively replicating TB organisms” 
without clinical manifestation of disease.  Active TB has also been shown to 
have “diverse pathological manifestations in both animal and human studies 
ranging from sterile tissues to liquefied cavities with large numbers of 
replicating organisms” (Barry et al., 2009: 846). To arrive at a more complete 
understanding of TB infection Barry et al (2009) propose that LTBI and active 
TB be viewed as part of a continuous spectrum of TB infection. Increasingly 
research is focused on trying to ascertain at which point of the spectrum the 
risk of progression from latent to active TB is highest. Preventative therapy 
should then be targeting this high risk group as part of TB control efforts. 
 
Health care workers (HCWs),as a high risk occupational group, find 
themselves at the forefront of the dual epidemics of TB and HIV. It is well 
recognized that they have an increased risk of contracting tuberculosis on 
account of their occupational exposure to tubercle bacilli(Baussano et al., 
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2011; Menzies, Joshi & Pai, 2007; Joshi et al., 2006).Furthermore this risk 
has been demonstrated to be greater among health care workers in LMICs 
which account for 90% of the global TB burden. Due to limited resources and 
the magnitude of the TB caseload in such countries, resources tend to be 
focused on community case-finding and implementation of the directly 
observed treatment supervision (DOTS) strategy. There is therefore little 
focus on prevention of TB in HCWs or the implementation of interventions 
aimed at reducing TB transmission in health care facilities(Farley et al., 2012; 
Naidoo, Seevnarain & Nordstrom, 2012; Kasprowicz et al., 2011; Harries, 
Maher & Nunn, 1997). 
 
HCWs in high TB-incidence countries are at risk of contracting TB in their 
dual role as carers to those who have contracted TB and by virtue of 
belonging to communities where TB is highly prevalent. Whilst they are 
considered a high-risk occupational grouping for contracting TB, there is 
limited research that attempts to describe and quantify their risk in this 
regard. There is, however,  a growing recognition globally that the increasing 
impact of TB and HIV on healthcare workers in such settings could have a 
profoundly negative influence on the success of important public health 
programmes and the capacity of  health systems to respond effectively to the 
TB and  HIV epidemics. To address this problem a Policy Guideline to 
promote access to care for HCWs with a specific focus on TB and HIV has 
recently been published (WHO, UNAIDS & ILO, 2010). The Joint WHO‐ILO‐
UNAIDS Policy Guidelines on Improving Health Workers’ access to HIV and 
TB prevention, Treatment, Care and Support Services outlines fourteen 
recommendations which require action with regard to policy, workplace 
practices, budget and monitoring and evaluation. It promotes the 
strengthening of occupational health policy to better protect health care 
workers and advocates regular screening, improved infection control, access 
to prophylactic and effective treatment for those at risk of or infected with TB 
and HIV.  
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Whilst the lack of progress in implementing TB prophylactic treatment in high 
incidence countries is primarily due to a lack of resources, there are also 
limited data to provide reliable estimates of TB infection risk in HCWs in such 
settings. Furthermore the available tools have suboptimal sensitivity in 
accurately diagnosing those with recent TB infection, in discriminating 
between latent and active TB and in identifying those at highest risk of 
progression from latent to active TB disease (Kasprowicz et al., 2011). The 
deficiencies are further complicated by the lack of a gold standard for the 
diagnosis of LTBI, making it difficult to interpret results from screening 
programmes of high risk groups such as health care workers.  
 
 
2.2 THE EPIDEMIOLOGY OF LATENT TB INFECTION AND TB 
DISEASE IN HEALTH CARE WORKERS IN HIGH BURDEN 
SETTINGS 
 
Prevalence and incidence of LTBI 
 
Low TB incidence settings 
 
In low TB incidence countries such as the United States the risk of TB 
infection and disease in HCWs declined in tandem with a declining incidence 
of TB in the general population (Harries, Maher & Nunn, 1997). Following 
several outbreaks of MDR TB among HCWs in the US between 1985 and 
1993, renewed focus was placed on the implementation of preventative 
strategies and infection control measures to reduce nosocomial transmission 
of TB (Jensen et al., 2005).  
 
A review of TB infection prevalence in HCWs from high-income countries, 
which are generally associated with low TB incidence settings, demonstrated 
a median LTBI prevalence of 24% (4 – 46%) in HCWs. This is almost a third 
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of the estimate for HCWs in LMICs(Menzies, Joshi & Pai, 2007). Similarly the 
LTBI incidence in HCWs in low TB incidence countries at 2.9% (IQR 1.8 %-
.8.2%), equates to less than half the incidence in high-TB incidence countries 
(Baussano et al., 2011).  In low TB incidence settings the implementation of 
targeted surveillance and prevention of tuberculosis transmission among 
HCWs have been shown to decrease the overall risk of tuberculosis infection 
among HCWs(Baussano et al., 2007). 
 
Intermediate and high TB incidence settings 
 
A systematic review of 51 studies by Joshi et al (2006: 2381-2382) estimated 
the burden of tuberculosis among HCWs working in LMICs. The prevalence 
of  LTBI among HCWs was found to range from 33 % to 79%, with more than 
half of HCWs infected with TB in many settings. In this review LTBI incidence 
was measured in six studies only, which showed an annual risk of infection 
ranging from 3.9% to 14.3%, with the risk attributable to occupational 
exposure ranging from 2.6% to 11.3%. This suggests that most cases of TB 
infection in HCWs are attributable to occupational exposure. A more recent 
review by Baussano et al (2011) estimated the median incidence of LTBI in 
HCWs in high incidence countries to be 7.2%(IQR 4.1% - 14.3%), but makes 
no distinction between occupational and non-occupational infection. 
 
Several other studies have evaluated LTBI prevalence among HCWs in 
intermediate and high incidence TB countries such as India, Russia, China, 
Thailand, Vietnam and Brazil (Christopher et al., 2010; He et al., 2010; Lien 
et al., 2009; Drobniewski et al., 2007; Pai et al., 2005; Roth et al., 2005; 
Yanai et al., 2003; Do et al., 1999). These studies have found the prevalence 
of LTBI as measured by TST or Interferon-gamma release assays (IGRAs) to 
vary between 40-70% and to be higher than that found in the general 
population. In Africa very few studies have been conducted to evaluate LTBI 
prevalence and risk factors in HCWs. This is due to a limited focus on LTBI 
diagnosis and treatment, given the magnitude of the TB burden in many 
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African countries and the limited resources available for testing. A study of 
HCWs in Cote  d’ Ivoire reported a LTBI prevalence of 79% , whilst one in 
Ugandan HCWs found the LTBI prevalence to be 57%(Kayanja et al., 2005; 
Kassim et al., 2000). 
 
In South Africa the treatment of LTBI in the general population is limited to 
those considered to be at high risk of progression to active disease, such as 
HIV-infected individuals, children under the age of five years and individuals 
with silicosis (de Jager et al., 2014; National Department of Health South 
Africa, 2009). Until very recently there has been no clear guideline that 
specifically addresses LTBI in HCWs (Tshitangano, 2013). 
 
Studies of HCWs from high TB incidence countries display considerable 
heterogeneity due to differences in methodological quality, study design, 
sampling strategy and populations sampled(Baussano, 2011: 493).This 
heterogeneity is reflected in the suboptimal precision of estimates generated 
to reflect TB infection risk in HCWs. In the absence of effective 
implementation of large scale surveillance and TB screening programs of 
HCWs in high burden countries, arriving at an accurate estimate of TB 
infection risk of HCWs, remains elusive. 
 
Risk factors associated with latent TB infection in health care workers 
 
Few studies have tried to identify the host or occupational and environmental 
risk factors associated with increased susceptibility to TB infection in HCWs.  
 
Low TB incidence settings 
 
In HCWs from high income countries the prevalence of LTBI as 
demonstrated by a positive TST is consistently associated with non-
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occupational factors such as older age, foreign birth, and previous BCG 
vaccination(Menzies, Joshi & Pai, 2007).Occupational factors that show 
variable association with LTBI are years of work in health care, working in 
internal or respiratory medicine and increased exposure to TB patients. Most 
studies evaluating LTBI incidence have been conducted in the US, with 
incidence rates substantially higher than that of the general population at 1% 
(0.2% – 12%). LTBI incidence in such settings is positively associated with 
increased risk of exposure (high numbers of TB patients) and an absence of 
infection control measures. The imprecision of LTBI incidence estimates may 
in part be due to the inclusion of study settings with variable TB infection 
rates and differences in testing protocols and definitions of conversion 
employed for LTBI.   
 
Intermediate and high TB incidence settings 
 
In LMICs  the prevalence of LTBI has been found to be positively associated 
with increasing age and duration of employment in a health care facility. 
Similar associations have been demonstrated in studies from intermediate 
and high incidence countries such as India, Russia, China, Thailand, 
Vietnam and Brazil(Christopher et al., 2010; He et al., 2010; Lien et al., 2009; 
Drobniewski et al., 2007; Pai et al., 2005; Roth et al., 2005; Yanai et al., 
2003; Do et al., 1999). In addition, the prevalence of LTBI has been found to 
be to be consistently associated with occupational TB exposure, 
occupational category and variably associated with BCG vaccination and 
male sex. With regard to occupational category, several studies have 
reported a higher prevalence of LTBI in nurses than in other HCWs (Joshi et 
al., 2006).Additional independent occupational predictors of LTBI are working 
in medical wards, participation in procedures such as sputum collection and 
performance of autopsies, and a history of contact with TB patients. A study 
of Ugandan HCWs found LTBI prevalence to be positively associated with 
employment location and older age (Kayanja et al., 2005).A recent study 
among South African HCWs and medical students in Johannesburg found 
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significant differences in LTBI prevalence between the two groups, with 
HCWs displaying a two to fourfold increase in LTBI prevalence compared to 
medical students ( 56.7% v. 26.6% TST positive; 69.2% v.15.2% IGRA 
positive) (van Rie et al., 2013). This suggests that occupational exposure to 
TB and/or duration of employment may be important risk factors for LTBI. 
 
Prevalence and incidence of TB Disease 
 
TB disease is characterized by signs and symptoms of infection and / or 
microbiological or radiological evidence of disease. TB disease is considered 
to represent part of the TB infection spectrum which extends from sterilizing 
immunity through to fulminant active disease(Barry et al., 2009). In the 
absence of a gold standard to evaluate diagnostic test performance for LTBI, 
TB disease has been used as a proxy gold standard for LTBI, in order to 
evaluate test sensitivity. The assumption is that LTBI must be present 
concurrently or have preceded the development of TB 
disease.“Geographically LTBI prevalence mirrors that of TB disease with the 
highest prevalence of infection found in high TB disease burden regions such 
as Sub-Saharan Africa and the Indian subcontinent”(Kasprowicz, 
2011:S1169).  
 
Low TB disease incidence settings 
 
Studies of TB disease risk in HCWs in high income countries have produced 
highly variable estimates, with most studies relying on TB case registries to 
describe TB associated morbidity and mortality.“The best-designed studies 
have demonstrated a two to threefold increased risk of TB disease among 
HCWs when matched for employment and socio-economic status with the 
general population” (Menzies, 2007: 600). This is more pronounced in 
younger HCWs. The median incidence of TB disease among HCWs was 
estimated to be 67/100 000 and 91/ 100 000 in low and intermediate TB 
incidence countries respectively. Comparison to TB incidence rates in the 
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general population have yielded an incidence rate ratio (IRR) of 2.0 and 1.4 
respectively (Baussano et al., 2011). 
 
Intermediate and high TB disease incidence settings 
 
Tuberculosis disease incidence among HCWs from LMICs has been found to 
be generally higher than in the general population. The estimated incidence 
due to nosocomial exposure ranges from 25 – 5361/100 000 per year. 
Baussano et al (2011) in reviewing TB disease among HCWs in high 
incidence countries estimated the median incidence of TB disease to be 
1180/100 000 (IQR 91 – 3.222) which is fivefold greater than the median TB 
incidence rate in the population [IRR 5.4; IQR 1.7 -9.1]. The percentage of 
cases attributable to exposure in health care settings was estimated to be 
81%. 
 
Several studies have been conducted to evaluate TB disease in HCWs in 
Africa but have not reported on the potential role of occupational factors in 
contributing to their TB disease risk. In Malawi HCWs were found to be at 
greatly increased risk of all types of TB disease (IRR 11.9; 95% CI 9.5 -17.7) 
in a study conducted at 40 hospitals.  The annual incidence of treated TB 
cases among this sample of HCWs was 3.6% (Harries et al., 1999). TB was 
also cited as an important cause of death among HCWs in urban areas in 
Malawi, accounting for 47% of deaths in one study(Harries et al., 2002). In 
Nigeria a study of hospital-acquired TB showed clinical staff to be at highest 
risk among HCWs of contracting occupational TB, with HIV co-infection 
being present in 47% of cases. Female prevalence was double that of 
males(Salami & Oluboyo, 2008).  Similarly a Mozambican study highlighted a 
reported TB and HIV prevalence among staff of 21% and 28%, respectively 
(Casas et al., 2011). 
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Several studies have been conducted in different groups of South African 
HCWs to determine the prevalence and /or incidence of TB disease and 
evaluate factors associated with increased risk of contracting tuberculosis 
(Table 2.1).A study based on a record review of staff health records between 
1986 and 1997 from four dedicated TB centres in Mpumulanga, South Africa, 
concluded that HCWs were not at increased risk of TB when compared to 
the general population (Balt, Durrheim & Weyer, 1998: 363). Wilkinson and 
Gilks (1998: 501) similarly demonstrated a lower incidence of TB among staff 
at a South African district hospital when compared to the general population 
during the same period. However this study demonstrated an increasing 
incidence of TB among health care workers which was attributed to the rising 
HIV epidemic during this period. 
 
More recent studies, however, have shown the opposite association. In a 
retrospective cohort study which involved staff from eight regional hospitals 
in Kwazulu Natal, Naidoo and Jinabhai (2006:679) demonstrated a 
consistently higher incidence of TB in health care workers than the general 
population, with a median incidence of 1133/ 100 000. A substantial 
proportion of the cases (23.5%) presented with extra-pulmonary TB and 3% 
were diagnosed with multi-drug resistant TB. A recent screening programme 
of health care workers employed as adherence counselors and support staff 
in TB programmes located in the Western Cape demonstrated a TB and HIV 
prevalence of 5% and 20% respectively(Kranzer et al., 2010:224). This 
represents a five-fold increase in TB prevalence when compared to the 
general population, suggesting that these lay health care workers are at 
greatly increased risk of contracting TB. Similarly, the Desmond Tutu TB 
Centre has demonstrated a twofold increase in TB incidence in a small 
cohort of health care research workers compared to the general population 
(Claassens et al., 2010:1578).This suggests that HCWs are at increased risk 
of TB due to occupational exposure. 
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The emergence of extensively drug-resistant (XDR) tuberculosis has 
aggravated the occupational risk faced by HCWs in South Africa (Jarand et 
al., 2010; O'Donnell et al., 2010). HCWs in KZN were shown to have a 
fivefold increased risk of being hospitalized for multidrug resistant (MDR) TB 
(5.46, 95%CI 4.75 – 6.28) and a near sevenfold increased risk of being 
hospitalized for XDR TB (6.69, 95% CI 4.38 – 10.20) relative to the general 
population. They were also less likely to report previous TB treatment than 
the general population and had a similar HIV positive prevalence. This 
evidence strongly points to occupational exposure as a contributing risk 
factor to drug resistant TB in HCWs.   
 
A recent large study evaluating infection control measures at primary care 
facilities in five provinces of South Africa found the standardized incidence 
ratio for smear positive TB disease in HCWs to be double that of the general 
population(Claassens et al., 2013).HCWs have been shown to have HIV 
infection rates which approximates that of the general population ranging 
from 11 – 20% among HCWs in SA (Table 2.2)(Kranzer et al., 2010; 
Connelly et al., 2007; Shisana et al., 2004).Given these high rates of HIV 
infection coupled with occupational exposure to tuberculous bacilli and high 
background prevalence of TB disease in the community, there are likely to 
be many HIV-infected HCWs in South Africa with recent LTBI and therefore 
at considerable risk of progressing from LTBI to active TB disease. 
 
Risk factors associated with the development of TB disease 
 
Several risk factors have been identified as being associated with the 
progression from LTBI to TB disease. These arewell-established risk factors 
such as HIV co-infection, malnutrition and young age. Diabetes mellitus, 
heavy alcohol intake or problem drinking and smoking, iatrogenic 
immunosuppression and indoor air pollution are considered emerging risk 
factors(Narasimhan et al., 2013; Kasprowicz et al., 2011). For these reasons, 
in TB control programmes, LTBI testing has been limited to those considered 
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at highest risk of developing TB disease. In South Africa, such interventions 
are primarily aimed at children under the age of five years, high-risk TB 
contacts, HIV-co-infected individuals and silicotic individuals. 
 
There has been less focus on identifying occupational and environmental risk 
factors associated with the development of TB disease. Whilst it is known 
that certain occupations, such as HCWs and mineworkers, face an increased 
risk of developing TB disease, few studies have investigated the relationship 
between occupational and environmental exposures and TB risk in high 
burden settings.  In the South African mining sector, resources are being 
devoted to research and interventions to address the epidemic of silicosis 
and tuberculosis, especially since the emergence of HIV, which has greatly 
increased TB rates among mineworkers(Dharmadhikari et al., 
2013).Increasingly too, efforts are being focused on the diagnosis and 
treatment of LTBI among mineworkers in an attempt to improve TB control in 
this high risk population and reduce TB disease incidence(Churchyard et al., 
2014; Lewis et al., 2013; Fielding et al., 2011).This has culminated in the 
recent development of a clinical guideline on isoniazid preventive therapy for 
patients with silicosis in South Africa(de Jager et al., 2014). 
 
There is similarly an increasing awareness of the need for improved 
protection of HCWs, but there has been limited and fragmented 
implementation of programmes to adequately protect HCWs in South Africa 
(Naidoo et al., 2013; Adams et al., 2012; Naidoo, Seevnarain & Nordstrom, 
2012; Zungu & Malotle, 2011). Whilst the high rate of TB among SA HCWs is 
indicative of a substantial occupational transmission risk, the effectiveness of 
tools to evaluate infection control practices at primary care clinics in SA is not 
proven. This suggests that there is a need for such evaluation tools to be 
tested and validated for local high burden settings (Claassens et al., 
2013).TB prevention programmes for HCWs will need to be informed by 
accurate estimates of TB infection and disease prevalence and incidence 
and a complete understanding of occupational and environmental risk factors 
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associated with increased transmission of tuberculous bacilli in healthcare 
settings. 
 
Low TB incidence settings 
 
In addition to well-known host factors of which HIV co-infection is the most 
important,  several studies from low TB burden settings have highlighted 
occupational risk factors as contributing to TB disease incidence in HCWs. 
Specific occupations, shorter duration of employment and occupational 
location characterized by increased exposure to TB patients have been 
associated with greatly increased risk of TB disease in HWCs in several 
studies (Skodric-Trifunovic et al., 2009; Jo et al., 2008; Sotgiu et al., 2008; 
Hosoglu et al., 2005; Cuhadaroglu et al., 2002; Babus, 1997).Occupational 
titles were not uniform across all studies, and differed by study setting, 
making direct comparisons difficult. Most studies, however, showed nurses 
and staff with direct exposure to TB patients such as pulmonologists to have 
an increased risk of LTBI, compared to other HCWs.  
 
Some studies from low burden settings have shown TB incidence rates to be 
similar to that of the general population. The authors of a review on 
tuberculosis risk in HCWs argue that comparison to the general population 
may underestimate the contribution of occupational exposure (Menzies, 
Joshi & Pai, 2007). This on account of HCWs higher socio-economic status, 
being younger in age and healthier than the general population (on account 
of the healthy worker effect), which should result in them having a lower 
background risk of TB disease. The excess risk may therefore plausibly be 
attributed to occupational exposure. Baussano et al (2011) estimates that 
49% of TB cases of TB in HCWs in low incidence countries are attributable 
to exposure in health care settings. 
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Intermediate and high incidence TB disease settings 
 
TB disease in HCWs has been positively associated with low HCW: TB 
patient ratio as well as with certain locations and occupational categories 
within health facilities(Joshi et al., 2006).Associations with occupational 
category have been shown in countries such as China where medical staff 
had a higher TB prevalence than administrative staff (6.7/1000 v. 
2.5/1000)(He et al., 2010). Russian HCWs in Samara Oblast similarly were 
found to have a tenfold increase incidence of TB disease when compared to 
the general population, with staff in the TB services at greatest risk(Dimitrova 
et al., 2005). HCWs at a university hospital in Brazil showed high rates of 
extra-pulmonary TB (48%) (do Prado et al., 2008).In Thailand the TB disease 
incidence rate of HCWs within a large hospital setting was positively 
associated with work site (emergency room) and occupation 
(nursing)(Jiamjarasrangsi, Hirunsuthikul & Kamolratanakul, 2005).In a study 
of hospital staff in Kenya strong associations were demonstrated between 
TB disease in HCWs and occupational exposure even after controlling for 
living conditions(Galgalo et al., 2008). In Indian HCWs low body-mass index 
(BMI), frequent contact with patients and employment location in the medical 
wards or microbiology laboratories were found to be independently 
associated with increased risk of acquiring TB (Mathew et al., 2013). 
 
Studies from South Africa have evaluated risk factors for TB disease in 
HCWs, focusing mainly on host and not occupational determinants. One 
study highlighted the increasing incidence of TB disease in tandem with the 
growing prevalence of HIV infection(Wilkinson & Gilks, 1998).Naidoo and 
Jinabhai (2006) similarly showed an increasing incidence of TB among 
HCWs with younger age-group and paramedical staff having the highest TB 
incidence rates. In KZN. HCWs with drug-resistant TB (MDR-TB or XDR-
TB)were mainly female (78%), of younger age (median age,35 years), with a 
high percentage of HIV infection among those tested (67%)(O'Donnell et al., 
2010). In another study evaluating the impact of infection control measures 
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at primary care facilities, TB disease risk was similar for HCWs in primary 
care and those in hospital-based settings (Claassens et al., 2013). 
 
Studies among HCWs in South Africa, as elsewhere, have been conducted 
with fairly small sample sizes on select groups of HCWs and have been 
conducted in specific localities. These deficiencies limit their generalizability, 
i.e. they do not provide a representative estimate with good precision of TB 
risk of HCWs in South Africa. This limitation is further compounded by the 
varying prevalence of TB within different regions of the country. However, all 
the studies with the exception of those performed by Balt and Wilkinson 
show that HCWs in South Africa, as elsewhere, face a greater risk of TB 
infection and disease than the general population. The factors associated 
with such risk are poorly understood and the role of occupational and 
environmental factors in driving TB infection and disease rates in HCWs has 
not been elucidated. Identification of those factors is necessary for the 
implementation of targeted interventions in the future that is aimed at 
decreasing HCWs risk to TB infection and disease in high burden settings. 
 
 
 
 
 
 
 
 
 
 
 
33
  
Table 2.1 Incidence estimates from studies conducted among South African health care workers to evaluate their risk of tuberculosis compared to 
that of the general population 
 
Study author (year)  year   N  Estimates of TB incidence  Risk ratio (95% CI)  
          
 
 
Balt (1998)   1986 - 1997  726*  275 / 100 000    1.0 
  
Wilkinson (1998)  1991 - 1996  388  558 / 100 000    0.4 
           
Naidoo (2006)   1999   3711  1024 / 100 000    2.7 
 
    2000   3819  1206 / 100 000    3.8 
 
    2001   4807  834 / 100 000    1.9 
 
    2002   6887  945 / 100 000    1.7 
 
    2003   8445  1149 / 100 000    1.5 
 
    2004   4226  1641 / 100 000    - 
 
         1133 / 100 000** 
 
 
Claassens (2008)  2005 - 2007   180  4477 / 100 000    2.3  
 
Claassens (2013)  2006   1439  834 / 100 000    2.4 (1.2 – 2.4) 
 
    2007   1649  1 092 / 100 000    3.0 (1.8 – 4.7)  
    
    2008   1917  887 / 100 000    2.3 (1.3 – 3.7)    
                
 
N= number of health care workers observed during study period. 95% CI=95% confidence interval and is only provided if quoted in the study. Risk ratio is calculated by dividing the incidence of TB 
in HCWs by the incidence in a community-based reference population. 
* Measured as nursing years; ** Median incidence over the time period of the study    
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Table 2.2 HIV prevalence among South African health care workers  
 
 
Study author (year)    n     HIV prevalence (95% CI)   
 
 
Shisana (2004)     595     15.7% (12.2 -19.9) 
 
Connely (2007)     2032     11.5% 
 
Kranzer (2010)     215     20% 
 
Van Rie (2014)     199     11% 
 
n=sample size.95% CI=95% confidence interval and is only provided if quoted in the study. 
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2.3 AGREEMENT BETWEEN IGRA ASSAYS AND TST AND A 
COMPARISON OF TEST PERFORMANCE USING LATENT CLASS 
ANALYSIS 
 
It is estimated that one third of the world’s population is latently infected with 
TB. (Dye et al., 1999) This large reservoir of infected individuals are at 
increased risk of developing active TB. Estimates based on the natural 
history of TB suggest that 5% of infected individuals will progress to active 
TB within the first 2 years following initial infection. Immune competent 
infected individuals have a lifetime risk of 5 - 10% for developing TB (Lalvani 
& Pareek, 2010).The diagnosis and treatment of LTBI are increasingly being 
recognized as an important strategy to aid tuberculosis control worldwide 
(Chee et al., 2013). 
 
Groups at high risk of progression have been identified as; 
immunocompromised individuals, young children, those with recent TB 
infection and high risk occupational groups such as health care workers and 
mineworkers. Whilst programmes of targeted LTBI diagnosis and treatment 
are routinely implemented in low TB incidence countries, this has been far 
more difficult to implement in high TB incidence countries (Kasprowicz et al., 
2011). Recent strategies proposed by WHO especially relevant to South 
Africa, which accounts for a quarter of the global burden of HIV-associated 
TB, include intensified case-finding (ICF), improved TB Infection control, 
provision of antiretroviral therapy (ART) and isoniazid preventative therapy 
(IPT) (World Health Organization, 2008).  Whilst large-scale ART 
programmes have been rolled out throughout Africa, there has been less 
focus on infection control and IPT. This is in part due to the limitations of 
existing tools to diagnose LTBI and identify those individuals at most at risk 
of progression to active disease (Kasprowicz et al., 2011). 
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Diagnosis of latent TB infection 
 
Globally the diagnosis of LTBI has primarily been made using the tuberculin 
skin test (TST). The past decade has seen the development of novel 
diagnostic tests for LTBI, in the form of interferon-gamma release assays 
(IGRAs). A large body of evidence has accumulated as researchers have 
focused on their utility in diagnostic programmes. These include serial 
screening of high risk populations such as health care workers in order to 
implement targeted IPT. However, very little research has been conducted 
among HCWs to evaluate test performance and utility in  high burden 
settings (Zwerling et al., 2012). 
 
Tuberculin skin test 
 
Test properties and immunology 
 
The TST has been around for more than a century and until fairly recently 
the diagnosis of LTBI globally has been made using only this test(Chee et 
al., 2013; Lalvani & Pareek, 2010). A positive skin test in the absence of 
symptoms or signs of clinical disease is considered diagnostic of LTBI. The 
TST detects a delayed hypersensitivity to purified protein derivative (PPD) in 
the form of a skin reaction. PPD constitutes a mix of over 200 M. 
Tuberculosis proteins. This renders it susceptible to cross-reactivity with 
bacille Calmette- Guerin (BCG) and several species of environmental 
mycobacteria, diminishing its specificity. It also has suboptimal sensitivity in 
anergic individuals such as those who are HIV-infected or those on 
immunosuppressive medication, leading to a high rate of false negatives. 
The TST measures a cellular immune response which manifests as a skin 
induration 48-72 hours after intradermal inoculation with PPD. It requires 
trained personnel to administer and read the TST and two visits within the 
required time to obtain the result. These logistic requirements in part have 
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contributed to low uptake of TST in resource poor countries despite the 
affordability of the test. 
 
Test performance 
 
The lack of a gold standard for LTBI has also complicated the interpretation 
of TST test performance. In evaluating sensitivity of TST, active TB has been 
used as a proxy measure for LTBI, as it is assumed that LTBI must be 
present for active TB to develop. This is less than ideal as it is known that 
with overwhelming infection with TB bacilli and HIV co-infection, cellular 
immunity may be impaired leading to a falsely negative TST. Furthermore 
TST is not able to discriminate between LTBI and active TB.  
 
A further reason for low programmatic uptake is that some authorities have 
considered TST to have  suboptimal test performance. TST sensitivity has 
been estimated to range from 70%-80% in community based studies, which 
excluded high risk occupational groups, using active TB as a surrogate for 
LTBI(Menzies, Joshi & Pai, 2007). The specificity of TST has been evaluated 
in populations at very low risk for LTBI and has ranged from 56% in BCG 
vaccinated to 98% in non- BCG vaccinated individuals.  
 
TST may also be subject to boosting when used in serial screening, making 
it difficult to discriminate between true conversion or new infection and 
immune priming as a consequence of antecedent TST administration. Serial 
administration of TST has also resulted in larger positive TST skin reactions 
on follow-up testing(Menzies, 1999;Mandalakas et al., 2008; French et al., 
2006). Boosting typically manifests as increased tuberculin reactions upon 
retesting in the absence of new infection. It is believed to result from recall of 
waned cell-mediated immunity. The boosting effect is maximal if the interval 
between the first and second test is between 1 and 5 weeks, but has been 
shown to be present one or more years after a first negative tuberculin test. 
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In low burden countries, the prevalence of boosting is common in foreign-
born, elderly individuals and BCG-vaccinated populations.TST positivity is 
also considered to be a reflection of cumulative exposure and does not 
always correlate well with recent exposure especially in BCG vaccinated 
populations. This feature renders it less useful as a tool for contact tracing 
and outbreak investigations because of the risk of false positives(Menzies, 
Pai & Comstock, 2007). 
 
Test utility 
 
Despite these drawbacks TST does have some predictive value as recent 
LTBI, reflected in TST conversion, has been associated with a 5% risk of 
progression to active TB in the first 2 years following infection. In addition 
those with LTBI have a lifetime risk of  5% -10 % of developing active 
TB.(Blower et al., 1995;Lalvani & Pareek, 2010). The risk is greatly increased 
in individuals who are HIV positive and disease progression rates are 
estimated at 3.5–16.2 % per person-year of observation in HIV positive 
contacts of index cases in LMICs(World Health Organization, 2012).TST 
positivity is also associated with IPT benefit as HIV-infected individuals with a 
positive TST have been shown to have a greater reduction after IPT in 
subsequent risk of developing TB disease than those with negative TST 
(Akolo et al., 2010). 
 
Interferon- gamma release assays 
 
Test properties and immunology 
 
Two new T-cell-based assays have been developed for diagnosing LTBI and 
have been commercially available in recent years (Menzies, Pai & Comstock, 
2007: 340). The one test is an enzyme-linked immunosorbent assay (ELISA), 
the QuantiFERON-TB Gold-in –tube (QFT-GIT) (Cellestis Ltd, Carnegie, 
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Australia) which measures the production of antigen-specific interferon-
gamma (IFN- γ) by circulating T-cells in whole blood. The other is the T-
SPOT.TB (Oxford Immunotec, Oxford, UK)which uses an Elispot technique 
to measure peripheral blood mononuclear cells (PMBCs) that produce IFN-γ. 
Both assays are characterized by the use of more specific M. Tuberculosis 
antigens – the early secretory protein-6 (ESAT-6) and the culture filtrate 
protein-10 (CFP-10)  which are encoded by genes found in the region of 
difference (RD1) on the M.tuberculosis genome. These genes are not 
present in the genome of M.bovis BCG or certain non-tuberculous 
mycobacteria such as M.avium. resulting in improved specificity of the tests 
and equivalent sensitivity when compared to TST. IGRAs do however come 
at a higher cost than TST, a requirement for good laboratory infrastructure 
and are invasive (requires the taking of blood samples), all of which may 
serve as barriers to their practical uptake in low-resource settings.    
 
Test performance 
 
Results from meta analyses show IGRAs to have very good specificity, 
unaffected by BCG vaccination, for LTBI diagnosis whilst T-SPOT.TB has 
superior sensitivity over TST and QFT-GIT for TB disease(Pai, Zwerling & 
Menzies, 2008; Diel, Loddenkemper &Nienhaus, 2010).The pooled 
sensitivity of T-SPOT.TB has been reported as 90% (86-93%) which is 
superior to that of QFT-GIT at 70% (64 – 93%), using active TB as a 
surrogate marker for LTBI. Estimates of pooled specificity have been 
reported as 96% (94 – 98%) for the QFT-GIT and 93% (86 – 100%) for the 
TSPOT.TB (including its pre-commercial ELIspot version).The meta analyses 
have in the main been based on studies conducted among BCG vaccinated 
individuals at low risk for LTBI, in low TB incidence countries. 
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Test Utility 
 
IGRAs have certain advantages over the TST in that they are in vitro tests. 
This feature reduces the risk of potential adverse effects and eliminates the 
effect of boosting. These advantages together with superior test qualities 
make them ideal for serial screening of high risk populations such as health 
care workers. They have thus been recommended for incorporation into LTBI 
screening guidelines in both the United States (USA) and the United 
Kingdom (UK) (Mazurek et al., 2010; National Institute for Health and Clinical 
Excellence (NICE), 2006; Mazurek et al., 2005). The Centers for Disease 
Control (CDC) have recommended that QFT may replace TST in the 
diagnosis of LTBI in certain instances, whilst the UK’s National Institute for 
Clinical Excellence (NICE) has recommended the use of IGRAs as an 
adjunct to TST for the diagnosis of LTBI.  
 
Preliminary studies evaluating the use of IGRAs in screening programmes in 
low TB incidence settings have suggested that such a strategy is cost-
effective. This on account of superior sensitivity and specificity which may 
substantially decrease the number of individuals needing further investigation 
and IPT following screening for LTBI(Nienhaus et al., 2011). Whilst the 
screening costs associated with IGRA testing may be considerable initially, 
this is offset by the reduction in post-screening costs through better targeted 
implementation of IPT.  
 
In the absence of a gold standard for LTBI, comparison of diagnostic 
performance between TST and IGRAs has relied on the use of surrogate 
markers for LTBI. These have included the presence of active TB, degree of 
exposure to infectious cases and to assess specificity, the presence of IGRA 
negativity in low risk populations (healthy BCG vaccinated individuals with no 
risk factors for TB disease) (Lalvani & Pareek, 2010).Using degree of 
exposure to TB as a surrogate for LTBI, both IGRA assays have been shown 
to agree at least as well with TB exposure as the TST.This has rendered 
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IGRAs useful for outbreak and contact tracing investigations in low burden 
settings.  
 
Preliminary research has also suggested that IGRAs may be less affected by 
anergy and therefore more suitable for the screening of 
immunocompromised individuals, especially those who are HIV-infected and 
at high risk of progression to TB disease (Lalvani & Pareek, 2010). A recent 
review of the utility of IGRAs for the diagnosis of LTBI in HIV-infected 
showed T-SPOT.TB to be less affected by immunosuppression than QFT 
and TST. However, IGRAs were not consistently more sensitive than TST in 
studies that were based on direct comparison between IGRAs and TST in 
the same sample(Cattamanchi et al., 2011). 
 
There is also no consistent evidence that either IGRA is more sensitive than 
TST for the diagnosis of active tuberculosis. Currently neither the TST nor 
IGRAs are considered to have value for active tuberculosis diagnosis in 
adults, especially in the presence of HIV co-infection (Metcalfe et al., 2011; 
Ling et al., 2011). 
 
Utility in high TB incidence settings  
 
Whilst very few studies have been performed utilizing IGRAs for LTBI 
diagnosis in HCWs in high TB burden settings, preliminary evidence from 
both community and occupational studies have suggested that IGRA 
performance is different in such settings and that IGRAs may have  
suboptimal sensitivity for the detection of LTBI (Zwerling et al., 2012; Dheda 
et al., 2009). 
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IGRAs have some predictive value for progression to TB disease which have  
varied according to risk groups (Chee et al., 2013).Reported estimates of 
progression from latent to active TB disease have ranged from 8% in HIV-
infected individuals and silicotics to 12.9% in close contacts of infectious 
cases (Chee et al., 2013). Whilst very few longitudinal studies have been 
conducted in high burden settings, a systematic review and meta analyses 
(inclusive of high burden settings and HCW studies)  that evaluated the 
predictive value of IGRAs for development of TB disease across  varied 
populations did not show IGRAs to have stronger predictive value for TB 
disease than TST (Rangaka et al., 2012).In contrast, a recent study has 
shown QFT conversion to be associated with an approximately 8-fold higher 
risk of progression to tuberculosis disease (than non-converters) in a cohort 
of adolescents in a high TB incidence setting in South Africa(Machingaidze 
et al., 2012). 
 
Comparison of TST and IGRAs  
 
Concordance studies among health care workers 
 
Many studies have been conducted in HCWs, predominantly in low TB 
incidence countries where LTBI testing of high risk populations such as 
HCWs form an integral part of the TB Control Programme. Head to head 
comparisons between TST and IGRAs have been done evaluating LTBI 
prevalence, test performance, association with TB exposure and active TB 
disease. Cost benefit analyses have also been carried out, leading to some 
countries adopting IGRAs as part of their diagnostic testing for LTBI. In 
contrast the evidence base from high incidence countries is very sparse, 
despite the fact that HCWs from such countries could benefit greatly from a 
diagnostic test that has greater sensitivity and specificity than TST and is 
relatively unaffected by immunosuppression and BCG vaccination. 
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Low TB incidence settings 
 
Studies among HCWs in low burden countries have generally revealed poor 
agreement between IGRA assays and TST (Swindells et al., 2009).A more 
recent review by Zwerling et al (2012: 64) have found that out of 25 studies 
that compared IGRA with TST, all but one  showed a lower prevalence of 
LTBI as measured by a positive IGRA (QFT or T-SPOT.TB) than that by 
TST. In 17 of these 24 studies a statistically significant difference was found 
in comparing test positivity. A higher prevalence of BCG vaccination in the 
study population was not necessarily associated with a higher prevalence of 
positive TST or a larger difference between the TST and IGRA test positivity.  
Concordance was generally weak between TST and IGRAs in these studies, 
with kappa (k) values ranging widely from 0.05 (in a study using a 12mm 
TST cut-off) to 0.56 (in a study using a 15 mm TST cut-off)among BCG-
vaccinated individuals. Three studies showed that agreement could be 
improved by employing a more stringent TST cut-off (i.e. 15 mm rather than 
10 mm). The predominant type of discordance in all studies that reported on 
discordance was that of TST+/IGRA- subjects. The prevalence of positive 
IGRA was lower than that of positive TST. This difference in prevalence was 
significant in studies from low and intermediate TB incidence settings. 
 
Intermediate and High TB incidence settings 
 
 
Only four studies have been performed that evaluated TST and QFT-GIT in a 
head-to-head comparison among HCWs in high TB incidence settings (Table 
2.3)(van Rie et al., 2013; He et al., 2012; Lien et al., 2009; Pai et al., 2005). 
These have showed fair to substantial agreement and an inconsistent 
association of BCG vaccination with such agreement. Three of the studies 
measured agreement between QFT and TST at varying cut-points for TST. 
Pai et al (2005)showed good agreement at a TST cut-point of 10mm but 
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poorer agreement when comparing QFT to a lower or higher than 10mm cut-
point for TST. A study of Chinese HCWs showed worsening of   agreement 
with increase in TST cut-point with best agreement occurring at a TST level 
of ≥ 5 mm. Among Indian HCWs, factors associated with discordance (TST 
+/ IGRA-) were increasing age, increasing years in health care and 
occupational category (attending physicians/ faculty vs. medical students), 
whilst BCG vaccination had no association with concordance. None of the 
factors remained significant following multivariate analysis (Pai et al., 2005).  
 
The above finding is in contrast to that in Vietnamese HCWs among whom 
Lien et al (2009) showed poorer agreement in BCG vaccinated than in non-
BCG vaccinated individuals (ƙ 0.29 vs. 0.55). Age, years in health care, type 
of hospital and BCG vaccination were associated with TST +/ IGRA - 
discordance, with BCG vaccination remaining a significant predictor of 
discordance following multivariate analysis(Lien et al., 2009). In a South 
African study more HCWs tested positive on IGRA than TST (69.2% vs. 
56.7) whilst medical students were more likely to test positive on TST than 
IGRA (26.6% vs. 15.2%)(van Rie et al., 2013).Factors associated with 
discordance were not reported in this study. 
 
Latent Class analysis 
 
In the absence of a gold standard for LTBI, studies have relied on clinical 
scenarios where the presence of a specific immune response to M. 
Tuberculosis is likely to serve as surrogate measures for true latent infection. 
These have included having active TB disease, a history of active TB or 
being a close contact of an infectious index case (Chee et al., 2013). 
Although these surrogate measure are not optimal as Tcell responses may 
frequently be absent, IGRAs have been shown to be well correlated with 
measures of exposure, with equivalent and in some cases superior 
sensitivity to TST. For specificity, analyses have focused on the performance 
of TST and IGRAs to detect an immune response in low risk settings and has 
45
  
shown IGRAs to have superior specificity especially in BCG vaccinated 
populations. The use of tests with dichotomous outcomes in the setting 
where no gold standard is available does, however, affect the accuracy of 
prevalence estimates generated by such tests as well as measures of test 
performance such as sensitivity and specificity.  
 
Latent class analysis is a statistical method that has been used to estimate 
prevalence and diagnostic test sensitivity in the absence of results from a 
perfect diagnostic test or gold standard. It therefore has particular application 
in the context where multiple tests may be used to determine disease status 
in the absence of a true gold standard as in LTBI(Dendukuri, Hadgu & Wang, 
2009; Pai et al., 2008). LCA modeling also allows for the consideration of 
conditional dependency as tests may not be independent of each other and 
may exhibit a degree of correlation, as between IGRA assays, which may 
affect estimates. To estimate the sensitivity and specificity of different 
diagnostic tests, latent class analysis is based on the premise that the results 
of various imperfect tests for the same condition are influenced by a common 
underlying latent variable, which represents the true disease status 
(Christopher et al., 2011; Christopher et al., 2010; Dendukuri, Hadgu & 
Wang, 2009; Pai et al., 2008). It therefore allows for a more direct 
comparison of test sensitivity and specificity in a given population. The 
availability of model-based techniques offers a more realistic approach to 
prevalence estimation that accounts for the imperfect nature of the test, and 
allows simultaneous analysis of multiple imperfect dichotomous tests. Pai et 
al (2008)evaluated LTBI prevalence in Indian HCWs using both mixture and 
LCA models. They have shown that the application of LCA using both TST 
and QFT for the diagnosis of LTBI, provided more information on the 
sensitivity, specificity and predictive value of such tests than when using only 
one test. The authors suggest that future studies should consider using LCA 
and at least three diagnostic tests to improve prevalence estimation of LTBI.  
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2.4 SERIAL SCREENING FOR LATENT TB INFECTION IN HEALTH 
CARE WORKERS 
 
 
Serial screening of HCWs has been implemented in low TB incidence 
countries as part of prevention efforts to allow for targeted treatment of LTBI 
and prevention of progression to active TB in HCWs. The superior specificity 
of IGRAs together with the absence of a boosting effect make them ideal 
tests to be employed in serial testing programmes for HCWs. Some 
countries have incorporated IGRAs into surveillance programmes that 
employ serial testing for LTBI.  
 
Estimates of the median annual incidence of LTBI based on TST conversion 
in HCWs in countries with low, intermediate and high TB incidence have 
been reported as 3.8%, 6.9% and 8.4% respectively(Baussano et al., 2011). 
When compared with the general population this translates into incident rate 
ratios (IRRs) of 2.4, 2.4 and 3.7 respectively and is indicative of the higher 
risk of LTBI infection among HCWs, which rises in tandem with background 
TB prevalence. 
 
The evidence base for utilization of IGRAs in serial testing is growing, but 
studies have yielded varying results. A recent review presents results of eight 
studies from low and intermediate TB incidence countries that have reported 
IGRA conversion rates among HCWs(Zwerling et al., 2012). Estimates of 
conversion have ranged from 1.8% to 14.4% with most studies showing 
higher rates of IGRA conversion than TST conversion. IGRA conversion was 
not shown to be consistent with TB exposure in all studies. One study 
showed an association between male gender and older age with IGRA 
conversion.  
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On the other hand, reversion rates from both low and intermediate TB 
incidence countries reported in three studies have ranged from 40% to 53%, 
with baseline values closest to the cut-point more likely to revert to a 
negative IGRA test at follow-up. These findings were replicated in 
subsequent studies of German and Portuguese HCWs with the highest 
conversion and reversion rates produced when using conventional 
dichotomous definitions of positive and negative(Ringshausen et al., 
2010;Torres Costa et al., 2011; Torres Costa et al., 2009). More recent data 
from HCW screening programmes have highlighted areas of uncertainty 
relating to the interpretation of sequential IGRA assays results and the 
influence on LTBI treatment programmes (Slater et al., 2013; Zwerling et al., 
2013a; Fong et al., 2012; Loddenkemper, Diel & Nienhaus, 2012; Zwerling et 
al., 2012; Dorman et al.,2014). These latest data suggest that sequential 
IGRA results display considerably variability, resulting in high rates of 
conversion and reversion, which to some extent is influenced by type of test 
used and cut-off definition employed to denote a positive test. This raises 
concerns about whether the current cut-points are sensitive enough to 
accurately identify new infection and provide an accurate picture of LTBI 
rates in high risk populations.    
 
Only two studies from high incidence settings have evaluated IGRA 
conversion in HCWs in high TB incidence settings (Zwerling et al., 2012). 
The rates of conversion have ranged from 11.6% to 21% and have varied 
depending on which cut-point was used. Reversion rates were even higher 
and have been reported as ranging from 18% to 40%. Neither study reported 
data to show that IGRA conversion was more strongly associated with TB 
exposure than TST conversion. Given the limited research and the evidence 
emerging from low incidence settings, the World Health Organization (WHO) 
has in the interim issued a report[by the Strategic and Technical Advisory 
Group for Tuberculosis (STAG-TB)] that discourages the use of IGRAs for 
the screening of LTBI among high risk groups such as HCWs in LMICs 
(World Health Organization, 2010).  
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2.5 RESEARCH GAPS AND AREAS OF UNCERTAINTY 
 
Despite the increased utilization of IGRAs for baseline and serial screening 
of HCWs in high income countries and low TB incidence settings, many 
areas of uncertainty remain (Loddenkemper, Diel, & Nienhaus, 2012).These 
have in the main been related to sensitivity of IGRAs in certain high risk 
groups, limited prognostic power for identification of those at highest risk of 
progression to active TB, limited utility in active TB and unexplained high 
rates of reversion and conversion(Whitworth et al., 2013). 
 
Whilst IGRAs are considered to have equivalent sensitivity to TST, the 
sensitivity of the assays appears to be reduced in key subgroups such as 
children and HIV-infected individuals, leading to an increased rate of false 
negatives(Moyo et al., 2011;Cattamanchi et al., 2011; Metcalfe et al., 
2011).This has implications for the screening of HCWs with high background 
prevalence of LTBI and HIV working in high TB prevalence settings as such 
individuals are at high risk of progression from LTBI to active disease. 
Studies conducted among HCWs in high TB incidence settings have not 
reported on HIV status or evaluated the potential influence of HIV status on 
prevalence estimates.  
 
In low incidence settings IGRAs generate lower prevalence estimates for 
LTBI than TST and are better correlated with TB exposure, resulting in lower 
numbers needed to treat (NNT) to prevent progression to active TB. But the 
prognostic power of IGRAs is still not optimal as IGRAs are not able to 
distinguish those with recent LTBI and therefore at highest risk of 
progression, from those with more remote exposure to TB. Among HCWs in 
high TB incidence settings, TB transmission is likely to be ongoing given the 
high background rate of TB and the poor implementation of control measures 
in health care facilities. It is unclear how IGRA performance is affected in 
such settings, and longitudinal studies are needed to evaluate LTBI 
incidence and factors associated with acquisition of recent infection. 
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The use of IGRAs in serial screening have also raised concerns about the 
interpretation of sequential test results arising from such screening and 
whether observed changes are due to innate variability of these assays or 
represent true conversion and therefore new infection(Zwerling et al., 2013a; 
Fong et al., 2012; Zwerling et al., 2012). Based on findings of some of these 
more recent large studies which are based on more mature serial screening 
programmes, IGRAs appear to have considerable variability which negatively 
affects their short-term reproducibility (Slater et al., 2013; Joshi, Monson & 
Woods, 2012; Nienhaus et al., 2013). The exact cause of the high rates of 
conversion and reversion has not been identified. These latest findings have 
resulted in a more cautious approach to the use of IGRAs in serial screening 
of high risk groups in low-incidence settings such as the USA and 
Canada(Canadian Tuberculosis Committee, 2010; Mazurek et al., 2010). 
 
The evidence base from high TB incidence settings for the use of IGRAs in 
high risk populations such as HCWs remains sparse. Only three studies 
have been conducted among HCWs evaluating a head to head comparison 
of both TST and IGRAs or the utility of IGRAs in serial testing of 
HCWs(Zwerling et al., 2013b; Zwerling et al., 2012).Evidence from high 
incidence settings have shown that HCWs are at increased risk of LTBI using 
the TST. It is not known whether IGRAs are really more sensitive than TST 
at detecting LTBI in HCWs living in countries characterized by high 
background TB and HIV prevalence. The role and contribution of 
occupational TB exposure, as opposed to community exposure, to LTBI 
prevalence and incidence have also not been elucidated. This is despite it 
being known that infection control measures and practices are poorly 
implemented in health care facilities in countries such as South Africa, and 
despite the high TB burden and the emergence of extremely drug-resistant 
TB(Farley et al., 2012; Naidoo, Seevnarain & Nordstrom, 2012).Furthermore, 
to arrive at a true comparison of TST and IGRAs with respect to specificity, 
factors associated with discordance, specifically TST positive IGRA negative 
discordance, require closer examination.   
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Studies that have evaluated serial testing using IGRAs in high incidence 
settings, have shown considerable variability in IGRA test results. This is 
reflected in high rates of conversion and reversion, with no study showing 
IGRA conversion to be better correlated with TB exposure than TST 
conversion. This raises questions about the test stability in such settings and 
the interpretation of sequential IGRA tests. Concurrent administration of TST 
with IGRA at baseline may also result in boosting of subsequent IGRA test 
response, further confounding serial test interpretation. There is emerging 
agreement on the need for the revision of IGRA cut-points to account for 
such variability and to accurately denote true conversion. The use of 
alternative definitions of conversion has been proposed(Zwerling et al., 
2012). Such definitions include “an absolute increase from the baseline result 
(as with TST), a proportional increase from baseline or a grey zone” to 
account for innate test variability (Zwerling, 2012: 68). 
 
Despite numerous systematic reviews which have evaluated IGRA 
performance, data from high TB incidence countries which have been 
included in such reviews have been limited in informing clear 
recommendations (Cattamanchi et al., 2011; Metcalfe et al., 2011). 
Specifically, the utility of IGRAs in HCW screening in such settings is 
uncertain(Zwerling et al., 2012). To answer some of these questions studies 
of HCWs from high TB incidence settings using a longitudinal study design 
are needed. Such studies should evaluate prevalence estimates, compare 
test agreement and performance between IGRAs and TST, as well as 
provide estimates of LTBI incidence and factors associated with recent 
infection. Quantification of test conversion and reversions should also be 
evaluated to inform the need for improved estimations of LTBI incidence and 
revised criteria for what truly constitutes new infection. This might well be 
different for HCWs in high TB incidence settings from those working in low 
TB incidence settings. This thesis aims to answer some of these questions.
51
  
Table 2.3 LTBI prevalence and test agreement among health care workers in countries with intermediate or high TB incidence using TST and IGRA 
assays 
 
Study author (year)  N   LTBI Prevalence   Test agreement   Kappa (95% CI)  
      
Country     TST*   IGRA* 
_____________________________________________________________________________________________________________________________ 
 
Pai (2005)   719  41%   40%   81%    0.61 (O.56 – 0.67) 
India 
 
Mirtskhulava (2007)  265  77%   60%   74%    0.43 (0.33 – 0.55)  
Georgia 
 
Lien (2009)   255  66%   47%   73%    0.44 (0.43 - .45) 
Vietnam 
 
He (2012)    999  54%   68%   67%    0.19 (0.13 – 0.25)  
China 
 
Zhang (2013) **   96  55%   29%   59%    0.18 (0.01 – 0.52)                               
China 
 
Van Rie (2014)   199  45%   48%   68%    0.37 
South Africa 
 
CI: confidence interval.* Cut- points used were 10mm for TST, cut-point ≥ 0.35 IU/ml for QFT-GIT and ≥ 6 spot forming units for TSPOT.TB. 
**TST compared to QFT-GIT in all studies except Zhang (2013) where the comparison is with TSPOT.TB.   
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CHAPTER 3 
 
3. 1 STUDY SETTING AND PARTICIPANTS 
 
3.1.1 Study design and setting 
 
This was a longitudinal study conducted among health care workers 
employed at seven health care facilities in the greater Cape Town area, 
South Africa. The selection of facilities was made following consultations with 
health service managers and the researchers. Factors taken into 
consideration were that such facilities should serve communities with a high 
TB and HIV prevalence, that there should be an interest in and need for such 
research and that research staff would receive support and co-operation 
from management and staff at the facilities. Facilities chosen as study sites 
were three clinics and two community health centres classified as primary 
level care facilities, and two TB hospitals, classified as secondary level 
facilities.  
 
The five primary care facilities identified as study sites were the Delft 
community health centre, Nolungile Community health centre, Nyanga clinic, 
Kuyasa clinic, and Site B clinic. Nolungile, Kuyasa and Site B were located in 
Khayelitsha, an area with one of the highest TB and HIV prevalence in the 
Western Cape (Garone et al. 2001).The two secondary level facilities were 
the Brooklyn Chest and D.P. Marais TB hospitals which function as referral 
centres for clinically complicated or drug resistant TB cases referred from 
primary level facilities.   
 
There were marked differences in the patient profile and scope of services 
delivered at these two types of facilities. The primary health care facilities in 
the sample were community based health centres which offered a range of 
health services including diagnostic and treatment services for tuberculosis 
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sufferers and primary health care services which were both preventive and 
curative in nature. These facilities relied on staff supplied by non- 
governmental organizations for the successful implementation of important 
public health programmes such as the national tuberculosis programme and 
utilized large numbers of community health care workers to support such 
programmes. Facilities were based within the communities allowing for quick 
access to primary health care and a high load of undiagnosed patients 
entering through the doors, this in many cases representing their first contact 
with a health service.  
 
In contrast the two TB hospitals included in the study were both secondary 
level facilities aimed primarily at providing long-term or in–hospital curative 
care for patients with complicated or drug-resistant tuberculosis. They 
functioned as referral centres and were located at some distance away from 
the communities that they served. Patients were admitted as in-patients after 
being referred from primary care centres. The facilities therefore offered a 
level of specialized care not available at the primary level. Patients served 
were those with confirmed TB, with possible complications and or drug 
resistant TB and who would benefit from specialist in-hospital and long-term 
care. 
 
A study protocol was developed and approval obtained from the University of 
Cape Town’s Faculty of Health Sciences Research Ethics Committee for 
conducting this study in November 2008. The baseline phase of the study 
commenced in May 2009 and was concluded in June 2010. Recruitment at 
the seven facilities took place sequentially over a period of one year using a 
trained nurse interviewer to perform the data collection, administer tuberculin 
skin test (TST) and draw bloods for the processing of study assays. Data 
collection for the follow-up phase of the study immediately followed the 
baseline phase and took place from July 2010 to June 2011, allowing for a 
one year interval between test responses as per the study protocol. The 
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study was commenced at the primary level facilities and concluded at the 
secondary level facilities for both phases. 
 
Prior to starting with recruitment, presentations were done to staff outlining 
the objectives of the study, clarifying questions from staff and inviting them to 
participate in the study. Leaflets were distributed among staff outlining the 
objectives and benefits of the study and posters were put up in the facility, 
providing information on the study.   
 
3.1.2 Participants 
 
For the purposes of the study a broad definition of health care worker was 
employed to include all those engaged in the support and delivery of health 
services at a selected health facility. This is in line with the approach adopted 
by the World Health Organization that proposes the inclusion of all those 
involved in the provision of health services, as well as management and 
support workers, in such a definition. It furthermore includes subsectors of 
workers engaged in community-based and home-based care (WHO, 
UNAIDS & ILO, 2010; Oxlade et al., 2009).Participation in the study was left 
up to individual choice following group presentations and information 
sessions and occurred during work-time only. 
 
The study sample therefore included both support staff (administrative, 
security staff and community health care workers) and clinical staff (interns, 
researchers, nurses and doctors). Presentations were made to staff at all 
facilities informing them about the study and inviting their participation. 
Exclusion criteria were stipulated as pregnancy, allergy to tuberculin and age 
younger than eighteen years. A formal sample size calculation was made 
based on the expected estimates of LTBI in the population. It was estimated 
that a sample size of 300-400 HCWs would produce fairly precise estimates, 
i.e. within 5% of the expected estimate for LTBI positivity detected by either 
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TST or IGRA. Sample sizes were calculated using Stata and was based on a 
range of LTBI prevalence (30% - 60%) as the exact population prevalence 
was unknown. It was assumed that TST positivity would be approximately 
60% and IFN-γ positivity approximately 40% in the study sample. This was in 
keeping with data from a recent review of LTBI prevalence in HCWs in low- 
and middle-income countries (LMICs) which reported an LTBI prevalence of 
33-79% (median prevalence 54%) detected by TST (Joshi et al., 2006). 
 
Table 3.1 Possible prevalence of LTBI, desired precision and sample size estimation 
 
Prevalence of LTBI 
 
Desired precision 
 
Sample size (n) 
 
TST or IGRA positivity 
  
60% 54% – 66% 300 
60% 55% – 65% 400 
50% 44% – 55% 300 
50% 45% – 55% 400 
40% 35% – 45% 400 
40% 34% – 46% 300 
30% 25% – 36% 300 
30% 26% – 35% 400 
 
 
 
3.2 BASELINE DATA COLLECTION INSTRUMENTS AND 
INVESTIGATIONS 
 
3.2.1 Questionnaire 
 
Each participant was required to answer a standard questionnaire eliciting 
data on age, sex, home language, current medical conditions, HIV testing, 
place of employment, duration of employment, job category, smoking, 
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exposure to secondary smoke, alcohol use and HIV status(appendix 1). A 
section of the questionnaire focused on specific occupational tasks (e.g. 
interviewing, examining, or performing sputum collection from TB patients), 
awareness of the presence of environmental control measures (facility 
implementation of ventilation measures, provision of N95 masks)and the 
practice of administrative controls (infection control policy, early triage, 
separation of TB patients) to minimize TB risk in the facilities of employment. 
Questions on health workers’ perception of their risk of infection were also 
included.   
Previous studies in clinical settings have described the use of symptom 
scores as a diagnostic tool to distinguish subjects with and without TB (den 
Boon et al., 2006). However, these are not always applicable to survey 
settings as the prevalence of TB and symptoms is higher in clinical settings. 
This questionnaire followed a method used previously in a survey setting to 
characterize TB symptoms. Questions focused on the presence and duration 
of the cardinal TB symptoms of cough, haemoptysis, weight loss, night 
sweats, chest pain and fever. Questions on factors which could potentially 
confound LTBI test response such as BCG vaccination and a history of 
previous TB were included. Parental employment status during childhood 
was used as a proxy variable for socio-economic status and a detailed 
section on smoking history and alcohol consumption was included. 
 
To evaluate the risk of exposure to tuberculosis infection, an exposure index 
was developed using exposure indicators demonstrated in one study to be a 
reasonable accurate reflection of such exposure and potentially associated 
with tuberculous infection and disease.(Menzies, Joshi &Pai, 2007; Joshi et 
al., 2006).Exposure was evaluated both in the community and occupational 
context. Community contact questions that were included as part of the 
exposure index related to the infectivity of the index / contact case (ranging 
from unknown sputum result to sputum positive contact),proximity of living 
arrangements to the contact (e.g. ranging from no contact to sleeping in 
same room) and duration of contact (ranging from nil to ≥12 hours). For 
occupational exposure, the index incorporated the type of service provision 
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to patients as a proxy measure for potential contact with infectious cases 
(ranging from non-clinical to clinical services provision or a combination 
thereof), proximity to TB patients in the facility (no direct exposure to direct 
exposure in the same room) and the average duration of contact per day with 
TB patients (ranging from 0 – 3 hours to ≥12 hours). Maximum scores of 11 
and 8, were assigned to community and occupational exposure indices 
respectively. Participant scores were treated as a numeric variable to 
evaluate the relationship with LTBI test outcomes. Questions were also 
posed to determine whether participants had been provided with health and 
safety training on TB infection control.  
 
The questionnaire was developed in English and translated into Afrikaans 
and Xhosa, two local languages spoken in the Western Cape. Back 
translation was done to assess the validity and reproducibility of the content. 
A trained interviewer administered the questionnaire in a standardized 
manner. As far as possible subjects were interviewed in their language of 
choice. 
 
3.2.2 Chest radiograph 
 
All participants were required to undergo a postero-anterior digital chest 
radiograph to exclude active TB. The chest radiograph was read by an 
occupational health physician and pulmonologist, two experienced clinicians 
trained in the Chest Radiograph Review System (CRRS); a radiological 
review system specifically aimed at developing competency in the 
radiological diagnosis of TB(Pinto et al., 2013). The two readers classified 
the films as normal, inactive TB, active TB or other pathology (not TB 
related). The two readers did not read strictly according to the CRRS format, 
relying on prior training and clinical experience to classify radiographs. 
Where disagreement occurred between the two readers, an expert 
radiologist was requested to read the film to arrive at a final classification. 
This final classification was recorded as the chest radiograph result. 
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3.2.3 HIV test 
 
All participants were requested to have an HIV test which was a rapid 
enzyme–linked immunosorbent assay (ELISA) test which was performed in 
the field in accordance with the manufacturer’s instructions. A positive result 
was followed up with a confirmatory test using a rapid ELISA test from a 
different manufacturer as per the study protocol and current department of 
health screening practice. The first-line test used in this study was the 
Abbot’s Determine ® HIV-1/2 test(Direct relief international, 2014), whilst the 
second line test was the SD Bioline (Standard diagnostics incorporated, 
2013).This procedure was in accordance with current testing practice 
employed in large HIV testing programmes of the City of Cape Town’s health 
department as well as WHO guidelines(World Health Organization, 2004). 
 
Participants were allowed to report their HIV test result if previously tested, 
without undergoing the test in this study. All participants were provided with 
pre-and post-test counselling using a strategy that incorporated the advice, 
consent, test and support (ACTS) approach. This methodology has been 
adopted by the health department’s HIV counselling and testing (HCT) 
programmes. Both the nurse interviewer and principal investigator underwent 
training in ACTS prior to starting the data collection. Refusal to disclose a 
previous HIV result or undergo a test as part of this study did not 
compromise their eligibility for inclusion or continued participation in the 
study.  
 
3.2.4 Tuberculin skin test 
 
All participants were required to undergo the tuberculin skin test. The one 
step TST protocol was employed to test health care workers at baseline. Two 
tuberculin units (0.1ml) of RT23 PPD (Staten Serum Institute, Copenhagen), 
were injected intra-dermally on the volar aspect of the forearm. The 
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induration was then measured by a trained reader after 48 – 72 hours using 
the ballpoint and ruler method(Moran-Mendoza et al., 2013).An induration of 
≥ 10mm was considered a positive test at baseline. In the case of an HIV 
positive individual an induration of ≥5mm was considered a positive test at 
baseline. 
 
3.2.5 Interferon-gamma release assays 
 
Venesection was performed by a trained nurse to obtain blood samples for 
the interferon-gamma assays (IGRAs). All bloods were taken at the same 
occasion when TST was done or within 3 days of TST administration, to 
eliminate the effect of boosting (van Zyl-Smit et al., 2009a; van Zyl-Smit et 
al., 2009b). Blood samples were transported to the laboratory on the same 
day and within a few hours of it being collected for processing. Two IGRA 
assays were used to evaluate LTBI test response viz. the QuantiFERON-TB 
Gold In-Tube (QFT-GIT)and the T-SPOT.TB.  
 
QuantiFERON-TB Gold In-Tube 
 
All health care workers were tested at baseline with the QFT-GIT test 
(Cellestis Ltd, Carnegie, Australia). Blood samples were drawn directly into 
three blood tubes supplied by the manufacturer that contained the following 
M. tuberculosis antigens: early secretory antigen- 6 (ESAT-6), culture filtrate 
protein-10 (CFP-10) and TB7.7 combined, the nil control or the positive 
control mitogen (PHA) (Whitworth et al., 2013). Whole blood was incubated 
at 37°C overnight (16-24 hours). Incubation with antigens allowed for the 
activation of antigen-specific effector T-cells and subsequent interferon- 
gamma (IFN-γ) release into the extra-cellular fluid. Following incubation, the 
blood tubes were centrifuged to separate the plasma (supernatant) 
containing the secreted IFN-γ and samples could then be stored at 4°C for 
up to 28 days (or at -20°C for longer periods) prior to assay output 
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development. The final step involved the measurement of IFN- γ release 
using an enzyme–linked immunosorbent assay (ELISA). In the QFT-GIT 
ELISA, development of a yellow colour indicated that IFN-was released into 
the plasma TB-specific T-cells. It was expected for colour to develop in the 
positive control as well but not (or very minimally) in the negative control well. 
Colour in the TB antigen well was considered indicative of infection. 
 
Optical density was measured using a micro plate reader and results were 
calculated using specialized analysis software supplied by the manufacturer. 
A series of IFN-standard concentrations were run alongside the samples in 
order to quantify IFN-levels. QFT- GIT was considered positive if the if the 
interferon-gamma response minus the nil antigen was ≥0.35 IU/ml.  
 
T-SPOT.TB 
 
A second IGRA assay the T-SPOT.TB assay (Oxford Immunotec, Abingdon, 
UK) was administered at baseline. The test was performed in accordance 
with the manufacturer’s instructions and blood was drawn at the same time 
as for the QFT-GIT. Venous blood was drawn into cell preparation tube 
(CPT) vacutainers (Becton Dickinson, Oxford, UK) and was transported 
within 6hours to the laboratory. In brief peripheral blood mononuclear cells 
(PBMCs) were isolated from heparinized whole  blood, before culturing 
PMBCs at 37°C for 18 (± 2 hours) with Mtb antigens. (Whitworth et al., 
2013)Incubation takes place in four wells of a 96 well plate, precoated with 
IFN-γ –specific monoclonal antibodies. PBMCs at a concentration of 250,000 
cells/well in AIM V® cell culture medium (Invirogen Corporation, Carlsbad, 
USA) are exposed to ESAT-6 and CFP-10 individually and to positive 
phytohemagluttinin (PHA) and negative (culture media controls).Overnight 
incubation of the cells takes place at a temperature of 37°C in 5% CO2. This 
results in activation and release of IFN-γ from antigen specific effector T cells 
that are present in the culture. This IFN-γ will be captured by monoclonal 
antibodies present on the membrane of the 96-well plate. 
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 Immediately following culture, cells and antigens are washed off with 
phosphate buffered solution (PBS) and conjugate (an alkaline phosphatase-
conjugated secondary IFN-γ specific monoclonal antibody). Addition of an 
alkaline phosphatase chromogen substrate results in the formation of a 
visual spot where alkaline phosphatase is present. Each spot represents the 
release of IFN-γ  by  a s ingle T-cell responding to specific antigenic 
stimulation. The result for the TSPOT.TB assay is expressed in number of 
spot-forming cells (SFCs) per well. It is expected that SFCs be detected in 
the positive control and be absent from the negative well. SFCs detected in 
either or both of the antigen containing wells is indicative of tuberculosis 
infection. Enumeration of the SFCs in the TSPOT.TB may be done 
immediately or at another date. An ELIspot reader with appropriate software 
supplied by Oxford Immunotec is used to generate counts. However in low-
resource settings, a microscope or magnifying glass may be used. In this 
study a cut–off of six or more spots was treated as a positive result. To 
minimize inter-operator and inter-laboratory variability, all assays were done 
by the same operator in the same laboratory. 
 
Samples were transported on the same day to the laboratory usually within a 
few hours of the blood samples being drawn. Stimulation happened in the 
test tube which was coated with reagent and then incubated overnight. Tests 
were batched for analysis which happened at regular intervals every few 
days. An Elispot reader was used to analyse the result for T-SPOT.TB. 
 
In this study, the use of cut-points for test positivity was based on the 
manufacturer’s instructions and software provided for assay analysis at the 
time that the study was conducted. For T-SPOT.TB this represented a 6 spot 
increment. Later recommendations, based on emerging evidence from 
studies performed, advised that a 5-7 spot increments be treated as a grey 
zone, and that an 8 spot or greater increment be considered a positive test. 
Whilst the original criterion of a 6 spot increment was used in our study, the 
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revised cut point was taken into consideration in the multivariate analysis. 
Current evidence suggests that further revision of cut points is required 
which may be considerably higher than those currently recommended (Slater 
et al., 2013). 
 
The table below outlines the differences in methodology and processing of 
the two IGRA assays and is adapted from an article by Whitworth et 
al(2013).For further information links are provided to the relevant websites 
for both QFT-GIT and TSPOT.TB in the reference list(Oxford Immunotec, 
2013; Qiagen, 2011). 
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Table 3.2 Comparison of commercially available IGRAs for the diagnosis of TB 
 
  
T-SPOT.TB 
 
QuantiFERON Gold in-tube 
 
Sample 
collection 
 
1 x tube heparinized blood 
Minimum blood volume=5ml 
 
3 x QFT blood tubes containing nil 
control. Mtb antigens (combined) 
or mitogen control 
1 ml blood per tube 
Total blood volume = 3 ml 
 
Pre-
incubation 
sample 
preparation  
 
PBMC isolation and addition of 
PMBCs to T-SPOT.TB 96 well 
plate (250 000/well) containing 
negative control Panel A and B 
Mtb antigens (individually) or 
positive control  
Mtb antigens: ESAT-6, CFP-10 
 
Inversion of tubes to ensure mixing 
of antigens/ controls with blood 
 
Mtb antigens: ESAT-6, CFP-10, 
TB 7.7 
 
Incubation 
 
16-20 hour incubation in 
TSPOT.TB in 96 well plate (37°, 
5% CO2) 
 
16 – 24 hour incubation in QFT 
blood tubes (37°C) 
 
Post-
incubation 
sample 
preparation 
 
Removal of cells and antigens / 
controls by washing 
 
Centrifugation of QFT blood tubes 
for separation of plasma 
 
Assay 
preparation 
 
ELIspot for enumeration of IFN-γ 
producing cells  
Result determination using 
ELIspot reader 
 
ELISA for quantification of plasma 
IFN-γ levels 
 
Result determination using ELISA 
reader 
Adapted from Whitworth et al, 2013. 
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3.2.6 Sputum microscopy and culture 
 
Participants who tested positive on symptom screen or had a chest x-ray 
suggestive of active TB were investigated further using sputum microscopy 
and culture, to exclude active TB. Two sputum samples were collected on 
separate days for TB investigation and culture was performed on both 
samples. Investigation of sputum was done at the National Health Laboratory 
Service based at Groote Schuur hospital. Microscopy was done using 
Fluorescent techniques and auramine staining. The results were reported 
within 48hours as number of acid fast bacilli (AFBs) seen on smear per high 
power field. All TB sputum samples were further investigated by means of 
culture using a liquid medium. The Mycobacterial Growth Inhibitor Tube 
(MGIT) 960 system was used which detects bacterial growth using a 
fluorescence- quenching based oxygen sensor within each tube. As 
mycobacteria multiply within the tube, oxygen is consumed and fluorescence 
is detected by the system. A positive culture may be due to growth of TB but 
also bacteria, fungi and non-tuberculous mycobacteria. Smear microscopy 
requires approximately 10 000 TB bacilli per ml of sputum to be 
detected/positive. Culture can be positive with only 10 - 100 TB bacilli per ml 
of sputum. For a tube that flagged positive (culture positive result), the 
growth in the tube was stained and examined microscopically to detect the 
presence of mycobacteria and tested for the presence of TB using molecular 
probe-based assays (PCR) to rapidly confirm the presence of MTB complex. 
 
3.3 FOLLOW-UP DATA COLLECTION INSTRUMENTS AND 
INVESTIGATIONS 
 
3.3.1 Questionnaire  
 
At follow-up one year later a questionnaire was again administered inclusive 
of a symptom screen (appendix 2). Additional questions related to smoking 
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status, HIV status and employment characteristics were included. Questions 
were also included to assess compliance with clinical referral at baseline and 
whether participants had found it easy to access clinical care. In additions 
responses were elicited on their preferred model for the delivery of 
occupational health services to HCWs.  
 
3.3.2 Chest radiograph 
 
Participants were requested to undergo a routine chest radiograph at the 
same facility using the same digital technology. The same two readers who 
evaluated the films at baseline, reviewed the follow-up films. Where 
necessary the previous films were consulted to verify whether interval 
radiographic change had occurred. These were also made available to the 
chest radiologist to resolve disagreement between the two readers where 
this occurred. 
 
3.3.3 HIV test 
 
As previously, all participants were requested to have an HIV rapid test 
(ELISA) which was performed in the field in accordance with the 
manufacturer’s instructions. A positive result was followed up with a 
confirmatory test using a rapid ELISA test from a different manufacturer as 
per the study protocol and current department of health screening practice. 
Participants were allowed to report their HIV test result if previously tested, 
without undergoing the test in this study. All participants were provided with 
pre-and post-test counselling using a strategy that incorporated the ACTS 
approach. Refusal to disclose a previous HIV result or undergo a test as part 
of this study did not compromise their eligibility for inclusion or continued 
participation in the study.  
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 3.3.4 Tuberculin skin test 
 
The tuberculin test was repeated using the one step TST protocol on all 
participants, irrespective of their baseline result. Two tuberculin units (0.1ml) 
of RT23 PPD (Staten Serum Institute, Copenhagen), was injected intra-
dermally on the volar aspect of the forearm. The induration was then 
measured by a trained reader after 48 – 72 hours. An induration of ≥ 10mm 
was considered a positive test at baseline. In the case of an HIV positive 
individual an induration of ≥5mm was considered a positive test at baseline.  
Refusal to undergo a repeat TST test did not disqualify participants from 
continuing in the study. 
 
3.3.5 Interferon-gamma release assays 
 
Both IGRAs were repeated using the same methodology described earlier. 
All participants were required to undergo repeat testing irrespective of their 
test result at baseline. 
 
3.2.6 Sputum microscopy and culture 
 
Participants who tested positive on symptom screen or had a chest x-ray 
suggestive of active TB were investigated further using sputum microscopy 
and culture, to exclude active TB. Two sputum samples were collected on 
separate days for TB investigation and culture was performed on both 
samples. 
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3.4  STATISTICAL ANALYSIS 
 
Prevalence of LTBI and associated factors  
 
Statistical analyses were performed using Stata version 11 (Stata Corp, 
College Station, Texas). The outcomes evaluated included test positivity for 
TST, QFT-GIT and TSPOT.TB. The prevalence of TB associated risk factors 
and test outcomes were calculated. Stratified analysis was carried out to 
differentiate between staff from primary and secondary facilities following 
preliminary analysis which showed important demographic differences 
between the two groups. Results were separately summarized.  
 
Risk factors for test positivity were evaluated using odds ratios (ORs) with 
95% confidence intervals (95% CIs) presented for all estimates. Univariate 
logistic regression analysis was performed to evaluate the relationship 
between risk factors for TB infection and all three test outcomes. Individual 
multivariate regression models were then run for all variables of interest in 
relation to test outcomes, adjusting for covariates such as age and gender. 
Adjusting the analysis for multiple testing was not done. Multivariate models 
were also applied to the strata investigating determinants separately for staff 
employed at primary and secondary level facilities. Confidence intervals for 
all point estimates were calculated based on the following formula: point 
estimate ± 1.96 x standard error of the mean (SEM) 
 
Logistic regression was used to develop models that best predicted test 
outcomes for each of the three tests. Through a process of model building, a 
model was derived which best predicted a positive test outcome for each of 
TST and the two IGRA assays individually. The best predictive model was 
determined by  examination of the log likelihoods, the log-likelihood ratio 
tests, associated p-values and the  Akaike’s information Criterion (AIC) 
generated by successive models, with the final model chosen as 
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representing that with the lowest AIC. The strength and precision of the 
associations were summarized using odds ratios, confidence intervals and p 
values.   
 
Agreement analysis and latent class modelling 
 
At baseline, agreement analysis was conducted to evaluate concordance 
between test outcomes and factors associated with discordance were 
examined. The kappa statistic (κ) was used to quantify agreement between 
tests and 95% confidence intervals were calculated for each kappa value. 
The kappa statistic measure of agreement is scaled to be 0 when the amount 
of agreement is equal to what would be expected to be observed by chance 
and 1 when there is perfect agreement. Kappa categories of agreement 
according to Landis and Koch are therefore: poor if below 0; slight if ≤2.0; fair 
if 0.21 – 4.0; moderate if equal to 0.41-0.60, substantial if 0.61 -0.80 and 
almost perfect if 0.81-1.00(Munoz & Bangdiwala, 1997). In view of the 
variability observed in studies with serial administration of IGRAs  and the 
potential impact of boosting of IGRA test response by TST, agreement 
analyses using higher cut-offs for test positivity were also performed on 
baseline results. Agreement analyses were also carried out on the test 
outcomes generated from repeat testing of the cohort one year later. This 
agreement was also calculated on absolute values using standard cut-offs 
for test positivity and did not take into consideration the baseline test results.  
 
Factors associated with discordance were explored using a multinomial 
logistic regression model that compared discordant groups with a 
comparison group displaying perfect agreement between test outcomes. 
Discordant groups for both IGRA assays were defined as having a positive 
TST/negative IGRA or a negative TST/ positive IGRA.  
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To estimate the sensitivity and specificity of different diagnostic tests, latent 
class analysis (LCA) was used. This is a statistical modelling technique that 
is based on the premise that the results of various imperfect tests for the 
same condition are influenced by a common underlying latent variable which 
represents the true disease status(Christopher et al., 2010; Dendukuri, 
Hadgu & Wang, 2009; Pai et al., 2008). A pre-condition for a meaningful LCA 
model (i.e. for the model to be identifiable) is that the number of diagnostic 
tests used on the study sample must provide at least as many degrees of 
freedom as the number of parameters to be estimated. If not then a Bayesian 
estimation approach can be used to place reasonable bounds on some 
parameters about which prior information is available. This would allow for 
the estimation of the remaining parameters conditional on this prior 
information. 
 
For this study design that involved three dichotomous tests, the problem is 
identifiable if it is assumed that the results of individual diagnostic tests for a 
given disease status are independent (conditional independence) and that 
observed associations between tests are due solely to the latent variable. In 
this study this condition could not be met as there were similarities in the 
technological properties and immunological mechanism underlying the two 
IGRA assays, which could potentially result in correlation between test 
results (conditional dependence). An alternative model was therefore also 
considered that allowed for conditional dependence between QFT and 
TSPOT given subjects’ truly positive, conditional dependence between QFT 
and TSPOT given subjects truly negative. The conditional dependence is 
assumed to be positive in both groups.  
 
In the analysis, a non-informative prior is used for the prevalence which is 
unknown. Prior information on the accuracies of the three tests was elicited 
from Pai et al (2008) using data on the sensitivity and specificity of TST and 
QFT-GIT based on systematic reviews and meta-analyses. The prior 95% CI 
of each parameter is constructed in such a way that the prior 95% CI covers 
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all the 95% CIs from individual studies included in the meta-analysis. 
Therefore it is equivalent to the prediction interval resulting from the meta-
analysis. Non-informative priors were used for the conditional dependence 
terms and the method introduced by Dendukuri and Joseph (2001)was used 
to construct the priors. The prior set is represented in Table 5.1. 
 
In applying a latent class model, subjects with both determinate and 
indeterminate results were included, as participants with indeterminate 
results in one test may still have relevance in the analysis on account of 
determinate results in the remaining two tests. A fixed effects model allowing 
for conditional dependence between QFT-GIT and TSPOT.TB was used to fit 
the data (Dendukuri& Joseph, 2001).WinBUGS software was used to 
analyse the data. Twenty thousand samples were drawn from the posterior 
distribution after discarding a burn-in of 1000 iterations. Convergence of the 
Monte Carlo Markov chain was assessed using the Gelman-Rubin statistic 
which is named BGR within WinBUGS. 
 
Test conversion and factors associated with incident TB infection 
 
During the follow-up phase of the study the main outcomes of interest were   
test positivity at follow-up and the annual rate of TST and IGRA conversion 
which was used to define annual incidence of infection. The prevalence of 
TB associated risk factors, occupational and environmental factors and test 
outcomes was calculated at baseline for this cohort. Differences between 
participants included in the follow up and those lost to follow-up were 
explored using Chi-squared statistics, to evaluate the likely operation of 
attrition bias. Further analysis focused on identifying predictors of TST and 
IGRA conversion. Univariate and multivariate logistic regression analysis to 
explore the strength of associations with conversion were performed. An 
annual incidence of infection on the different tests was calculated.  
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3.5 ETHICS  
 
The study was approved by the research Ethics Committee of the University 
of Cape Town’s Health Science Faculty. All participants gave written 
informed consent for participation in the study at recruitment (appendix 3) 
prior to commencement of the survey and during participation in the follow-
up phase of the study (appendix 4). 
 
Prior to giving consent a verbal explanation was provided to participants of 
the study purpose and a description of the study requirements. A written 
copy of this document which formed part of the consent document 
(appendices 3 and 4) and which included the contact details of the 
researcher was provided to participants. Issues of confidentiality and 
autonomy were also addressed in this document.   
 
An undertaking was given to communicate all results to participants in a 
confidential personal report at baseline (appendix 5)and at follow-
up(appendix 6). The only results not reported to participants were those for 
the IGRA assays which were being administered as research assays, as 
their utility in high burden settings was unknown. All results were immediately 
available once laboratory tests were processed, except in the case of those 
needing further investigations for active TB. 
 
In accordance with the prevailing standard of care and clinical practice, all 
HIV infected individuals with a positive TST and in whom active TB was 
excluded, were referred for Isoniazid (INH) prophylaxis, by means of a formal 
referral letter completed by the study’s principal investigator at both baseline 
and follow-up (Appendix 7).  
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Those individuals diagnosed with active TB during the course of the survey 
were referred for TB treatment to a facility of their choice. They were also 
reported to the Compensation Commissioner, Department of Labour, as 
cases of occupational TB in accordance with the Compensation for 
Occupational Injuries and Diseases Act of 1993. Participants were consulted 
during all such process and due consideration for confidentiality was upheld. 
 
HIV-infected individuals, who worked in high risk settings e.g. TB clinics, 
were also recommended for redeployment to a lower risk setting, with their 
consent. This was achieved by means of a formal discussion between the 
facility manager and the principal investigator.  
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CHAPTER 4 
 
PREVALENCE AND DETERMINANTS OF LATENT TUBERCULOSIS 
INFECTION IN HEALTH CARE WORKERS 
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CHAPTER 4 
 
4.1 INTRODUCTION AND OBJECTIVES 
 
It is well established that health care workers are at increased risk of 
contracting TB infection and disease due to occupational exposure 
(Baussano et al., 2011; Menzies, Joshi &Pai, 2007). In high TB and HIV 
settings, such as South Africa, this risk has not been well studied. Thisis on 
account of scarce surveillance data and limited occupational health service 
provision to this high risk population (Adams et al., 2012; Zungu & Malotle, 
2011).The implementation of infection control strategies have been shown to 
have a positive impact on TB risk in health care workers in low TB incidence 
settings (Centers for Disease Control and Prevention, 2005). A recent study, 
however, that was conducted in South African primary health care facilities 
has not shown a protective association between infection control practices 
and TB incidence in healthcare workers. The researchers conclude that this 
may call into question the suitability and validity of current tools used to 
measure infection control implementation in this study setting (Claassens et 
al., 2013). This suggests that validated tools are required which are adapted 
to local conditions to measure infection control measure implementation and 
that accurate data are needed to evaluate trends in TB infection and disease 
among health care workers. 
 
The emergence of novel interferon γ-release assays (IGRAs) with claimed 
equivalent sensitivity to tuberculin skin test (TST) and improved specificity 
hasraised the possibility of more accurate diagnosis of latent tuberculosis 
infection (LTBI) in high risk populations such as health care workers (Pai et 
al, 2008). Most of these studies have been performed in low TB incidence 
countries with limited BCG vaccination where targeted LTBI screening and 
treatment of high risk groups form an integral part of TB control programs. 
Consequently IGRA assays have been incorporated into surveillance 
programme in countries such as the USA and UK (Mazurek et al., 2010; 
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National Collaborating Centre for Chronic Conditions (UK) & Centre for 
Clinical Practice at NICE (UK), 2011). In some cases it is advocated that 
IGRAs be used in conjunction with TST, whilst in others it is used in place of 
TST. Little is known about the utility of these assays in high-incidence 
settings such as Sub-Saharan Africa where health care workers work at the 
forefront of the HIV and TB epidemics, but within settings that often lack 
proper infection control measures. Several studies have shown that health 
care workers in South Africa have a relatively high HIV prevalence 
approximating that of surrounding communities (Kranzer et al., 2010; Naidoo 
& Jinabhai, 2006; Wilkinson & Gilks, 1998;Shisana et al., 2004; Connelly et 
al., 2007). Coupled with occupational exposure, HIV co-infection places 
those infected at high risk of progression from latent infection to active TB 
disease.  
 
Strategies aimed at decreasing TB risk among healthcare workers need to 
be informed by data that provideestimates of TB infection and disease 
among health care workers. Evaluation of occupational and environmental 
risk factors and their association with TB infection and disease may assist in 
the identification of potentially modifiable factors. This in turn needs to be 
addressed in further research or in policies on health and safety or infection 
control aimed at improving protection of health care workers. 
 
In an attempt to generate some of these data and also to evaluate the utility 
of interferon γ-release assays (IGRAs) in a local health care worker 
population,  a cross sectional study was conducted from May 2009 to June 
2010 among staff at seven health care facilities in the greater Cape Town 
area, South Africa.These participants also served as the cohort for the 
follow-up phase of the study, which is the subject of the analyses in chapter 
6. 
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The data collected allowed for the calculation of estimates for the main 
outcomes of interest as previously outlined in the thesis objectives: 
 
1. To determine the prevalence of LTBI using both TST and IGRAs; 
2. To evaluate occupational and environmental factors that may be 
associated with LTBI; 
3. As a secondary objective, to evaluate the prevalence of active TB in 
this population. 
 
4.2 METHODS  
  
4.2.1 Structured questionnaire administered by trained nurse interviewer 
 
A structured interview was administered to all participants by a nurse. The 
questionnaire elicited data on relevant demographic factors such as age, 
sex, home language,  current medical conditions, HIV testing, place of 
employment, duration of employment,  job category, smoking, exposure to 
secondary smoke , alcohol use and HIV status. It also focused on 
participants’ awareness of potential occupational risk factors and 
environmental control measures in their places of employment.  Questions 
related to TB specific factors such as BCG vaccination, previous TB 
screening and treatment as well as current TB symptoms were included. The 
questionnaire is reproduced in appendix 1. 
 
4.2.2 Tuberculin skin test 
 
The one step TST protocol was employed to test health care workers at 
baseline. Two tuberculin units (0.1ml) of RT23 PPD (Staten Serum Institute, 
Copenhagen), was injected intra-dermally on the volar aspect of the forearm. 
The induration was then measured by a trained reader after 48 – 72 hours. 
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An induration of ≥ 10mm was considered a positive test at baseline. In the 
case of an HIV positive individual an induration of ≥5mm was considered a 
positive test at baseline. 
 
4.2.3 Interferon γ-release assays 
 
All health care workers were tested at baseline with the QuantiFERON-TB 
Gold In-Tube (QFT-GIT) test (Cellestis Ltd., Carnegie, Victoria, Australia) in 
accordance with the manufacturer’s instructions. THE QFT-GIT was 
considered positive if the interferon-gamma response minus the nil antigen 
was ≥0.35 IU/ml.  
 
The T-SPOT.TB assay (Oxford Immunotec, Abingdon, UK) was performed in 
accordance with the manufacturer’s instructions and blood was drawn at the 
same time as for the QFT-GIT. A cut-off of six or more spots was treated as 
a positive result.  
 
4.2.4 HIV test 
 
All participants were requested to have an HIV test which was a rapid 
enzyme–linked immunosorbent assay (ELISA) test which was performed in 
the field in accordance with the manufacturer’s instructions. A positive result 
was followed up with a confirmatory test using a rapid ELISA test from a 
different manufacturer as per the study protocol. Participants were allowed to 
report their HIV test result if previously tested, without undergoing the test in 
this study.  
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4.2.5 Digital Chest radiograph 
 
All participants were required to undergo a postero-anterior digital chest 
radiograph to exclude active TB. The chest radiograph was read by two 
experienced clinicians trained in the Chest Radiograph Review System 
(CRRS); a radiological review system specifically aimed at developing 
competency in the radiological diagnosis of TB (Pinto et al., 2013). 
 
4.2.6 Sputum microscopy and culture  
 
Participants who tested positive on symptom screen or had a chest x-ray 
suggestive of active TB were investigated further using sputum microscopy 
and culture, to exclude active TB. Two sputum samples were collected on 
separate days for TB investigation and culture was performed on both 
samples. If sputum could not be obtained, participants were provided with a 
referral letter to a TB clinic of their choice for further investigation and 
exclusion of active TB.  
 
4.2.7 Statistical methods  
 
Statistical analyses were performed using Stata version 11 (Stata Corp., 
College Station, Texas). The outcomes evaluated were test positivity for 
TST, QFT-GIT and T-SPOT.TB. The prevalence of potential TB associated 
risk factors and test outcomes were calculated. Stratified analysis was 
carried out to differentiate between staff from primary and secondary facilities 
and results were separately summarized.  
 
Risk factors for test positivity were evaluated using odds ratios (ORs) with 
95% confidence intervals (95% CIs). Univariate logistic regression analysis 
was performed to evaluate the relationship between potential risk factors for 
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TB infection and all three test outcomes. Individual multivariate regression 
models were then run for all variables of interest in relation to each test 
outcome, adjusting for covariates such as age and gender. Multivariate 
models were also applied in a stratified analysis, looking at determinants 
separately for staff employed at primary versus secondary level facilities. 
 
Logistic regression was used to develop models that best predicted test 
outcomes for each of the three different tests. Through a process of model 
building, a model was derived which best predicted a positive test outcome 
for the different TST and the two IGRA assays, individually. The best 
predictor model was determined by examination of the log likelihoods, the 
log-likelihood ratio tests, associated p-values and the Akaike’s information 
Criterion (AIC) generated by successive models with the final models chosen 
as representing that with the lowest AIC . The strength and precision of the 
associations were summarized using odds ratios, confidence intervals and p 
values.   
 
4.3 RESULTS  
 
4.3.1 Participant description 
 
The total study population sample eligible for participation was 764 health 
care workers from seven facilities. The latter were selected by a method of 
purposive sampling. Researchers were guided by Department of Health staff 
in choosing facilities that served high TB and HIV prevalence communities. 
Based on records supplied by the human resource management of the 
seven facilities, a total of 764 health care workers were employed and 
therefore eligible for the study.  
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Since participation was voluntary, 510 health care workers were recruited to 
participate in the survey, representing a 67% participation rate. The results of 
only 505 participants were included in the analysis as five participants did not 
meet the inclusion criteria (one was not in the employ of any of the facilities; 
whilst four others were pregnant). 
 
Participants were drawn from five primary level facilities, of which three were 
clinics, viz. Ubuntu, Kuyasa and Nyanga clinics, and two community health 
centres viz. the Delft and Nolungile Community Health Centres (CHCs). 
Clinics differ from the CHCs in the spectrum of services offered, but all 
facilities provide diagnostic and treatment services for potential TB patients. 
The facilities were located in areas that serve communities with a high 
prevalence of tuberculosis and HIV infection. Five facilities were located in 
Khayelitsha, which has a population of approximately 400 000 (based on 
2011 census data) and a TB case notification rate of over 1600/100 000, 
70% of which are co-infected HIV (City of Cape Town, 2011; Médecins Sans 
Frontières, 2011). 
 
The other two facilities were secondary level hospitals dedicated to the care 
of TB patients with complicated, multi-drug-resistant or extremely drug 
resistant TB cases. The Brooklyn Chest and DP Marais Hospitals are in the 
main referral centres situated a distance away from the communities that 
they serve. Patients referred are known TB patients requiring a greater level 
of expertise and care to manage their disease.   
 
With respect to employer category, participants were drawn from those 
employed by the Western Cape Provincial Health Department, the City of 
Cape Town Health Department or non-governmental organizations (NGOs) 
supporting health care programmes at a facility. Health care workers were 
defined broadly as any employeeor trainee based at the facility and engaged 
in the support and delivery of health services to the community.  This meant 
that clinical staff as well as administrative workers, community based health 
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workers, students in training and those tasked with the cleaning and security 
of facilities, were eligible for inclusion in the study.  
 
 
Figure 4.1. Recruitment and participation 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Primary care facilities staff 
at 5 facilities 
 
N = 427 
Secondary care facilities 
staff at 2 facilities 
 
N = 337 
Participants from 5 primary 
care facilities 
 
N = 267 
Participants from 2 secondary 
level facilities 
 
N = 243 
 
Total participants recruited 
 
N = 510 
Eligible study population 
N = 764 
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4.3.2 Demographic characteristics of participants 
 
Health care workers who participated in the study were predominantly female 
(74%), Xhosa-speaking (51%) (Table 4.1) and were evenly representative of 
primary and secondary level facilities. Participants were relatively young with 
marginally more health care workers aged below forty (52%) than above forty 
(48%). Participants were characterized by a high prevalence of current 
smokers (22%) and current alcohol use (32%).  
 
A large proportion of the participants(37%) reported being on treatment for 
other medical conditions .The most common conditions were asthma and 
hypertension with 8% reportedlybeing diagnosed or on treatment for diabetes 
. 
 
There was substantial awareness of the importance of HIV testing as 83% of 
participants indicated that they had previously been tested,with 97% of them 
willing to disclose their test result.Twelve percent reported having an earlier 
positive HIV test result and there was good uptake with 70% indicating their 
willingness to undergo a repeat test as part of the study protocol. The HIV 
prevalence, defined as reporting a positive test or being diagnosed positive 
in the study, was 11% in this population.  
 
Analysis of parental employment during childhood which was used as a 
proxy measure for childhood socio-economic status showed that only 8% of 
participants had neither parents working with the remainder having one or 
both parents working. Whilst data on educational status specifically was not 
collected, participants were asked about whether they had a formal health 
qualification with 38% indicating that they possessed some form of training in 
healthcare.  Overcrowding, a known risk factor for tuberculosis, was found to 
not be a problem as the median number of people sharing a bedroom was 2 
[IQR: 1- 2].Nurses (27%) and support staff (27%) comprised the largest 
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occupational categories of participants, followed by lay health care workers 
(17%) and administration staff (14%).  
 
In recognition of the differences in the scope and functions of the two types 
of facilities included in the study, a stratified analysis was carried out to 
explore demographic differences between participants from primary and 
secondary facilities.  Significant differences were found in the gender and 
age distribution between the facilities with staff at primary level facilities 
comprising more females (79% vs. 68% P=0.005) and younger employees 
(58% vs. 45%P=0.001). Fewer staff at primary level facilities reported having 
a professional qualification (31% vs. 44% P=0.002) and this was reflected in 
the marked differences in representation across different occupational 
categories with significantly fewer nursing staff in employment (21% vs. 34%; 
P=0.000) but a far higher number of lay health care workers (31% vs. 2%; 
P=0.000). Primary level staff also had significantly shorter duration of 
employment in a health care environment (median 9 versus 12 years; 
P=0.005) when compared to secondary level staff. These differences are to 
be expected and are in large part driven by the level of service and care 
provided at the different facilities. 
 
4.3.3 TB associated variables 
 
Evaluation of TB associated variables demonstrated high coverage of BCG 
vaccination (91%) which was classified as either having a history of or 
evidence of a vaccination scar upon inspection,as evidence of BCG 
vaccination (Table 4.2). Forty percent of participants indicated that they had 
previously been screened for TB. The most common screening tools 
employed were either chest radiography or sputum microscopy. There was a 
high prevalence of individuals who had previously been treated for TB (13%) 
in this study population. Screening for current active TB demonstrated a high 
prevalence of chest x-ray abnormality (23%) (X-ray compatible with active or 
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inactive TB) and a positive TB symptom screen (26%)  (defined as yes to the 
presence of any TB symptoms).  
 
Whilst participants were requested to consent to the administration of three 
tests for LTBI, not all the test results could be used in the analysis. For TST, 
test results were used only if the test was read by the trained observer within 
the 72 hours cut-off in accordance with the protocol. TST reactions that were 
not read in the specified time were therefore not included in the analysis 
yielding 484 valid results. A graphic presentation of the frequency distribution 
of TST reactions is shown in figure 4.2. For QFT-GIT 497 participants had 
the test done with one indeterminate result which could not be used in the 
analysis leaving 496 valid test results. For T-SPOT.TB there was a lower 
yield of valid results. Of the 493 participants who had a T-SPOT.TB test 
result, 465had a valid test result whilst 28 (6%)had indeterminate results. 
 
With regard to test outcomes, there were marked differences between the 
LTBI test positivity prevalence for the different tests used. For TST 84% of 
participants were shown to be positive (skin induration of 10mm or higher). 
For the IGRA assays the prevalence was considerably lower at 65% for 
QFT-GIT and 60% for T-SPOT.TB. 
 
There were differences between staff from primary and secondary level 
facilities with regard to the distribution of TB associated risk factors. 
Secondary level staff demonstrated greater BCG vaccination coverage (88% 
versus 80%; P=0.025). More primary level staff reported ever having been on 
treatment for TB (18% VS 7%; P=0.000) and HIV infection was also 
significantly higher (19% versus 2% P=0.000) in this group. Chest x-ray 
abnormality was more frequent in this group with a larger number of x-rays 
reported as being compatible with inactive TB and active TB respectively  
(20% vs. 11% and 10% vs. 5%; P=0.001).  
 
105
Despite these marked differences, which are suggestive of increased risk, 
there were no significant differences with respect to the outcomes of latent 
TB infection as reflected in TST and IGRA test results. However, the 
prevalence of test positivity was consistently higher for primary level staff 
across all three tests .The median TST reaction was higher in primary level 
staff compared to secondary level staff (19mm versus 16mm; P=0.001).    
 
 
Figure 4.2. TST size and frequency distribution (n=484) 
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4.3.4 Occupational and environmental characteristics  
 
An assessment of the distribution of occupational and environmental risk 
factors for TB across the whole group revealed that most employees 
perceived their exposure as high risk with 90% reporting having daily contact 
with TB patients and 76% reporting having recent contact (in the last 3 
months) with a newly diagnosed TB patient (Table 4.3). The majority of those 
who reported having had a recent exposure to TB patients indicated that 
such exposure occurred in the occupational setting (96%) rather than the 
household or another setting.An occupational exposure index was developed 
using a composite of measures related to proximity to infectious source, 
duration of exposure and infectivity of source, with a maximum exposure 
score equal to 11 points. The median occupational exposure score was 7 
[IQR 5 – 9]. 
 
Large numbers of employees were engaged in occupational tasks directed at 
providing care to TB patients such as interviewing of patients (48%), 
counselling of patients (42%) and general nursing care (30%). High-risk 
procedures associated with increased TB risk such as sputum collection and 
bronchoscopy procedures were less frequently performed (21% and 1%, 
respectively) by staff.  
 
Knowledge and practice of environmental measures were evaluated by 
gauging whether staffwere aware of specific engineering, administrative and 
aware of infection control measures such as the presence safe working 
practices that were practiced or available in their facilities.A high proportion 
of employees reported being of natural/ mechanical ventilation (93%) 
measures in their facilities, provision of disposable masks for patients with 
suspected TB (96%), provision of N-95 masks to staff (93%) and teaching of 
cough etiquette to patients (79%). The reported awareness of the  provision 
of on-site diagnostic services was high (78%), but administrative measures 
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such as knowledge of an infection control policy, separating TB patients from 
other patients and early triage of potential TB patients were less prevalent. 
 
Notably the majority of employees perceived themselves as being at high 
risk of contracting TB (58%). However, a large proportion reported having 
had no training to protect themselves from infection (38%) or reported having 
had no training to prevent spread of TB between patients (43%). 
 
4.3.5 Univariate analysis of factors associated with Latent TBInfection 
 
Univariate analysis for the whole group was performed to explore the 
relationships between individual variables and latent TB infection test 
outcomes as reflected in test positivity for eitherof the IGRA assays and the 
TST(Table 4.4).  Increasing age was positively associated with the presence 
of LTBIfor all 3 tests.BCG vaccination was not significantly associated with 
test positivity. Staff involved in home- based care were more likely to have a 
positive TSPOT-TB (OR= 3.83, CI 1.56 – 9.37) as were those working in 
institutions where cough etiquette was advocated (OR= 1.73, CI 1.10 – 
2.71). Duration of employment is a known risk factor for LTBI in a health care 
environment and this relationship showed a consistently positive association 
across all the tests, althoughnot significant for any one of the tests. No 
significant associations were demonstrated for any of the other occupational 
and environmental risk factors and the prevalence of LTBI. Sputum positivity 
for active disease was associated with increased risk of test positivity for the 
IGRA assays. So too was having daily exposure to TB patients. 
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4.3.6 Multivariate analysis of factors associated with LTBI  
 
Multivariate analysis was conducted adjusting for age category and 
gender(Table 4.5). Separate models were developed for each variable to 
explore associations after adjustment. There were no significant associations 
with TST positivity after adjustment in the combined group.  
 
For a positive test result on QFT-GIT, BCG vaccination emerged as a 
negative predictor [OR=0.43; (95% CI 0.20 – 0.91)]. Participants with a chest 
radiograph suggestive of active TB were more likely to test positive on QFT-
GIT [OR2.27; (95%CI 0.99 – 5.18)]. 
 
TSPOT positivity was associated with, being a Xhosa speaker (OR=1.49, CI 
1.02 – 2.19) in the multivariate analysis. Being involved in home-based care 
continued to be anindependent predictor of a positive test [OR=4.14; (95% 
CI 1.66 – 10.29). As was, being employed at a health facility that advocated 
cough etiquette [OR=1.68; (95% CI 1.06 – 2.66)].  
 
Stratified analysis was performed which evaluated relationships between 
covariates and test outcomes separately for staff at primary and secondary 
level facilities. These multivariate models were then adjusted for age and 
gender. In all cases where significant associations had been demonstrated in 
unadjusted models, these remained with some associations also 
demonstrating increased strength following multivariate adjustment.  
 
For TST outcome in primary level staff, participants with HIV positive status 
were less likely to test positive on TST [0R=0.41; (95% CI 0.17 – 
0.95)](Table 4.6.1) whilst those with long employment duration were more 
likely to have a positive TST [OR=4.17; (95% CI 1.12 – 15.62)] . In 
secondary level staff individuals who had undergone some training on self- 
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protection from TB infection, were also less likely to test positive [OR=0.38; 
(95% CI 0.16 – 0.91).  
 
In primary level staff a positive QFT-GIT test was more likely in individuals 
who had a history of ETS exposure [OR=2.37; (95% CI 1.34 – 4.22)], were 
involved in sputum collection [OR=3.25; (95% CI 1.28 – 8.09)] or were 
employed in healthcare for more than 20 years [OR= 2.42; (95% CI 1.09 – 
5.38)](Table 4.6.2). As with TST, secondary level staff were less likely to 
have a positive test if they had undergone some training on self- protection 
from TB infection [OR=0.41; (95% CI 0.22 – 0.77)].  
 
A positive TSPOT-TB test was strongly associated with being engaged in 
providing home-based care to TB patients [OR= 4.14; (95% CI 1.60 – 
10.70)], working at a facility where cough etiquette was advocated [OR=2.06; 
95% CI (1.04 – 4.10)] and where disposable surgical masks were provided to 
potentially infectious patients [OR=3.65; (1.16 – 11.51)]. These associations 
were however only applicable to staff working at a primary level facility 
(Table 4.6.3). 
 
4.3.7 Predictors of LTBI in logistic regression models 
 
Predictive models that best estimated TST positivity across both groups 
suggest that those of male gender who spoke an African home language and 
reported exposure to environmental tobacco smoke were most likely to test 
positive for TST (Table 4.7). By contrast, for QFT-GIT male gender, older 
age, a history of BCG vaccination and being engaged in sputum collection 
were most predictive of a positive test.For LTBI measured by TSPOT-TB 
those who were older, of male gender, had a history of BCG vaccination,who 
worked at facilities that practised cough etiquette and provide disposable 
masks  were at greater risk of testing positive. 
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4.3.8 Characteristics of newly diagnosed TB cases 
 
Two participants indicated that they were currently receiving TB treatment, 
one of whom was HIV positive. Of the 103 participants referred for sputum 
investigation, a further five tested positive for active disease. This translates 
into an overall prevalence of 7/505 or 14 / 1000 for active TB in this 
population. Of the five new cases detected none tested positive on sputum 
microscopy and all five were culture positive. Three tested positive on 
symptom screen , three on chest radiograph and three were HIV positive 
(Table 4.8). One case did not test positive on either chest radiograph or 
symptom screen, but was referred for sputum at her own request as she had 
felt unwell and had a colleague recently diagnosed with TB as a result of the 
study. This represented a deviation from the study protocol.All cases were 
TST positive, three were QFT and four were T-SPOT.TB positive.   
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Table 4.1 Demographic and general health qualities of participants (N=505) 
 
Participant characteristics    Number (%) of participants 
         
Gender 
 
-Male       134 (26%) 
-Female      371 (74%) 
 
Age 
 
- <30 years      126 (25%) 
- 31-40 years      136 (27%) 
- 41-50 years      134 (27%) 
- >50 years      109 (22%) 
 
Parental employment  
     
-Parents not working      40 (8%) 
-Single parent working     215 (43%) 
-Both parents working     250 (50%) 
 
Type of facility where employed 
 
-Primary level      263 (52%) 
-Secondary level     242 (48%) 
 
Home language 
       
-English      74 (15%) 
-Afrikaans      148 (30%) 
-Xhosa       256 (51%) 
-Other       27 (5%)  
 
Smoking history 
 
-Current      110 (22%) 
- Ex-smoker      63 (12%) 
- Non-smoker      332 (66%) 
 
Alcohol use 
 
-Ever consume alcohol     280 (55%) 
-Current consumption of alcohol    160 (32%) 
 
On treatment for other medical condition  186 (37%) 
 
Diabetes 
-Diagnosed      38 (8%) 
-On treatment      31 (6%) 
 
Data are presented as % or median (interquartile range) unless otherwise indicated.  
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Table 4.1 (continued). Demographic and general health qualities of participants 
(N=505) 
 
Participant characteristics    Number (%) of participants 
        
 
HIV testing and status 
 
-Ever tested for HIV      419 (83%) 
-Willing to disclose result of test     405 (97%) 
-Positive for HIV on previous test     49 (12%) 
-Willing to be tested now     354 (70%) 
 
 
*Overcrowding 
 
-No of people in house (median and IQR)    4 (3 – 5) 
-No of bedrooms in house (median and IQR)    3 (2 – 3) 
-No of people per room (median and IQR)    2 (1 – 2) 
 
Occupational status 
 
Professional health qualification     190 (38%) 
 
Job category 
 
-Management       13 (3%) 
-Doctors       12 (2%) 
- Nurses       137 (27%) 
-Research        12 (2%) 
-Support staff       137 (27%) 
-Lay health care workers      85 (17%) 
-Administration staff       71 (14%) 
     
Years of employment in a health environment    6 (2 -18)  
 
Data are presented as % or median (interquartile range) unless otherwise indicated.  
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Table 4.2 Frequency and distribution of TB specific variables (N=505) 
 
Variable      Number (%) of participants  
        
 
 
History BCG vaccination 
 
-Yes       423 (84%)    
-No       26 (5%)   
-Do not know      56 (11%) 
 
Vaccination scar     398 (79%) 
    
Ever treated for TB     65 (13%) 
 
Currently on TB treatment    2 (0.4%) 
     
Previous TB screening 
 
- All methods of screening     201 (40%) 
- Screening by chest radiograph for TB (N=201)  160 (80%)    
-Screening by sputum test for TB (N=201)  115 (57%)   
  
Current TB symptoms 
 
-Current cough       96 (19%) 
-Cough >2weeks     31 (6%) 
- Haemoptysis      2(0.4%) 
- Weight loss      56 (11%) 
-Night sweats      28 (6%) 
- Fever >2weeks     46 (9%) 
-Chest pain>2 weeks     54 (11%) 
 
Chest radiograph 
 
-Normal/other      381 (77%) 
-Inactive TB      78   (16%) 
-Active TB      37   (7%) 
 
Sputum positive (N=103)   ` 5     (5%) 
 
*TST reading      18 (13 – 22) 
 
**TST Positive (N=484)     405 [80% -87%] 
          
**QFT-GIT positive (N=496)    324 [61% – 70%]  
          
**TSPOT-TB positive (N=465)    277[55% - 64%] 
 
*For TST reading data presented as median and IQR.** For test outcomes 95% CI shown. 
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Table 4.3 Occupational and environmental risk factors for exposure to M. tuberculosis 
 
 
Exposure       N (%) of participants 
 
 
Daily contact with suspected TB patients     456 (90%) 
 
Recent contact with newly diagnosed TB patient (last 3 months) 385 (76%) 
 
Involvement in occupational tasks directed at TB patients 
 
-Clerking / interviewing         241 (48%) 
-Counselling         213 (42%) 
-Clinical examination       112 (22%) 
-Sputum collection       104 (21%) 
-General nursing care       153 (30%) 
-Home-based care         1 (8%) 
-Bronchoscopy procedures (N=502)     6 (1%) 
 
Knowledge and practice of infection control measures 
 
-Awareness of a facility infection control policy    313 (62%) 
-Presence of ventilation measures (natural / mechanical)   472 (93%) 
-Presence of UV radiation      224 (44%) 
-Teaching of cough etiquette to patients     397 (79%) 
-Early triage of potentially infectious patients    321 (64%) 
-Separating TB patients from other patients in clinic areas (N=501) 239 (47%) 
-Provision of on-site TB diagnostic services     396 (78%) 
-Provision of disposable surgical marks to infectious patients  485 (96%) 
-Provision of N-95 masks for staff to wear    472 (93%) 
- Provision of PPE       456 (90%) 
 
Recent exposure to TB 
 
- History of recent exposure      385 (76%) 
- Recent occupational exposure      367 (96%) 
- Occupational contact score (max score=11)    7 (5 – 9) 
 
Probability of infection (perception of risk) 
 
-Low         83 (16%) 
-Moderate        127 (25%) 
-High         296 (58%) 
 
Extent of training on self-protection 
 
-No training        191 (38%) 
-Some training        219 (43%) 
-Extensive training       95 (19%) 
 
Extent of training to prevent spread between patients 
 
- No training        216 (43%) 
-Some training        221 (44%) 
-Extensive training       68 (13%) 
 
N=number. Data are presented as % or median (interquartile range) unless otherwise indicated.  
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Table 4.4 Unadjusted logistic regression analysis of IGRA assays in comparison to TST (represented as odds ratios and 95% confidence intervals) 
 
 
VARIABLE    QFT-GIT    TSPOT-TB     TST  
  
 
Age category 
 
<30     1.00     1.00     1.00 
31-40     1.36 (0.82 – 2.25)   1.91 (1.14 – 3.19) *   2.08 (1.04 – 4.17)* 
41-50     2.18 (1.28 – 3.72) **   2.49 (1.46 – 4.23) **   1.85 (0.93 – 3.67) 
>50     1.31 (0.77 – 2.24)   2.05 (1.19 – 3.55) *   1.11 (0.58 – 2.13) 
 
Gender  
 
Female     1.00     1.00     1.00 
Male     1.40 (0.91 – 2.16)    1.39 (0.90 – 2.13)   1.53 (0.84 -2.81) 
 
Smoking 
 
Non-smoker    1.00     1.00     1.00  
Ex-smoker    0.90 (0.51 – 1.58)   1.06 (0.59 – 1.89)   1.14 (0.53 – 2.46) 
Current smoker    0.95 (0.60 – 1.51)   0.78 (0.49 – 1.23)   1.03 (0.56 – 1.90) 
 
ETS exposure    1.44 (0.96 – 2.16)   1.20 (0.80 – 1.81)   1.56 (0.93 – 2.60) 
 
Home language 
 
Afrikaans, English, other  1.00     1.00     1.00 
Xhosa     1.26 (0.87 – 1.82)   1.42 (0.98 – 2.06)   1.64 (1.00 - 2.69) 
_____________________________________________________________________________________________________________________________ 
ETS: environmental tobacco smoke. 
*P<0.05; **P<0.01; ***P<0.001. 
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Table 4.4 (continued). Unadjusted logistic regression analysis of IGRA assays in comparison to TSTs (represented as odds ratios and 95% 
confidence intervals) 
 
 
VARIABLE    QFT-GIT    TSPOT-TB     TST  
  
 
Type of facility 
 
Primary level facility   1.00     1.00     1.00 
TB hospital    0.95 (0.65 – 1.37)   0.82 (0.57 – 1.19)   0.87 (0.53 – 1.41) 
 
Risk factors for LTBI 
 
BCG vaccination   0.53 (0.25 – 1.09)   0.96 (0.49 – 1.89)   0.84 (0.34–2.07) 
Diabetes diagnosis   0.90 (0.45 – 1.79)   1.13 (0.56 – 2.25)   1.23 (0.46 - 3.27) 
Current alcohol use   0.95 (0.64 – 1.41)   0.95 (0.64 – 1.42)    0.66 (0.40 -1.09) 
Previous TB treatment   1.04 (0.60 – 1.81)   1.64 (0.91 – 2.95)   1.18 (0.56 – 2.51) 
Current TB treatment   0.53 (0.03 – 8.52)   -     - 
Symptom screen positive  1.29 (0.84 – 1.98)   1.19 (0.78 – 1.82)   0.88 (0.51 -1.52) 
 
HIV status (N=431) 
 
Positive / reported as positive  0.69 (0.38 – 1.23)   1.18 (0.64 – 2.19)   0.66 (0.32 – 1.43) 
 
Sputum (N=96) 
 
Positive     1.43 (0.89 – 2.31)   2.17 (0.23 – 20.24) 
 
Chest radiograph (N=456) 
 
Normal / other    1.00     1.00     1.00 
Inactive TB    1.01 (0.61 – 1.68)   1.29 (0.77 – 2.16)   1.76 (0.80 -3.84) 
Active TB    2.05 (0.91 – 4.60)   1.45 (0.68 – 3.08)   1.63 (0.55 – 4.77) 
*P<0.05; **P<0.01; ***P<0.001. 
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Table 4.4 (continued). Unadjusted logistic regression analysis of IGRA assays in comparison to TSTs (represented as odds ratios and 95% 
confidence intervals) 
 
 
VARIABLE    QFT-GIT    TSPOT-TB     TST  
  
 
Occupational Factors  
 
Health qualification   0.96 (0.65 – 1.40)   0.88 (0.60 – 1.29)   0.97 (0.59 – 1.59) 
Clerking / interview TB patients  1.02 (0.70 – 1.48)   1.19 (0.82 – 1.73)   1.03 (0.63 – 1.68) 
Counselling    0.83 (0.57 –1.20)   0.94 (0.64 – 1.36)   0.84 (0.51 – 1.37) 
Examination    0.82 (0.53 -1.28)   0.81 (0.52 – 1.26)   0.95 (0.53 – 1.69) 
Sputum collection   1.43 (0.89 – 2.31)   1.14 (0.72 – 1.82)   0.95 (0.53 – 1.71)  
Nursing     1.09 (0.73 – 1.63)   0.89 (0.59 – 1.33)   0.91 (0.54 – 1.54) 
Home-care    1.44 (0.70 – 2.96)   3.82 (1.56 – 9.35) **   1.27 (0.48 – 3.37) 
Bronchoscopy    1.06 (0.19 – 5.86)   0.45 (0.07 – 2.71)   - 
Infection Control Policy   1.02 (0.70 – 1.49)   1.03 (0.71 – 1.51)   0.80 (0.48 – 1.35) 
Ventilation measures   1.14 (0.54 – 2.39)   1.14 (0.54 – 2.40)   1.35 (0.53 – 3.41) 
UV lights    0.88 (0.61 – 1.28)   0.82 (0.57 – 1.19)   1.00 (0.61 – 1.63) 
Cough etiquette    1.20 (0.77 – 1.87)   1.69 (1.08 – 2.64)*   1.35 (0.77 – 2.36)  
Early triage    1.06 (0.72 – 1.56)   1.09 (0.74 – 1.61)   0.96 (0.58 – 1.60) 
Separation TB patients   1.20 (0.83 – 1.74)   1.20 (0.83 – 1.74)   0.98 (0.60 – 1.60) 
Diagnostic services   0.94 (0.60 – 1.49)   0.81 (0.51 – 1.29)   1.43 (0.81 – 2.52) 
Disposable surgical masks  1.39 (0.55 – 3.52)   2.09 (0.82 – 5.30)   2.10 (0.73 – 6.07) 
Provision of N95 Masks   1.42 (0.69 – 2.91)   1.74 (0.84 -3.57)   0.97 (0.36 – 2.62) 
PPE provision    1.39 (0.76 – 2.56)   1.39 (0.74 – 2.59)   1.12 (0.50 – 2.51) 
 
*P<0.05; **P<0.01; ***P<0.001. 
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Table 4.4 (continued). Unadjusted logistic regression analysis of IGRA assays in comparison to TSTs (represented as odds ratios and 95% 
confidence intervals) 
 
 
COVARIATE    QFT-GIT    TSPOT-TB     TST  
  
 
Training on self-protection 
 
No training    1.00     1.00     1.00    
Some training    0.68 (0.45 – 1.03)   0.81 (0.54 – 1.23)   0.73 (0.42 – 1.25) 
Extensive training   0.99 (0.57 – 1.70)   0.89 (0.53 – 1.50)   0.87 (0.43 – 1.76) 
 
Training patient protection 
 
No training    1.00     1.00     1.00 
Some training    1.10 (0.74 – 1.64)   1.45 (0.97 – 2.16)   1.29 (0.77 – 2.18)   
Extensive training   1.25 (0.69 – 2.25)   1.11 (0.63 – 1.96)   1.10 (0.53 – 2.31) 
 
Employment in healthcare  
 
< 10 years    1.00     1.00     1.00    
10 – 19 years    1.09 (0.65 – 1.82)   1.19 (0.71- 2.01)   1.08 (0.55 – 2.12) 
>20 years    1.40 (0.90 – 2.20)   1.23 (0.79 -1.91)   1.35 (0.74 – 2.46) 
 
Recent contact with TB patient 1.14 (0.74 – 1.75)   1.16 (0.75 – 1.78)   0.97 (0.55 – 1.73) 
 
Daily contact with TB patient  1.22 (0.66 – 2.23)   1.21 (0.66 – 2.23)   1.09 (0.49 – 2.44) 
 
Occupational contact score  1.01 (0.93 – 1.10)   1.01 (0.93 – 1.10)   1.00 (0.89 – 1.11 
 
*P<0.05; **P<0.01; ***P<0.001. 
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Table 4.5 Adjusted logistic regression analysis of IGRA assays in comparison to TST (represented as odds ratios and 95% confidence intervals) 
 
 
VARIABLE     QFT-GIT    TSPOT-TB     TST  
  
 
Age category 
 
<30      1.00     1.00     1.00 
31-40      1.41 (0.85 – 2.34)   1.98 (1.18 – 3.32) **   2.19 (1.09 – 4.41)* 
41-50      2.29 (1.33 – 3.91) **   2.60 (1.51 – 4.46) ***   1.95 (0.98 – 3.89) 
>50      1.37 (0.80 – 2.34)   2.15 (1.23 – 3.74)*   1.17 (0.61 – 2.25) 
 
Gender  
 
Female      1.00     1.00     1.00 
Male      1.48 (0.95 – 2.30)    1.50 (0.97 – 2.34)   1.64 (0.89 -3.02) 
 
Smoking 
 
Non-smoker     1.00     1.00     1.00  
Ex-smoker     0.78 (0.42 – 1.43)   0.93 (0.49 – 1.75)   1.07 (0.47 – 2.43) 
Current smoker     0.85 (0.52 – 1.38)   0.70 (0.43 – 1.14)   0.97 (0.51 – 1.86) 
 
ETS exposure     1.43 (0.94 – 2.15)   1.18 (0.78 – 1.80)   1.48 (0.88 – 2.49) 
 
Home language 
 
Afrikaans, English, other   1.00     1.00     1.00 
Xhosa      1.29 (0.88 – 1.88)   1.49 (1.02 – 2.19)*   1.60 (0.97 - 2.2.66) 
 
Data adjusted for age and gender. *P<0.05; **P<0.01; ***P<0.001  
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Table 4.5 (continued). Adjusted logistic regression analysis of IGRA assays in comparison to TST (represented as odds ratios and 95% confidence 
intervals) 
 
 
VARIABLE    QFT-GIT    TSPOT-TB     TST 
   
 
Type of facility 
 
Primary level facility   1.00     1.00     1.00 
TB hospital    0.91 (0.62 – 1.33)   0.77 (0.52 – 1.13)   0.90 (0.54 – 1.49) 
 
Risk factors for LTBI  
 
BCG vaccination   0.43 (0.20 – 0.91)*   0.96 (0.49 – 1.89)   0.78 (0.30 - 1.98)   
Diabetes diagnosis   0.80 (0.39 – 1.62)   0.95 (0.46 – 1.93)   1.23 (0.45 - 3.34) 
Current alcohol use   0.90 (0.59 – 1.37)   0.94 (0.61 – 1.44)    0.61 (0.35 -1.04) 
Previous TB treatment   1.08 (0.61 – 1.88)   1.66 (0.91 – 3.04)   1.14 (0.53 – 2.43) 
Current TB treatment   0.84 (0.05 – 13.85)   -     - 
Symptom screen positive  1.28 (0.83 – 1.99)   1.20 (0.78 – 1.86)   0.87 (0.50 -1.52) 
 
HIV status (N=431) 
 
Positive / reported as positive  0.81 (0.44 – 1.50)   1.48 (0.77 – 2.84)   0.64 (0.29 – 1.42) 
 
Sputum (N=96) 
 
Positive     0.15 (0.01 – 1.55)   0.69 (0.06 – 8.70)   - 
 
Chest radiograph (N=456) 
Normal / other    1.00     1.00     1.00 
Inactive TB    0.88 (0.52 – 1.49)   1.14 (0.67 – 1.94)   1.60 (0.72 -3.52) 
Active TB    2.27 (0.99 – 5.18)   1.68 (0.77 – 3.64)   1.78 (0.60 – 5.26) 
 
Data adjusted for age and gender.  *P<0.05; **P<0.01; ***P<0.001.  
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Table 4.5 (continued). Adjusted logistic regression analysis of IGRA assays in comparison to TST (represented as odds ratios and 95% confidence 
intervals) 
 
 
VARIABLE    QFT-GIT    TSPOT-TB     TST  
  
 
Occupational Factors   
 
Health qualification   0.99 (0.67 – 1.47)   0.88 (0.59 – 1.30)   1.05 (0.63 – 1.78) 
Clerking / interview TB patients  1.06 (0.72 – 1.57)   1.20 (0.81 – 1.78)   1.02 (0.61 – 1.70) 
Counselling    0.87 (0.59 –1.28)   0.96 (0.65 – 1.42)   0.88 (0.53 – 1.46) 
Examination    0.88 (0.56 -1.38)   0.86 (0.54 – 1.35)   1.04 (0.56 – 1.87) 
Sputum collection   1.54 (0.94 – 2.50)   1.18 (0.73 – 1.90)   1.03 (0.57 – 1.89)  
Nursing     1.13 (0.74 – 1.73)   0.88 (0.58 – 1.34)   1.00 (0.58 – 1.72) 
Home-care    1.48 (0.71 – 3.08)   4.14 (1.66 – 10.29) **   1.27 (0.47 – 3.44) 
Bronchoscopy    0.95 (0.17 – 5.37)   0.38 (0.06 – 2.35)   - 
Infection Control Policy   1.00 (0.67 – 1.47)   0.97 (0.66 – 1.44)   0.81 (0.48 – 1.38) 
Ventilation measures   1.13 (0.54 – 2.40)   1.12 (0.52 – 2.39)   1.43 (0.56 – 3.65) 
UV lights    0.84 (0.57 – 1.24)   0.75 (0.51 – 1.10)   1.02 (0.62 – 1.69) 
Cough etiquette    1.19 (0.76 – 1.88)   1.68 (1.06 – 2.66)*   1.32 (0.74 – 2.36)  
Early triage    1.01 (0.69 – 1.50)   1.03 (0.69 – 1.53)   0.95 (0.57 – 1.60) 
Separation TB patients   1.20 (0.83 – 1.75)   1.20 (0.82 – 1.75)   0.99 (0.60 – 1.61) 
Diagnostic services   0.93 (0.59 – 1.48)   0.78 (0.48 – 1.25)   1.40 (0.79 – 2.47) 
Disposable surgical masks  1.22 (0.48 – 3.12)   1.83 (0.71 – 4.73)   1.98 (0.67 – 5.84) 
Provision of N95 Masks   1.33 (0.64 – 2.77)   1.51 (0.72 -3.17)   0.99 (0.36 – 2.73) 
PPE provision    1.28 (0.69 – 2.38)   1.18 (0.62 – 2.25)   1.11 (0.49 – 2.52) 
 
Data adjusted for age and gender. *P<0.05; **P<0.01; ***P<0.001.  
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Table 4.5 (continued). Adjusted logistic regression analysis of IGRA assays in comparison to TST (represented as odds ratios and 95% confidence 
intervals) 
 
 
VARIABLE     QFT-GIT    TSPOT-TB     TST  
  
 
Training on self-protection 
 
No training     1.00     1.00     1.00    
Some training     0.68 (0.45 – 1.04)   0.77 (0.50 –1.17)   0.76 (0.44 – 1.31) 
Extensive training    0.98 (0.57 – 1.71)   0.83 (0.49 – 1.42)   0.87 (0.42 – 1.77)  
 
Training patient protection 
 
No training     1.00     1.00     1.00 
Some training     1.11 (0.74 – 1.66)   1.42 (0.94 – 2.14)   1.33 (0.78 – 2.26)  
Extensive training    1.24 (0.68 – 2.25)   1.03 (0.57– 1.85)   1.14 (0.54 – 2.41) 
 
Employment in healthcare  
 
< 10 years     1.00     1.00     1.00    
10 – 19 years     0.96 (0.55 – 1.68)   0.87 (0.49- 1.54)   1.03 (1.00 – 1.07) 
>20 years     1.35 (0.78 – 2.33)   0.92 (0.53 -1.57)   1.68 (0.80 – 3.52) 
 
Recent contact with TB patient  1.16 (0.75 – 1.80)   1.16 (0.75 – 1.78)   0.95 (0.53 – 1.71) 
         
Daily contact with TB patient   1.12 (0.60 – 2.09)   1.05 (0.56 – 1.96)   0.98 (0.43 – 2.23) 
       
Occupational contact score   1.02 (0.93 – 1.11)   1.02 (0.93 – 1.11)   1.02 (0.91 – 1.14) 
  
Data adjusted for age and gender; *P<0.05; **P<0.01; ***P<0.001.  
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Table 4.6.1 Adjusted logistic regression analysis of significant determinants of TST in primary 
and secondary facilities (represented as odds ratios and 95% confidence intervals)  
 
 
COVARIATE    UNADJUSTED    ADJUSTED 
    
 
TST 
 
 
PRIMARY 
 
HIV status (N=431) 
 
Negative/ reported as negative  1.00     1.00   
Positive / reported as positive  0.41 (0.18 – 0.92)*   0.41 (0.17 –0.95)*
  
Employment in healthcare  
 
< 10 years    1.00     1.00   
10 – 19 years    1.04 (0.44 – 2.47)   1.04 (0.44 – 2.47) 
>20 years    3.47 (1.01 – 11.97)*   4.17 (1.12 – 15.62)*
      
SECONDARY 
 
Training to protect yourself 
        
Nil     1.00     1.00   
Some     0.38 (0.17 –0.87)   0.38 (0.16 – 0.91) 
Extensive    0.63 (0.21 –1.90)    0.69 (0.21 – 2.23) 
 
Data adjusted for age and gender. *P<0.05; **P<0.01; ***P<0.001.  
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Table 4.6.2 Adjusted logistic regression analysis of significant determinants of QFT-GIT 
positivity in primary and secondary facilities (represented as odds ratios and 95% confidence 
intervals)  
 
 
VARIABLE    UNADJUSTED    ADJUSTED   
 
 
QFT 
_________________________________________________________________________________ 
 
PRIMARY LEVEL FACILITY 
 
ETS exposure    2.21 (1.27 – 3.85) **   2.38 (1.34 –4.22) ** 
 
Sputum collection   3.16 (1.27 – 7.88) **   3.25 (1.28 – 8.09)*
    
Employment in healthcare  
 
< 10 years    1.00     1.00   
10 – 19 years    1.79 (0.88 – 3.65)   1.69 (0.78 – 3.65) 
>20 years    2.28 (1.11 -4.66)*   2.42 (1.09 – 5.38)*
    
SECONDARY LEVEL FACILITY 
 
Training to protect yourself  
       
Nil     1.00     1.00   
Some     0.38 (0.17 – 0.88)*   0.41 (0.22 – 0.77) ** 
Extensive    0.63 (0.21 – 1.93)   0.70 (0.29 – 1.65) 
 
Data adjusted for age and gender. *P<0.05; **P<0.01; ***P<0.001.  
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Table 4.6.3 Adjusted logistic regression analysis of significant determinants of T-SPOT.TB 
positivity in primary and secondary facilities (represented as odds ratios and 95% confidence 
intervals) 
 
 
VARIABLE    UNADJUSTED   ADJUSTED  
   
 
TSPOT.TB 
_________________________________________________________________________________ 
 
PRIMARY 
 
Years in health employment  1.04 (1.00 – 1.07)*  1.02 (0.98 – 1.06) 
   
Home-care    3.61 (1.44 – 9.06) **  4.14 (1.60 –10.70) ** 
    
Cough etiquette    2.03 (1.05 – 3.93)*  2.06 (1.04 – 4.10)* 
    
Disposable surgical masks  3.51 (1.16 – 10.63)*  3.65 (1.16 – 11.51)* 
  
Data adjusted for age and gender. *P<0.05; **P<0.01; ***P<0.001.  
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Table 4.7 Multiple logistic regression models of LTBI predictors among health care workers 
 
Factor     Estimate (OR)   95% CI    p Value 
TST 
 
African Home language   1.57    0.96 – 2.57   0.072 
Exposure to secondary smoke   1.47    0.88 – 2.46   0.144   
Male gender    1.60    0.87 – 2.94     0.129  
 
AIC =430.97 
QFT-GIT      
 
Exposure to secondary smoke   1.38    0.91 – 2.09   0.127 
History of BCG vaccination  0.51    0.29 – 0.91   0.022 
Sputum collection   1.77    0.95 – 2.56   0.077 
Male gender    1.41    0.90 – 2.22   0.135 
Age 31-40    1.53    0.91 – 2.58   0.108 
Age 41–50    2.59    1.49 – 4.52   0.001 
Age >50    1.55    0.89 – 2.70   0.125  
 
AIC = 633.19 
TSPOT.TB               
 
History of BCG vaccination  0.60    0.34 – 1.06   0.078 
Home care of TB patients  4.16    1.64 – 10.55   0.003 
Advocate cough etiquette  1.59    0.99 – 2.56   0.056 
Disposable masks available  2.11    0.78 – 5.69   0.139 
Male gender    1.64    1.03 – 2.59   0.036 
Age 31 – 40    2.07    1.21 – 3.55   0.008 
Age 41 – 50    2.57    1.46 – 4.54   0.001 
Age > 50    2.39    1.33 – 5.29   0.003 
 
AIC =601.35 
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Table 4.8 Characteristics of newly diagnosed TB cases 
_____________________________________________________________________________________________________________________________ 
 
   TST  QFT  TSPOT.TB Symptom CXR  HIV  Microscopy  Culture  
         Screen 
 
 
Case 1 (100)  +  +  +  +  +  -  -   + 
 
Case 2 (115)  +  +  +  -  +  -  -   + 
 
Case 3 (125)*  +  +  +  -  -  +  -   + 
 
Case 4 (142)  +  -  +  +  +  +  -   + 
 
Case 5 (220)  +  -  -  +  -  +  -   + 
 
Symptom screen: yes to any one cardinal symptom of TB.CXR: radiological picture of active TB. 
*Protocol deviation as symptom screen and CXR negative. 
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4.4 KEY FINDINGS 
 
1. Based on voluntary participation, a 67% participation rate was 
achieved for the study with staff equally drawn from primary and 
secondary level facilities. 
 
2. Participants were predominantly female (74%) and Xhosa speaking 
with nurses(27%) and support staff (27%) comprising the biggest 
occupational categories. 
 
3. BCG coverage was virtually universal and 13% of staff indicated that 
they had previously been treated for TB. 
 
4. There were significant differences in the demographic profiles of staff 
employed at primary and secondary level facilities. Primary care staff 
were younger, predominantly female, Xhosa-speaking, less likely to 
smoke, had a shorter duration of employment,were more likely tobe 
HIV positive and to have had treatment for previous TB. 
 
5. LTBI prevalence as measured by TST, QFT -GIT and T-SPOT-TB 
were 84%, 65% and 60% respectively for the group overall and 
surprisingly were not significantly different between primary and 
secondary level staff. 
 
6. Despite a high proportion of individuals testing positive on symptom 
screen (26%) and chest x-ray (7%), only five new cases of 
tuberculosis was diagnosed. This together with two co-prevalent 
cases already on treatment resulted in a TB disease prevalence of 
7/505 or 14/1000. 
 
7. All cases detected by screening were diagnosed on sputum culture. 
Three cases were HIV positive and three had radiographic evidence 
of TB whilst a further three were positive on symptom screen. 
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8. Occupational exposure to TB patients was highly prevalent, with good 
awareness of the practice of infection control measures demonstrated 
(44 – 93%) and awareness of personal protective equipment (90%). 
 
9. Despite a perception by 58% of participants that they were at high risk 
for contracting TB, 38% have had no training to protect themselves 
against TB.  
 
10. Following multivariate analysis that adjusted for age and gender a 
positive TST was significantly associated with long duration of 
employment (>20 years) and negatively associated with a positive HIV 
status in primary level staff. In secondary level staff, training in 
infection control was negatively associated with TST positivity. 
 
11. For QFT-GIT significant predictors of a positive test in primary level 
staff were long duration of employment (>20 years), performing 
sputum collection and exposure to environmental tobacco smoke. In 
secondary level staff, training in infection control was negatively 
associated with QFT-GIT positivity. 
 
12. T-SPOT.TB positivity was associated with the performance of home-
care to TB patients and paradoxically with the practice of infection 
control measures such as practice of cough etiquette and provision of 
disposable surgical masks by staff at primary level facilities.  
 
13. Models generated to best predict test outcome shows male gender to 
be a consistent positive predictor across all test outcomes, whilst 
increasing age showed a positive, and BCG vaccination a negative 
association with IGRA outcomes.  
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CHAPTER 5 
 
5.1  INTRODUCTION AND OBJECTIVES  
 
Health care workers (HCWs) are known to be at increased risk of 
Tuberculosis (TB) infection and disease on account of occupational exposure 
to infectious TB patients (Baussano et al., 2011; Joshi et al., 2006; Menzies, 
Joshi & Pai, 2007). TB infection prevalence among HCWs in low and middle-
income countries has been estimated to be 54% (range 33 – 79%) with an 
annual incidence of infection of 8.4% in high burden countries (i.e. >100/100 
000 TB cases per population). In high burden communities within South 
Africa, the community prevalence of TB infection has been shown to be 
greater than 80%, posing a challenge for TB control in this country(Mahomed 
et al., 2006). 
 
Until recently the tuberculin skin test (TST) was the only test available for 
evaluating TB infection. The TST measures a hypersensitivity response to 
purified protein derivative(PPD), a mixture of antigens some of which are 
common to Mycobacterium tuberculosis, M Bovis (the source of the Bacille 
Calmette-Guerin (BCG) and several nontuberculous Mycobacteria (NTM). 
Whilst the test has acceptable sensitivity, its specificity is suboptimal, in 
populations with BCG vaccination and significant infection with NTM. 
 
Recent advances in immunology have led to promising alternatives to the 
TST, for diagnosis of LTBI (Menzies, Pai& Comstock, 2007; Pai, 2005; Pai, 
Kalantri & Dheda, 2006). These are the in-vitro interferon-gamma (IFN-γ) 
assays which use antigens such as the early secreted antigenic target 6 
(ESAT-6) and culture filtrate protein (CFP-10). These proteins are encoded 
within the region of difference (RD1) of the M tuberculosis genome and are 
therefore more specific than PPD. Furthermore they are not shared by BCG 
strains or other NTM species that may lead to non-specific sensitization and 
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false positive reactions as with TST. IGRA assays have other advantages in 
that they require one visit, do not rely on trained readers, provide an 
objective laboratory measure of LTBI and may be used in serial testing 
without causing boosting. These assays are however more expensive and 
require laboratory infrastructure for processing. Furthermore there is limited 
research on the utility of IFN-γ assays in high TB incidence countries. 
 
Two IFN-γ assays for diagnosing LTBI have been developed and licensed for 
commercial distribution. These are the QuantiFERON-TB Gold-In-Tube 
(QFT-GIT) (Cellestis Limited, Victoria, Australia) and the T-SPOT.TB (Oxford 
Immunotec, Oxford, UK). The QFT-GIT uses an enzyme–linked 
immunosorbent assay (ELISA) to measure antigen specific production of 
IFN-γ by circulating T-cells in whole blood whilst the T-SPOT.TB measures 
peripheral blood mononuclear cells (PMBCs) that produce IFN-γ, using an 
Elispot technique (Pai, Zwerling & Menzies, 2008). Research in low 
incidence settings have suggested that IFN-γ assays have superior 
specificity, better correlation with recent TB exposure and are less affected 
by cross reactivity due to BCG vaccination (Pai, 2005). In such settings 
where serial screening for LTBI is generally implemented, IFN-γ assays have 
been incorporated into screening protocols for HCWs (Mazurek et al. 2010; 
National Collaborating Centre for Chronic Conditions (UK) & Centre for 
Clinical Practice at NICE (UK), 2011). 
 
The use of IGRAs instead of TST for one-time screening has resulted in a 
lower prevalence of positive tests than with TST and fewer HCWs who 
require LTBI treatment in low TB incidence settings. Studies among HCWs in 
low TB incidence countries that evaluated head-to-head comparison 
between TST and IFN-assays have shown varying levels of agreement and 
discordance between tests (Lien et al., 2009; Nienhaus et al., 2008;  
Zwerling et al., 2012a; Vinton et al., 2009). Whilst some of the discordance is 
driven by BCG vaccination, this in itself is not sufficient explanation for the 
discordance and has raised questions about their application in clinical 
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practice (Zwerling et al., 2012b). Very few studies involving a head-to-head 
comparison between IGRAs and TST have been conducted among HCWs in 
high TB incidence settings and whilst these have shown moderate to 
substantial agreement, the evidence base is currently too limited to support 
any recommendations for their routine use (Pai et al., 2009; Zwerling et al., 
2012b; World Health Organization, 2010). 
 
Meta-analyses and systematic reviews evaluating test performance have 
supported comparable sensitivity and superior specificity of IGRAs compared 
to TST. The context of such studies have in the main been low TB incidence 
settings (Pai, Zwerling & Menzies, 2008). Test performance has varied 
depending on BCG coverage of the study population. Data from high TB 
incidence settings are scarce and limited for high risk populations and 
immunocompromised persons.  
 
In the absence of a gold standard for LTBI, studies have relied on active TB 
as a proxy measures for LTBI. These two disease states occur at opposite 
ends of the TB infection spectrum and are considered two completely 
different clinical entities. It is known that cellular immunity is compromised in 
TB disease. This may influence TST test response resulting in a falsely 
negative result. Latent class analysis (LCA) is a statistical method that has 
been widely used to estimate prevalence and diagnostic test sensitivity in the 
absence of results from a perfect diagnostic test or gold standard. It therefore 
has particular application in the context where multiple tests may be used to 
determine disease status in the absence of a true gold standard as in latent 
TB infection (Dendukuri, Hadgu & Wang, 2009; Dendukuri & Joseph, 2001; 
Pai et al., 2008). LCA modelling also allows for the consideration of 
conditional dependency as tests may not be independent of each other and 
may exhibit a degree of correlation, e.g. as between two IGRA assays, which 
may affect estimates.  
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This study conducted LTBI screening of a local HCW population, using a 
head-to-head comparison between TST and IGRA tests administered in a 
high TB incidence setting. This allowed for the determination of agreement 
and discordance between tests and factors associated with concordance and 
discordance. The application of LCA furthermore allowed for a comparison 
between the relative sensitivity and specificity of the tests for the diagnosis of 
LTBI, in the absence of a gold standard. 
 
The data generated allowed for the calculation of estimates for the main 
outcomes of interest as previously outlined in the thesis objectives:  
1. To determine the level of agreement between TST and IGRA. 
2. To identify factors associated with discordance in health care workers 
in a high TB and HIV prevalence community. 
3. To compare sensitivity and specificity of the LTBI diagnostic tests in a 
high TB incidence population. 
 
5.2 METHODS  
 
5.2.1 Population and test outcomes 
 
All participants were required to undergo TST and venesection for QFT-GIT 
and T-SPOT.TB.TST was performed using 1 TU dose of PPD RT23 (Statens 
Serum Institut, Copenhagen, Denmark). Tuberculin was administered by a 
nurse experienced in administering the tuberculin skin test using the 
Mantoux method and skin induration was read after 48-72 hours. To prevent 
inter-reader variability only one person read the TST reaction, using a ruler 
and ballpoint method. An induration of at least 10mm was considered 
positive. In the case of known HIV infected individuals 5mm or more was 
considered a positive reading. 
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Participants were tested with the QFT-GIT and the T-SPOT.TB. Blood 
specimens for the IGRA assays were drawn concurrently with or within three 
days of administering the TST to eliminate the effect of potential boosting 
(van Zyl-Smit et al., 2009a; van Zyl-Smit et al., 2009b). The QFT-GIT test 
was considered positive if the interferon-gamma response minus the nil 
antigen was ≥0.35 IU/ml. The TSPOT.TB assay was performed in 
accordance with the manufacturer’s instructions. The number of IFN-λ spot 
forming T cells (SFC) per million peripheral blood mononuclear cells 
(PBMCs) was determined using an AIM ELISPOT reader and Oxford 
Immunotec software. A cut-off of six or more spots was treated as a positive 
result. To minimize inter-operator and inter-laboratory variability, all assays 
were done by the same operator in the same laboratory. Indeterminate 
results were treated as missing data and observations were not used in the 
agreement analyses.  
 
5.2.2 Agreement statistics 
 
Statistical analyses were performed using Stata version 11 (Stata Corp, 
College Station, Texas). Outcomes that were evaluated included agreement 
between the tests and factors associated with discordance. The kappa 
statistic (κ) was used to quantify agreement between tests and 95% 
confidence intervals were calculated for each kappa value. The kappa 
statistic measure of agreement is scaled to be 0 when the amount of 
agreement is equal to what would be expected to be observed by chance 
and 1 when there is perfect agreement. Kappa categories of agreement 
according to Landis and Koch are therefore: poor if below 0; slight if ≤  2.0; 
fair if 0.21 – 4.0; moderate if equal to 0.41-0.60, substantial if 0.61 -0.80 and 
almost perfect if 0.81-1.00 (Munoz & Bangdiwala, 1997). In view of the 
variability observed in studies with serial administration of IGRAs and the 
potential impact of boosting of IGRA test response by TST, agreement 
analyses using higher cut-offs for test positivity were also performed on 
baseline results. 
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Agreement analyses were also carried out on the test outcomes generated 
from repeat testing of the cohort one year later. This agreement was also 
calculated on absolute values using standard cut-offs for test positivity and 
did not take into consideration the baseline test results. 
 
Factors associated with discordance were explored using a multinomial 
logistic regression model that compared discordant groups with a 
comparison group displaying perfect agreement between test outcomes. 
Discordant groups for both IGRA assays were defined as having a positive 
TST/negative IGRA or a negative TST/ positive IGRA).  
 
5.2.3 Latent Class analysis 
 
To estimate the sensitivity and specificity of different diagnostic tests, latent 
class analysis (LCA) was used. This is a statistical modelling technique that 
is based on the premise that the results of various imperfect tests for the 
same condition are influenced by a common underlying latent variable, which 
represents the true disease status (Christopher et al., 2010; Dendukuri, 
Hadgu & Wang, 2009; Pai et al., 2008). A pre-condition for a meaningful LCA 
model (i.e. for the model to be identifiable) is that the number of diagnostic 
tests used on the study sample must provide at least as many degrees of 
freedom as the number of parameters to be estimated. If not, then a 
Bayesian estimation approach can be used to place reasonable bounds on 
some parameters about which prior information is available. This would allow 
for the estimation of the remaining parameters conditional on this prior 
information. 
 
For this study design that involved 3 dichotomous tests, the problem is 
identifiable if it is assumed that the results of individual diagnostic tests for a 
given disease status are independent (conditional independence) and that 
observed associations between tests are due solely to the latent variable. 
140
However, this assumption is questionable as there are similarities in the 
technological properties and immunological mechanism underlying the two 
IGRA assays, which could potentially result in correlation between test 
results (conditional dependence).Therefore, an alternative model was also 
considered allowing for conditional dependence between QFT and TSPOT 
given subjects truly positive, and conditional dependence between QFT and 
TSPOT given subjects truly negative. The conditional dependence is 
assumed to be positive in both groups. This conditional dependence model is 
no longer identifiable necessitating the use of prior information. 
 
In the analysis, a non-informative prior is used for the prevalence of LTBI 
which is unknown. Prior information on the accuracies of the three tests is 
elicited from Pai, Zwerling and Menzies (2008) using data on the sensitivity 
and specificity of TST and QFT-GIT based on systematic reviews and meta-
analyses. The prior 95% CI of each parameter is constructed in such a way 
that the prior 95% CI covers all the 95% CIs from individual studies included 
in the meta-analysis. Therefore it is equivalent to the prediction interval 
resulting from the meta-analysis. Non-informative priors are used for the 
conditional dependence terms and the method introduced by Dendukuri and 
Joseph (2001) is used to construct the priors. The prior set is presented in 
Table 5.1. 
 
In applying a latent class model, subjects with both determinate and 
indeterminate results were included as participants with indeterminate results 
in one test may still have relevance in the analysis on account of determinate 
results in the remaining two tests. A fixed effects model allowing for 
conditional dependence between QFT-GIT and TSPOT.TB was used to fit 
the data (Dendukuri & Joseph, 2001). WinBUGS software was used to 
analyse the data. Twenty thousand samples were drawn from the posterior 
distribution after discarding a burn-in of 1000 iterations. Convergence of the 
Monte Carlo Markov chain was assessed using the Gelman-Rubin statistic 
which is named BGR within WinBUGS. 
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Table 5.1 Prior information on sensitivity and specificity of tuberculin skin-test 
and IGRA assays* 
 
       Prior distribution range 
Parameter       (95% Cl) 
______________________________________________________________________ 
TST sensitivity     43 – 100 
TST specificity     27 – 100 
QFT-GIT sensitivity     52 – 99 
QFT-GIT specificity     67 – 100 
TSPOT.TB sensitivity    63 – 100 
TSPOT.TB specificity    77 – 100 
     *Dendukuri and Joseph, 2001 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
142
5.3 RESULTS 
 
5.3.1 Participants with TST and IGRA assay outcomes  
 
At baseline a valid outcome measure for TST was available for 484 
participants who had undergone TST and had a reading recorded. For 
participants who had a QFT-GIT test administered, valid results were 
available for 496 as one test result was indeterminate. For T-SPOT.TB the 
indeterminate rate was higher and only 465  test results were valid. Valid test 
pairs were available for comparison between TST and QFT-GIT for 482 
participants and between TST and T-SPOT.TB for 45Oparticipants. At follow-
up 339 participants had repeat IGRA assays done but only 147 had repeat 
TST administered as many participants refused repeat TST on account of 
discomfort experienced following the TST administered at baseline. This 
resulted in 147 participants with both TST and QFT-GIT and 138 participants 
with both TST and T-SPOT.TB that could be used in agreement analyses at 
follow-up.  For T-SPOT.TB and QFT-GIT there were 315 participants with 
valid test results for both assays at follow-up. 
 
5.3.2 Agreement and discordance between TST and IGRA assays 
 
There was only fair agreement between TST and QFT – GIT [κ=0.28, CI 0.19 
– 0.39] as well as between TST and T-SPOT.TB [κ =0.25, CI 0.18 – 0.33] 
(Table 5.2).  Agreement between the two IGRA assays as expected was far 
higher at 83.7% [κ = 0.65, 95% CI 0.56 – 0.0.74] which is indicative of 
substantial agreement.  Participants were followed up at one year interval 
and TST and IGRA assays were repeated, allowing for agreement 
comparison of tests performed at follow-up. Upon repeat testing at one year, 
agreement between QFT-GIT and TST improved from fair to moderate. This 
was however calculated on absolute values using standard cut-offs for test 
positivity and did not take into consideration prior test results. 
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5.3.3 Agreement and discordance between TST reactions and IGRA 
 assays 
 
At baseline agreement analysis was performed between the IGRA assays 
and three different cut-offs for TST (≥5, ≥ 10 and ≥15 mm) without taking HIV 
status into consideration (Table 5.3).  Agreement between QFT-GIT was fair 
and remained marginally unchanged across the different cut-offs for TST 
with slight improvement in kappa values from 0.25 – 0.29. Agreement 
between TST and TSPOT.TB was fair with slight improvement as TST 
induration increased (κ= 0.21 – 0.30). 
 
Because of uncertainty around IGRA cut-offs and a high degree of natural 
variability in test results obtained from sequential screening, agreement 
analyses were performed using different cut-offs. Agreement between TST ≥ 
15mm and QFT-GIT of 0.70 IU/ml which is twice the cut-off currently 
recommended as indicative of a positive test, did not show any improvement 
[κ=0.27, 95% CI 0.18 – 0.36]. Similarly using the more conservative cut-off of 
an 8 spot increment to denote a positive T-SPOT.TB and comparing this to a 
TSTS ≥15 mm did not alter the level of agreement [κ=0.28, 95% CI 0.19 – 
0.37] when compared to conventional cut-offs that denote test positivity.   
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Figure 5.1. TST and IGRA tests administered at baseline 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Study population 
N = 505 
QFT-GIT 
N = 496 
TST 
N = 484 
T-SPOT.TB 
N = 465 
PAIRED TST and QFT 
N = 482 
PAIRED TST and TSPOT.TB 
N = 450 
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Table 5.2 Agreement and discordance between TST and IGRA assays at baseline and follow-up 
 
      BASELINE       FOLLOW-UP 
      ___________________________________  __________________________________ 
      QFT-GIT (N=482) TSPOT.TB (N=450)  QFT-GIT (N=147) TSPOT.TB (N=138) 
 
 
Positive TST and positive IGRA assay  293    249    97   81 
 
Negative TST and negative IGRA assay  53   55    20   19 
 
Positive TST and Negative IGRA assay  112   126    26   33 
 
Negative TST and positive IGRA assay  24   20    4   5 
 
Agreement (%)     71.8%   67.6%    79.6%   72.5 
 
Kappa (95% CI)    0.28 [0.20 – 0.36] 0.25 [0.18 – 0.33]  0.45 [0.31 – 0.60] 0.34 [0.20 - 049] 
 
TST≥10mm or ≥5mm if HIV positive used to denote a positive TST test response at baseline. 
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Table 5.3 Agreement and discordance between TST reactions and IGRA assays at baseline using different cut-offs 
 
        TST≤5    TST≤10    TST≤15 
  
 
QFT-GIT (N=482) 
 
Positive TST & positive IGRA assay   307    293     257 
 
Negative TST & negative IGRA assay   39    53     77 
 
Positive TST & Negative IGRA assay   126    112     88 
 
Negative TST & positive IGRA assay   10    24     60 
 
Agreement (%)      71.8%    71.8%     69.3% 
 
Kappa (95% CI)     0.25 [0.18 – 0.31]  0.28 [0.20 – 0.36]   0.29 [0.20 – 0.37] 
 
 
TSPOT.TB (N=450) 
 
Positive TST and positive IGRA assay   259    249     221 
 
Negative TST and negative IGRA assay   40    55     84 
 
Positive TST and Negative IGRA assay   141    126     97 
 
Negative TST and positive IGRA assay   10    20     48 
 
Agreement (%)      66.4%    67.8%     67.8% 
 
Kappa (95% CI)     0.21 [0.14 – 0.28]  0.25 [0.16 – 0.33]   0.30 [0.21 – 0.39] 
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5.3.4 Agreement and discordant test responses 
 
Discordant test responses were evaluated using a multinomial regression 
analysis that compared discordant with concordant test responses which 
served as the reference group. For a TST positive/QFT-GIT negative 
discordant test response there were no significant predictors and specifically 
no association with BCG vaccination. Whilst there was a significantly 
negative association between years in healthcare employment and a 
discordant (TST -/ QFT-GIT+) test response (OR=0.94, 95% CI 0.89 – 0.99) 
i.e. longer serving employees were more likely to have a discordant test 
response (TST- / QFT-GIT+). Recent exposure defined as a recent contact 
with an infectious TB patient was not significantly associated with 
discordance. 
 
Negative predictors of discordance (TST+/TSPOT.TB-) were older age 
(OR=0.97, CI 0.95 – 0.99) and being engaged in home-based care 
(OR=0.32, 95% CI 0.11 – 0.94). Participants with a discordant test response 
(TST-/ TSPOT.TB +) were more likely to be HIV positive, have had TB 
treatment previously and to test positive on symptom screen when compared 
to those with concordant tests responses. They were also more likely to be 
working in a facility that practiced triaging of TB patients as a measure of 
infection control. As with TST-/ QFT+ discordance, TST-/ TSPOT.TB + 
discordance were negatively associated with years in healthcare 
employment. 
 
Discordance between IGRA assays were similarly evaluated using 
regression analysis. Being HIV positive was strongly associated with a 
discordant (T- SPOT.TB+/ QFT-GIT-) test response as was being engaged in 
home-based care and being a Xhosa speaker (Table 5.6).  Negative 
predictors of this type of discordance were being engaged in occupational 
tasks such as counselling of TB patients, sputum collection and nursing care 
of TB patients. Having a health qualification and working at a facility that 
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provided personal protective equipment (PPE) (during performance of high 
risk procedures) were similarly negatively associated with this pattern of 
discordance.  
 
No positive associations were found for QFT+/ T-SPOT.TB- discordance. 
Negative associations were demonstrated for age and for certain 
occupational factors such as being engaged in clerking of TB patients, 
working at facility that practices cough etiquette and provision of 95 
respirators and  PPE (during performance of high risk procedures).    
 
5.3.5 Latent class analysis  
 
A comparison between test performance using a traditional latent class 
analysis model assuming conditional independence and one that takes 
account of conditional dependency between IGRA assays (fixed effect 
model) is shown in Table 5.7. In the fixed effect model sensitivity is highest 
for TST (93.3%), followed by QFT-GIT (84.1%) and T-SPOT.TB (78.6%). 
Specificity on the other hand is lowest for TST (54.7%), followed by QFT-GIT 
(93.2%) and T-SPOT.TB (96.1%).   
 
The estimate of LTBI in this model was 77% (95% CI 63.8 – 91) and slightly 
higher than the prevalence generated by the traditional LCA model at 69.3% 
[95% CI 63.1 -74.6]. TST test performance showed an improvement in 
sensitivity and specificity with the application of a fixed effects model, whilst 
the values for both IGRA assays declined. In general, the confidence 
intervals for test sensitivity and specificity generated from the application of a 
fixed effects model all fell within the prior distributions, which were estimated 
from previous studies. 
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Table 5.4 Results of multinomial regression for discordant QuantiFERON-TB Gold-in-tube and tuberculin skin test 
                 
 
      Positive TST and negative   NegativeTST and positive    
      QFT-GIT test result    QFT-GIT test result 
      _________________________   _____________________________ 
Risk Factor     OR (95% CI)     OR (95% CI)   
                   
      N=112      N=24 
 
 
Older age, per each additional year  0.99   (0.70 – 1.01)                  1.01 (0.98 – 1.05)  
    
Male gender     0.93 (0.57 -1.52)    1.15 (0.46 – 2.87) 
  
BCG Vaccination    1.93 (0.79 – 4.71)    1.20 (0.27 – 5.32)  
  
HIV Positive / reported as positive  1.12 (0.55 – 2.25)    1.97 (0.63 –6.16) 
  
Previous TB Treatment    1.03 (0.55 – 1.94)    1.34 (0.44 – 4.09) 
  
Symptom screen positive   0.67 (0.40 -1.13)    1.56 (0.66 – 3.69) 
  
Years in healthcare    0.99 (0.97 – 1.01)    0.94 (0.89 – 0.99)* 
  
Home care of TB    0.73 (0.31 – 1.71)    0.99 (0.22 – 4.44) 
  
Separation of TB patients   1.00 (0.65 – 1.53)    2.30 (0.96 – 5.51) 
  
Recent contact with TB patients   0.75 (0.46 – 1.2 )    0.70 (0.28 – 1.74)  
  
Daily contact with TB patients   0.78 (0.39 – 1.5     1.12 (0.25 – 4.99)  
 
*P<0.05; **P<0.01; ***P<0.001 
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Table 5.5 Results of multinomial regression for discordant TSPOT.TB and tuberculin skin test  
 
 
      Positive TST and negative   Negative TST and positive    
      TSPOT.TB test result    TSPOT.TB test result 
      _________________________   _____________________________ 
Risk Factor     OR (95% CI)     OR (95% CI)   
                   
      N=126      N=20 
 
Older age, per each additional year      0.97 (0.95 – 0.99) **    1.00 (0.96 - 1.04)   
  
Male gender     0.93 (0.58 -1.50)    1.22 (0.45 – 3.29) 
  
BCG Vaccination    1.22 (0.55 – 2.67)    1.78 (0.23 – 13.81) 
  
HIV Positive / reported as positive  1.03 (0.50 – 2.11)    4.72 (1.64 – 13.59) ** 
  
Previous TB Treatment    0.88 (0.46 – 1.68)    3.00(1.09 – 8.28)* 
  
Symptom screen positive   1.05 (0.65 -1.68     2.95 (1.18 – 7.35)* 
  
Years in healthcare    0.98 (0.96 – 1.0)    0.94 (0.88 – 1.00)* 
  
Home-care     0.32 (0.11 – 0.94)*    1.74 (0.48 – 6.30) 
  
Separation TB patients    1.00 (0.66 – 1.52)    2.66 (1.00 – 7.11) 
  
Recent contact with TB patient   0.74 (0.46 – 1.19)    0.63 (0.23 – 1.72) 
  
Daily contact with TB patient   0.88 (0.45 – 1.71)    2.08 (0.27 – 16.09)  
 
*P<0.05; **P<0.01; ***P<0.001 
 
 
151
Table5.6 Results of multinomial regression for discordant QFT-GIT and T-SPOT.TB   
 
 
      Positive QFT-GIT and negative   Negative QFT-GIT and positive   
      T-SPOT.TB test result    T-SPOT.TB test result 
      _________________________   _____________________________ 
Risk Factor     OR (95% CI)     OR (95% CI)   
                   
      N=47      N=29 
 
Older age, per each additional year      0.97 (0.95 – 1.00)*    0.97 (0.92 - 1.01)    
Male gender     0.98 (0.50 -1.97)    1.09 (0.47 – 2.55)  
BCG Vaccination    0.46 (0.19 – 1.12)    1.09 (0.25 – 4.83)  
HIV Positive / reported as positive  1.18 (0.44 – 3.18)    5.11 (2.11 – 12.33) ***  
Previous TB Treatment    0.29 (0.07 – 1.22)    1.34 (0.49 – 3.67)  
Symptom screen positive   1.35 (0.70 -2.59)    1.09 (0.47 – 2.55)  
Years in healthcare    0.97 (0.93– 1.00)    0.97 (0.93 – 1.01)  
Home-care     0.26 (0.03 – 1.94)    3.10 (1.17 – 8.21)*  
Separation TB patients    1.29 (0.71 – 2.37)    1.61 (0.75 – 3.47)  
Recent contact with TB patient   077 (0.39 – 1.52)    0.77 (0.33 – 1.80)  
Daily contact with TB patient   0.59 (0.24 – 1.40)    0.64 (0.21 – 1.94)  
Xhosa home language    1.15 (0.63 – 2.12)    2.26 (1.00 – 5.08)* 
Health qualification    0.64 (0.33 – 1.24)    0.32 (0.12 – 0.84)* 
Clerking TB patients    0.43 (0.22 – 0.82)*    0.61 (0.28 – 1.33) 
Sputum collection    0.51 (0.21 – 1.25)    0.13 (0.02 – 0.93)* 
Nursing care      0.66 (0.32 – 1.33)    0.25 (0.07 – 0.83)* 
Cough Etiquette    0.48 (0.25 – 0.92)*    0.95 (0.37 – 2.42) 
N-95 masks     0.33 (0.13 – 0.82)*    0.36 (0.11 – 1.13) 
PPE provision     0.34 (0.15 – 0.78)*    0.31 (0.12 – 0.82)*   
*P<0.05; **P<0.01; ***P<0.001 
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Table 5.7 Sensitivity and specificity of three diagnostic assays for tuberculosis infection estimated among healthcare workers in Cape Town, 
South Africa by using a latent class model (LCA) with and without conditional dependency (N=472) 
_______________________________________________________________________________________________________________________________ 
      Sensitivity [95% CI]      Specificity [95%CI]    
    ____________________________________________  ________________________________________________ 
LTBI test   LCA    LCA with fixed effect  LCA   LCA with fixed effect 
_______________________________________________________________________________________________________________________________ 
Tuberculin skin test  93.1 [89.9 – 95.8]  93.3 [90 – 96.4]   38.1 [30 – 46.3]  54.7 [32.0 – 99.7] 
QuantiFERON-GIT  92.3 [88.4 – 96.2]  84.1 [71 – 94.5]   94.4 [84 – 100]  93.2 [79.4 – 100] 
T-SPOT.TB   86.9 [81.7 – 93]   78.8 [65.7 – 90.9]  97 [89.6 – 100]  96.1 [85.1 – 100] 
 
Covariates incorporated into the model to account for conditional dependency between QFT-GIT and TSPOT.TB. Covariate 1 for conditional dependence for subjects truly 
positive [mean= 0.058, 95% CI 0.0015 – 0.134] and covariate 0 for conditional dependency for subjects truly negative [mean=0.012, 95%CI 1.0 e-5 – 0.066]  
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5.4 KEY FINDINGS 
 
1. There was only fair agreement between TST and QFT-GIT as well as 
between TST and TSPOT.TB as reflected in κ values of 0.28 and 0.25 
respectively.  
 
2. Agreement between the two IGRA assays as expected was substantial 
with κ=0.65.   
 
3.  Varying the TST cut-off did not enhance agreement with the IGRA 
assays. 
 
4. Varying the IGRA cut-offs to higher levels than what is conventionally used 
to denote a positive test did not enhance agreement with TST≥15mm. 
 
5. Contrary to other studies, discordant test responses were not associated 
with BCG vaccination or recent TB infection. 
 
6.  TST negative / IGRA positive discordance was negatively associated with 
duration of employment in healthcare for both IGRA assays suggesting that 
participants with long duration of employment would tend to have concordant 
results. 
 
7. Negative predictors of discordance (TST+ / T-SPOT.TB-) were older age 
and being engaged in home-based care. 
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8. Positive predictors of a discordant test response (TST- / T-SPOT.TB +) 
were HIV infection, a history of previous TB treatment, testing positive on 
symptom screen or working in a facility separated TB patients from others, 
as part of infection control. 
 
9. There was also discordance between IGRA assays primarily related to 
HIV status, being engaged in home-based care and being a Xhosa speaker. 
Negative predictors of IGRA discordance were in the main related to 
occupational tasks and the practice of infection control measures.   
 
10. The markedly increased risk of a discordant test response in HIV-infected 
participants (OR=4.72) has been replicated in other studies in similar settings 
and suggests that T-SPOT.TB test performance is relatively unimpaired by 
HIV infection and potentially more sensitive than TST for detecting LTBI in 
HIV-infected participants (Rangaka et al., 2007; Mutsvangwa et al., 2010). 
The impairment of TST reaction may also be due to impaired immunity 
manifesting as anergy.  
 
11. The finding that those participants with previous TB or who were 
symptom screen positive were also more likely to have a discordant test 
response (TST- / T-SPOT.TB+) is unexplained. Previous TB may be 
considered a marker of remote exposure (whilst also a risk factor for 
developing TB) and therefore one would expect less correlation with T-
SPOT.TB as positive IGRAs are generally considered to be indicative of 
recent exposure. Unexplained discordance has been described in studies 
from both low and high TB incidence settings. It is postulated that both the 
epidemiological context and the use of standard cut-offs may contribute to 
such discordance (Pai, Kalantri & Menzies, 2006; Pai & Menzies, 2007).       
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12. Using Latent class analysis and a fixed effect model showed TST to have 
the highest sensitivity, followed by QFT-GIT and T-SPOT.TB with specificity 
lowest for TST followed by QFT-GIT and T-SPOT.TB. The differences in 
these estimates of sensitivity and specificity cannot however be considered 
statistically significant as there was still some overlap in confidence intervals 
for the three tests with the largest difference demonstrated between the 
sensitivity of TST and T-SPOT.TB.  
 
13. The use of a fixed effects model was associated with some improvement 
in specificity and sensitivity for TST but not for IGRAs.   
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CHAPTER 6 
 
6.1 INTRODUCTION AND OBJECTIVES 
 
Health care workers (HCWs) are globally considered a high risk occupational 
grouping for contracting tuberculosis (TB)(Baussano et al., 2011; Christopher 
et al., 2011; Joshi et al., 2006; Menzies, Joshi & Pai, 2007). Whilst TB in 
HCWs is a growing public health problem, data from high TB incidence 
countries (> 100/ 100 000 TB cases per population) is limited. In such 
countries, the median annual risk of new latent tuberculosis infection (LTBI) 
in HCWs is estimated at 7.2 % [Interquartile range (IQR) 4.1 - 14.3%], whilst 
the median incidence of TB disease has been estimated to be 1180 / 
100 000 (IQR 91-3 222) (Baussano et al., 2011). When compared to a 
population incidence of 311/ 100 000, the median estimated annual incidence 
rate ratio for active TB disease is 5.4 (IQR 1.7 -9.1) whilst the median 
difference is 409/100 000 (IQR 166 – 2817).These findings suggest that in 
high incidence settings 81% of TB cases in health care settings are 
occupationally acquired. 
 
In South Africa, a high TB incidence country, there are limited data to 
quantify HCWs’ risk of TB. Serial screening for LTBI is not routinely 
performed. Despite the proven efficacy of Isoniazid prophylaxis (IPT) as a 
means to prevent progression from LTBI to TB disease, this is also not 
routinely offered to HCWs in South Africa (Akolo et al., 2010; Lobue & 
Menzies, 2010; Tshitangano, 2013). Under the South African National TB 
program, those at highest risk of progression from LTBI to TB disease are 
offered IPT viz. children under the age of five years (who has had contact 
with a TB case) and HIV infected individuals. This is not necessarily always 
accompanied by testing for LTBI (Department of Health, South Africa, 2009; 
Department of Health, South Africa, 2013). 
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Whilst early studies conducted among South African HCWs showed no 
increased risk of tuberculosis compared to background, an increasing TB 
incidence in this population has been demonstrated in tandem with a growing 
HIV epidemic (Balt, Durrheim & Weyer, 1998; Naidoo & Jinabhai, 2006; 
Wilkinson & Gilks, 1998). More recent studies have demonstrated a 
consistently higher incidence of TB and markedly greater risk of drug-
resistant tuberculosis in HCWs than the general population (Jarand et al., 
2010; Naidoo & Jinabhai, 2006; O'Donnell et al., 2010, Claassens et al., 
2013). This finding has been replicated in smaller studies conducted among 
specific groups working in health care settings such as TB field researchers 
and community HCWs in the Western Cape (Claassens et al., 2010; Kranzer 
et al., 2010).  
 
There is increasing recognition that retention of skilled HCWs in the public 
health system is crucial to the implementation of programmes that address 
the large TB and HIV burden (Department of Health, South Africa, 2011). 
This has resulted in global advocacy for better protection of HCWs in the 
prevention, diagnosis and management of tuberculosis and HIV(WHO, 
UNAIDS & ILO, 2010). However, implementation of infection control 
measures, allocation of resources, and rational planning of intervention 
strategies require accurate estimates of the scale of the problem. Moreover, 
the success of preventative strategies, including infection control measures 
and targeted prophylaxis, needs to be measured through the use of validated 
tools and accurate estimates of the incidence of LTBI and disease 
progression in high risk populations or settings (Claassens et al., 2013; 
Farley et al., 2012).There are, however, a lack of data to inform prevention, 
diagnostic, and management strategies in this high-risk population in TB-
endemic countries such as South Africa (Zungu & Malotle, 2011; Adams et 
al., 2012).  
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Traditionally, screening for LTBI in HCWs in low burden settings was done 
using the tuberculin skin test (TST). More recently the interferon-gamma 
release assays (IGRAs) have been the focus of interest for the diagnosis of 
LTBI. There are two commercially available IGRA assays: the T-SPOT.TB 
assay (Oxford Immunotec, Abingdon, UK) and the QuantiFERON-TB Gold-
In-Tube (QFT-GIT) assay (Cellestis Ltd, Carnegie, Australia). These in-vitro 
assays have some advantages over the TST in that they only require one 
visit, are relatively easy to administer, are not subject to boosting, and deliver 
objective results. Their drawback is the cost and requirement for laboratory 
infrastructure, which may not be readily available in resource-constrained 
settings (Pai, 2005). IGRAs have been incorporated into testing guidelines in 
countries such as the USA and UK where serial LTBI testing of HCWs is 
routine (Mazurek et al., 2010; National Collaborating Centre for Chronic 
Conditions (UK) & Centre for Clinical Practice at NICE (UK), 2011).Serial 
screening with IFN-γ assays have however been plagued by the problem of 
variability in results obtained from sequential administration (van Zyl-Smit et 
al., 2009a;  van Zyl-Smit et al., 2009b).This has raised questions about their 
short-term reproducibility and whether current definitions of conversion is 
indicative of new infections or a reflection of test variability (Pai et al., 2006b; 
Pai& O’Brien, 2007; Zwerling et al., 2013; Gran, Assmuss & Dyrhol-Riise, 
2013; Slater et al., 2013; Fong et al., 2012). This has led to many advocating 
for a review of the current cut-offs for test positivity so that it better reflects 
new infections versus false positives. This has resulted in the proposal of 
borderline zones of uncertainty around the current recommended assay cut-
offs for both QFT-GIT (0.2 -0.7 IU/ml versus 0.35 IU/ml) and for T-SPOT.TB 
(5-7 spots versus 6 spots) (Mazurek et al., 2010; Zwerling et al., 2013). IGRA 
assays are subject to boosting by TST, if concurrently administered. This 
may potentially confound subsequent IGRA test responses. Data are 
currently very limited on serial screening using T-SPOT.TB as most studies 
have utilized QFT-GIT for serial screening of HCWs (Zwerling et al, 2012). 
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IFN-γ responses over time appear to be influenced by the epidemiologic 
setting and it is unlikely that a uniform threshold would apply to all 
populations and settings. There is a need for further research focusing on 
within subject variability and test performance in serial screening. Specifically 
the utility of serial screening using IFN-γ assays in high TB incidence settings 
with near universal BCG coverage is not known. TB infection incidence, if 
accurately measured, might provide some indication of TB risk in healthcare 
populations and the need for infection control measures in health care 
settings.  
 
This chapter includes data from the follow-up phase of the study and 
represents the first prospective TB infection study among HCWs in South 
Africa. In fulfilment of the thesis objectives, this chapter of the study 
addresses the following objectives: 
 
1. To document the prevalence and annual incidence of latent TB 
infection based on conversion rates using both IGRAs and TST in 
serial testing of health care workers. 
 
2. To evaluate the occupational and environmental risk factors 
associated with incident TB infection (based on LTBI test conversion) 
in health care workers and explore the potential role of occupational 
exposure as a contributing factor to high TB infection rates.  
 
6.2 METHODS 
 
6.2.1 Participation in the follow-up phase of the study 
 
This phase of the study was performed over 1 year from July 2010 to July 
2011 and represents the follow-up phase of the baseline study that was 
conducted in 2009-2010 to evaluate determinants of prevalent latent TB 
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infection (discussed in chapter 4) in HCWs employed at seven health care 
facilities in Cape Town, South Africa. All 505 participants were eligible for 
participation at follow-up and were required to complete a short follow-up 
questionnaire including a TB symptom screen, and undergo repeat testing 
with TST and IGRA assays (QFT-GIT and T-SPOT.TB) to evaluate interval 
test response over a one year period. A chest radiograph was also offered as 
an additional screening tool to exclude active TB and participants were 
invited to undergo a repeat HIV test. Due to the non-availability of the mobile 
clinic from which to conduct the research, the follow-up phase of the study 
was in the main conducted from a dedicated space at the health facilities that 
formed part of the study.   
 
Multiple attempts were made to contact participants who had participated in 
the baseline of the study to continue their participation in the follow-up phase 
of the study. These include bulk text messages sent via mobile phone 
technology, individual telephone calls to work telephones and personal 
cellphone numbers where these were available. Cross referencing was done 
with the facility human resource administration to try and obtain contact 
details of participants who had left the facility to minimize loss to follow-up. 
HCWs’ right to refuse further participation was however respected.   
 
6.2.2. Structured questionnaire  
 
A short structured questionnaire was administered by a trained nurse 
interviewer, who had initially also conducted the baseline interview. The 
questionnaire included a TB symptom screen and elicited updated personal 
and employment details. Participants were also asked about recent TB 
diagnosis, interim TB symptoms that may not have been present at baseline 
and HIV status. In addition questions regarding preferred models of 
occupational health service provision to HCWs with a specific focus on HIV 
and TB, were also included (This questionnaire is included as appendix 2). 
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6.2.3 TST testing and interpretation 
 
The one-step TST protocol was employed using two tuberculin units (0.1ml) 
of RT23 Purified Protein Derivative (PPD) (Staten Serum Institute  
Copenhagen), injected intradermally on the volar aspect of the forearm. The 
induration was measured by a trained reader after 48 – 72 hours using the 
ballpoint and ruler method. An induration of ≥ 10mm, or in the case of an HIV 
positive individual ≥5mm, w as considered a positive test at baseline. As the 
study aim was to evaluate serial test responses, all participants regardless of 
TST status at baseline were requested to undergo repeat testing. A TST 
conversion was defined as a previously negative test (<10 mm, or < 5mm if 
HIV infected) that changed to a positive test together with at least a≥10mm 
increment, as per American Thoracic Society/Centers for Disease Control 
and Prevention and Infectious Diseases Society of America standards 
standard guidelines (American Thoracic Society, 2000). A reversion was 
defined as a positive test at baseline changing to a negative test at follow-up. 
 
6.2.4 IGRA testing (QFT-GIT and T-SPOT.TB) 
 
Participants were re-tested with the QFT-GIT and the T-SPOT.TB tests 
irrespective of baseline IGRA test result. Bloods for the IGRA assays were 
drawn concurrently with or within three days of administering the TST to 
eliminate the effect of potential boosting,  which may manifest after this initial 
period (van Zyl-Smit et al., 2009b). The QFT-GIT test was considered 
positive if the interferon-gamma response minus the nil antigen was ≥0.35 
IU/ml. A QFT-GIT conversion was defined as a change from a negative test 
(IFN-γ<0.35 IU/ml) to a positive test (IFN-γ >0.35 IU/ml) as per the 
manufacturer’s instructions. Reversion was defined as change from a 
positive test at baseline to a negative test at follow-up. 
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The T-SPOT.TB assay was performed in accordance with the manufacturer’s 
instructions. The number of IFN-λ spot forming T cells (SFC) per million 
peripheral blood mononuclear cells (PBMCs) was determined using an AIM 
ELISPOT reader and Oxford Immunotec software. A cut–off of six or more 
spots was treated as a positive result. To minimize inter-operator and inter-
laboratory variability, all assays were done by the same operator in the same 
laboratory. For T-SPOT.TB, a negative test at baseline changing to a positive 
test (≥6 spots increment in either Panel A or B) on follow -up testing was 
required. Reversion was defined as a baseline positive test with a negative 
test at follow-up. Various cut points for conversion were explored for both 
IGRAs and for TST. 
 
6.2.5 Statistical analysis 
 
Statistical analyses were performed using Stata version 11 (Stata Corp., 
College Station, Texas). Outcomes evaluated included test positivity at 
follow-up for TST, QFT-GIT and T-SPOT.TB. The prevalence of TB 
associated risk factors, occupational and environmental factors and test 
outcomes was calculated at baseline for this cohort. At follow-up the main 
outcome of interest was annual rate of TST and IGRA conversion which was 
used to define annual incidence of infection. Differences between participants 
included in the follow up and those lost to follow-up were explored using Chi-
squared statistics, to evaluate the likely presence of attrition bias. Further 
analysis focused on identifying predictors of TST and IGRA conversion. 
Univariate and multivariate logistic regression analysis to explore the strength 
of associations with conversion were performed. An annual incidence of 
infection on the different tests was calculated.  
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6.3 RESULTS 
 
6.3.1 Demographic characteristics and participation 
 
The follow-up phase of the study commenced 1 year after the baseline. A 
total of 339 health care workers were followed up from the original cohort of 
505, a follow-up rate of 67%. The main reason for participants being lost to 
follow-up was leaving the facility (91 participants). Most had left for unknown 
reasons (68), three had resigned, three had retired and six were students 
who had completed their rotation, whilst another eleven had been transferred 
out(Figure 1). There were significant differences between participants who 
were followed up and those lost to follow up. Participants who continued with 
the second phase of the study were older (p=0.007), less likely to smoke 
(p=0.006), less likely to be HIV positive (p=0.026) and more likely to have 
had long duration of employment (>20years) in a health care environment 
(p=0.004).  
 
All participants in this phase completed the questionnaire. HIV results were 
available for 329 participants and chest radiographs for 288 participants. A 
substantial proportion (56%) declined to have a repeat TST administered so 
that only 142 participants had both a baseline and follow-up TST reading.  
 
Uptake of repeat interferon gamma release assays was excellent, with 99% 
of participants undergoing repeat testing. This resulted in 332 participants 
having valid paired results for QFT-GIT and 292 for T-SPOT.TB. 
 
The population consisted of predominantly females (71%) with 58% over the 
age of forty years(Table 6.1). Duration of employment in a health care 
environment was less than 10 years for the majority of participants (53%) 
whilst  30% reported a long duration of employment (>20 years).  
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6.3.2 Occupational and environmental characteristics 
 
Involvement in rendering health care services to TB patients ranged from 2% 
for bronchoscopy procedures to 49% for interviewing patients (Table 6.2). 
High-risk procedures such as nursing of TB patients and collection of sputum 
samples were performed by 30% and 22% of respondents respectively. 
 
There was varying reported facility compliance with environmental control 
measures for TB infection control with64% of participants reporting that their 
facility had a specific infection control policy. Most displayed an awareness of 
ventilation measures being implemented at their facility (93%), whilst 
reported institutional compliance with the provision of personal protective 
equipment was high (89 to 95%). 
 
6.3.3 Prevalence of TB associated risk factors and LTBI at follow-up 
 
The prevalence of BCG vaccination was high at 92% (Table 6.3). Three 
participants who had previously been negative at baseline, had a positive 
HIV test at follow-up representing an annual HIV infection incidence of 1% 
(95% CI 0.02 – 3).Two new cases of TB were diagnosed at follow-up and 
one participant not previously diagnosed had died of TB in the interval, 
yielding a TB incidence of 9/1000[1%; 95% CI 0.2 – 2.6].  LTBI prevalence 
was high at 84% for TST, and 69%   and 62% for QFT-GIT and T-SPOT.TB 
respectively. 
 
6.3.4 TST and IGRA Conversions and Annual Incidence of TB infection 
 
The conversion rate represents the annual incidence of new TB infection in 
this group as it measures new infections in those at risk after 1 year of 
observation.  At follow-up testing 13 out of 34 participants converted from a 
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negative to a positive TST, representing an annual rate of infection of  38% 
(95% CI: 22 – 56). One percent (4 participants) reverted from a previously 
positive to a negative test result (Table 6.4). 
 
For QFT-GIT, of those who were negative at baseline, 25/113 converted to a 
positive test representing an annual rate of infection of 22% (95% CI: 15 – 
31). The reversion rate was 7%. 
 
For T-SPOT.TB, owing to a higher yield of indeterminate results, only 292 
participants test results were utilized to generate conversion and reversion 
estimates. Of those who tested negative at baseline, 25/114 converted their 
test response to positive one a year later,  representing a conversion rate of 
22% (95% CI: 15 – 3). The reversion rate for this IGRA assay at 16% was 
considerably higher than that demonstrated by TST (Table 6.4). 
 
Different cut-offs were explored for IGRA conversion on account of the 
natural variability inherent in repeat use of these tests. For QFT-GIT, using 
the most stringent definition with a cut-off of 0.70 IU/ml, the conversion rate 
declined to 13%, whilst for T-SPOT.TB using an eight spot increment, it 
declined to 18% (Table 6.5). 
  
6.3.5 Univariate and Multivariate Analysis of Determinants of TST and 
IGRA Conversion  
 
Adjusted logistic regression models were applied to evaluate the relationship 
between a number of variables of interest and the conversion outcomes, 
treating age and gender as covariates (Table 6.6).In univariate analysis 
strongly positive associations (0R ≥ 2) were shown for TST conversion in 
those participants with the following characteristics: age > 40 years, 
exposure to environmental tobacco smoke, engaging in collection of sputum, 
TB symptom screen positive at follow-up and those who had a referral for 
171
HIV care and or TB investigations in the screening interval.   However, none 
of these associations had confidence intervals which excluded the null. 
Following multivariate analysis, only the following associations remained 
significant for TST. Individuals engaged in counselling TB patients were less 
likely to have a TST conversion [OR=0.12; (95% CI 0.15 – 0.92)].  
 
This same factor was however strongly associated with an increased risk of 
QFT conversion [OR=3.04; (95% CI 1.01 – 9.15) P=0.047]. Males were also 
four times more likely to have a QFT-GIT conversion than female participants 
in the study  [OR=4.02 (95% CI 1.40 – 11.58].  
 
Positive predictors of T-SPOT.TB conversion in adjusted analysis were 
employment sector-individuals in the local authority employ were 14 times 
more likely to convert than those working for the provincial health department 
[OR=14.19 (95% CI 1.28 – 157.75) P=0.031)] and having a positive TST at 
baseline  [OR=3.40; (95% CI; 1.02 – 11.34) P=0.047].  
 
Comparison with community based studies among adolescents in the 
Western Cape showed that health care workers have a greater than threefold 
risk of annual infection as measured by TST conversion. This risk is fivefold 
greater than healthcare workers in other high TB incidence populations 
(Middelkoop et al., 2008) (Table 6.7).   
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Table 6.1 Characteristics of participants who underwent repeat testing for latent TB 
infection by either TST and/or IGRA (N=339)  
 
Variable*      N= 339   % 
 
Gender 
 Female      241   71  
 Male      98   29 
 
Age group (years) 
 
 ≤30      54   16 
  31- 40      90   27 
 41 – 50      98   29 
>50      97   29 
      
Type of facility 
 
 Primary      173   51 
 Secondary     166   49 
 
Employment in health care 
 
 <10 years     178   53 
10 – 19 years     60   18 
≥20      101   30  
 
*Employment sector (N=334) 
 
Provincial Health Dept.    209   63 
City of Cape Town Health Dept.   23   7  
NGO      63   19 
Other      39   12 
 
Formal Health Qualification    131   39 
 
Diabetes (current)     29   9 
  
Current alcohol consumption    109   32 
 
*Smoking history (N=338)   
Non-smoker     216   64 
Ex-smoker     46   14 
Current smoker     76   22  
 
Exposure to environmental tobacco smoke  243   72  
 
*All variables as measured at baseline 
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Table 6.2 Prevalence of occupational and environmental risk factors among health 
care workers N=339 
 
 
Variable*      N   % 
 
 
Occupational tasks 
 
Interviewing    TB patients    166   49 
Counselling   TB patients    145   43 
Examining   TB patients     74   22   
Collecting sputum     73   22 
Nursing TB patients     103   30 
Homecare of TB patients    29   9 
Bronchoscopy       6   2 
 
Facility factors (Self-reported as present) 
 
Infection control policy     220   64 
Ventilation measures     315   93 
Ultraviolet lights      157   46 
Cough etiquette      265   78 
Early triage      205   60 
Separation of TB patients    157   46 
Diagnostic services     262   77 
Disposable surgical masks    322   95 
N-95 masks      317   94 
Personal protective equipment     303   89 
Training (on protection of self)    219   65 
Training (on protection of patients)   201   59 
 
*All variables as measured at baseline 
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Table 6.3 Prevalence of TB associated risk factors at follow-up  
 
Variable      N   % 
 
 
BCG vaccination*     313   92 
  
Daily contact with TB patients*    308   91 
 
HIV status check follow-up data(N=329)  
 
Positive      33   10 
Negative     296   90 
 
 
TB symptom screen positive [at F/U]   55   16 
 
CXR [at F/U](N=288) 
 
 Normal      242   84
 Inactive TB     41   14 
Active TB     5   2 
 
Interval Referral for TB / HIV     44   13 
 
History of TB Treatment (ever TB)*   44   13 
 
Interim TB Diagnosis     7   2 
  
Current TB diagnosis     2   1 
 
Baseline TST positive (n=329)*    275 / 329  84 
 
TST positive at follow-up    123 /147  84 
 
QFT-GIT test positive at follow-up   231/335  69 
  
TSPOT.TB positive at follow-up    198/317  62  
  
*Measured at baseline. F/U=Follow-up. 
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Figure 6.1. Healthcare worker cohort screened at follow-up for LTBI 
 
 
 
 
 
 
 
 
 
 
 TST     QFT    TSPOT-TB
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Available paired QFT-GIT 
N = 332 
Available paired TST’s 
N = 142 
Available paired T.SPOT-TB 
N = 295 
Number tested  152 
Not done   187 
Repeat TST not read  5 
No baseline TST result   5 
Number tested  337 
Not done  2 
Indeterminate follow-up 2 
No baseline test result     3 
BASELINE 
 
N=505 
 
FOLLOW-UP 
N = 339 
Number tested     337 
Not done    2 
Indeterminate    20   
No baseline test result     27
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Table 6.4 Results of latent tuberculosis infection testing at baseline and follow-up including annualized rates of conversion 
 
LTBI tests N (%)      TST    QFT    TSPOT.TB 
 
Variable 
Test status at baseline 
Number with follow-up test result     142     332     292   
Number tested positive       108 (76%)   219 (66%)   180 (62%)   
Number tested negative       34 (24%)   113 (34%)   115 (39%)  
  
Conversion and reversion 
Conversion rate       13 / 34 (38%)   25/113 (22%)   25 / 115 (22%)  
 Reversion rate       4/ 108 (1%)   15/219 (7%)   28 /180 (16%) 
Annual Rate of Conversion*     38% [22 – 56]   22% [15 – 31]   22% [15 – 31]  
*Annual rate based on conversion rates in uninfected sample with repeat testing done 1 year later and shown with 95% confidence intervals. 
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Table 6.5 IGRA conversion using different definitions  
_____________________________________________________________________________________________________________________________ 
Conversion variables              Number  %  
 
 
QFT-GIT (N=113) 
 
Baseline IFN-γ <0.35 IU/ml and follow-up IFN-γ>0.35 IU/ml        25/113   22% 
Baseline IFN-γ <0.35 IU/ml and follow-up IFN-γ>0.35 IU/ml, plus a 30% increase in IFN-γ over the baseline value  20/113   18% 
Baseline IFN-γ <0.35 IU/ml and follow-up IFN-γ>0.35 IU/ml, plus an absolute increase of 0.35 IU/ml over the  16/113   14% 
baseline value  
Baseline IFN-γ <0.35 IU/ml and follow-up IFN-γ>0.70 IU/ml        15/113   13% 
 
TSPOT TB (N=114) 
 
Baseline TSPOT.TB negative and follow-up positive using the≥ 6 spot increment      25/115   22% 
Baseline TSPOT.TB negative and follow-up positive using the ≥8 spot increment      23/128   18% 
   
Test outcomes for analytic purposes were based on prevailing manufacturer’s instructions and for QFT-GIT was defined as baseline IFN-γ <0.35 IU/ml and follow-up IFN-
γ>0.35 IU/ml and for T-SPOT.TB a negative baseline T-SPOT.TB with a follow-up positive ≥ 6 spots increment. 
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Table 6.6 Adjusted Associations between potential predictors and TST and IGRA conversions  
 
     TST [OR;95%CI]   QFT     TSPOT.TB   
     N= 13     N=25     N=25 
Variable  
 
Demographic 
Employment sector 
 
Provincial Health Dept.  1.00     1.00     1.00   
Local authority Health Dept. -     1.16 [0.10 – 13.45]   14.14 [1.30 – 160.27]*   
NGO    0.86 [0.06 – 12.50]   1.33 [0.35 – 5.13]   1.17 [0.32 – 4.27]  
 Other    0.50 [0.04 – 6.91]    1.17 [0.24 – 5.91]   0.90 [0.17 – 4.72] 
 
Formal health qualification  0.30 [0.04 – 2.05]   1.28 [0.46 – 3.52]   0.84 [0.32 – 2.25] 
 
Diabetes    1.58 [0.10 – 24.41]   2.21 [0.45 – 10.77]   - 
  
Current alcohol consumption  0.27 [0.43 – 1.68]   0.62 [0.21 – 1.82]   1.68 [0.64 – 4.42]  
 
Smoking history 
 
Non-smoker   1.00     1.00     1.00 
Ex-smoker   1.07 [0.08 – 14.20]   0.97 [0.22 – 4.66]   0.19 [0.02 – 1.80] 
Current smoker   1.36 [0.16 – 11.47]   0.64 [0.19 – 2.18]   1.45 [0.51 – 4.10] 
 
ETS exposure    2.58 [0.47 – 14.11]   1.25 [0.45 – 3.45]   2.83 [0.88 – 9.10] 
 
___________________________________________________________________________________________________________________________ 
 
*Bolded variables reached statistical significance (p<0.05) 
 
 
 
 
179
Table 6.6 (continued). Adjusted Associations between potential predictors and TST and IGRA conversions (Bolded variables reached statistical 
significance) 
 
      TST [OR; 95%CI]   QFT    TSPOT.TB 
Variable 
 
Occupational tasks 
Interviewing TB patients    0.29 [0.05 – 1.85]  2.96 [0.99 – 8.85]  0.38 [0.14 – 1.03] 
Counselling TB patients    0.12 [0.15 – 0.92]  3.04 [1.01 – 9.15]*  0.97 [0.37 – 2.52] 
Examining TB patients     0.39 [0.03 – 4.51]  2.46 [0.80 – 7.51]  0.30 [0.06 – 1.44]    
Collecting sputum    2.75 [0.25 – 29.97]  1.47 [0.42 – 5.09]  1.15 [0.36 – 3.62] 
Nursing TB patients    1.07 [0.14 – 8.31]  1.49 [0.49 – 4.50]  1.04 [0.37 – 2.92] 
Home-care of TB patients   -    6.74 [0.83 – 54.97]  - 
Bronchoscopy     -    8.21 [0.39 – 174.17]  1.92 [0.15 – 24.00] 
 
 
Presence of facility factors  
Infection control policy    -    1.16 [0.39 – 3.47]  1.16 [0.44 – 3.07] 
Ventilation measures    0.96 [0.05 – 20.19]  0.69 [0.14 – 3.42]  3.19 [0.38 – 26.73]   
UV lights     1.25 [0.22 – 7.10]  1.20 [0.45 – 3.16]  2.23 [0.86 – 5.78] 
Cough etiquette     0.54 [0.09 – 3.12]  0.91 [0.31 – 2.71]  1.42 [0.50 – 4.06]  
Early triage     0.19 [0.03 – 1.31]  0.54 [0.20 – 1.47]  0.86 [0.34 – 2.15] 
Separation of TB patients   1.10 [0.20 – 5.97]  1.37 [0.52 – 3.62]  0.87 [0.34 – 2.22] 
Diagnostic services    0.71 [0.12 – 4.19]  0.84 [0.26 – 2.67]  2.92 [0.76 – 11.29]   
Disposable surgical masks   0.28 [0.02 – 4.44]  2.88 [0.27 –30.73]  1.01 [0.18 – 5.55] 
N-95 masks     0.21 [0.01 – 8.34]  0.26 [0.05 – 1.24]  1.11 [0.19 – 6.42] 
PPE Provision     0.34 [0.02 – 4.98]  0.42 [0.11 – 1.58]  4.06 [0.45 – 36.27] 
 
 
 
180
Table 6.6 (continued). Adjusted Associations between potential predictors and TST and IGRA conversions  
 
      TST [OR; 95%CI]  QFT    TSPOT.TB 
Variable 
 
TB associated variables 
 
BCG vaccination*    -    0.52 [0.03 – 8.62]  0.81 [0.14 – 4.79] 
   
Employment in health care 
 
< 10      1.00    1.00    1.00 
10 – 20      0.51 [0.04 – 6.41]  0.15 [0.02 – 1.06]  0.32 [0.07 – 1.49] 
≥20      1.54 [0.98 – 24.27]  0.61 [0.13 – 2.89]  0.78 [0.18 – 3.45] 
 
HIV positive status    1.06 [0.10 – 11.50]  1.20 [0.27 – 5.35]  0.60 [0.12 – 3.00] 
 
TB symptom screen positive [at F/U]  7.31 [0.55 – 97.03]  1.22 [0.35 – 4.28]  0.90 [0.26 – 3.06] 
 
CXR  
 Normal     1.00    1.00    1.00 
 Inactive TB    -    2.01 [0.40 – 10.16]  1.49 [0.39 – 5.65] 
Active TB    -    -    - 
 
Interval Referral for TB / HIV   4.43 [O.51 - 38.33]  1.88 [0.41 – 8.61]   1.56 [0.36 – 6.77] 
 
History of TB treatment (ever TB)*  0.72 [0.02 – 22.85]  0.25 [0.03 – 2.29]  0.32 [0.04 – 2.64] 
 
Interim TB diagnosis    -    -    - 
 
Current TB diagnosis    -    -    - 
 
Baseline positive TST    -    2.03 [0.67 – 6.20]  3.31 [0.99 – 11.03]* 
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Table6.7. Comparison across different populations: LTBI test response and incidence of infection as measured by TST conversion rate  
 
Study author (year)   Country   N  Annual incidence of TB infection% (95% CI)  Incidence rate ratio  
              
Health care workers in this study 
Adams(2014)   South Africa  34   38% (22-56)      1.00 
 
Health care workers in high incidence settings 
 
Pai (2006)*   India   147  4.1% (2 – 9)      0.11(0.03 – 0.25) 
   
Christopher (2011)**  India   179   7.8% (4 -13)      0.21(0.10 -0.37) 
 
Community  
Middelkoop (2008)***  South Africa  83  11% (5 – 20)      0.29(0.15 – 0.56) 
_____________________________________________________________________________________________________________________________ 
*Studypopulation comprise nursing and medical students; **Study population comprise nursingstudents; ***Study population comprise adolescents aged 13 -22 in high HIV 
prevalent area   
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6.4 KEY FINDINGS 
 
1. The prevalence of LTBI based on TST at baseline and follow-up remained 
consistent at 84%. This prevalence issimilar to a population-based studies of 
LTBI in South Africa using a TST value of ≥10mm as cut -off (Mahomed et al, 
2006).Lower rates of TST positivity have been reported in HCWs in high-
burden TB countries such as India, Russia and Vietnam, ranging from 41% - 
61% (Pai et al., 2005; Drobniewski et al., 2007; Lien et al., 2009; Christopher 
et al., 2010) 
 
2. The LTBI prevalence for QFT-GIT and T-SPOT .TB increased marginally 
from baseline to follow-up. For QFT-GIT prevalence changed from 65% to 
69%, whilst for T-SPOT.TB it changed from 60% to 62%.  
 
3. The high background community rate of infection renders it difficult to 
ascertain the true contribution that occupational exposure makes to TB 
transmission rates in HCWs. 
 
4. The annual incidence of infection in this population was extraordinarily 
high at 38% and 22% using TST and IGRA assays, respectively.. 
 
5. Serial testing with IGRAs was characterized by high conversion rates of 
22%  in this study.   
 
6. There is considerable uncertainty as to what the best cut-point for 
conversion should be when using IGRAs for serial screening (van Zyl-Smit et 
al., 2009a; Zwerling et al., 2013). This is true for both high and low incidence 
settings. Varying the conversion cut-points by using more stringent 
definitions resulted in a modest decrease in the conversion rate in our study.   
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7. Serial IGRA test response was characterised by a higher rate of reversion 
than demonstrated for TST in our study (7-16%vs. 1%).  
 
8. In this study there were no factors consistently associated with test 
conversion for both the TST and IGRA assays. There were also no 
consistent associations for test conversion for the two IGRA assays. The 
threefold increased risk for QFT-GIT conversion associated with counselling 
of TB patients was the reverse of the negative association with TST 
conversion.  
 
9. The strong association between a baseline positive TST result and a later 
T-SPOT.TB conversion points to possible suboptimal sensitivity of the 
T.SPOT.TB in this population.  
 
10. In the analysis, the use of a borderline zone was considered and a 
multivariate analysis was conducted using an eight spot (5-7 spots increment 
considered borderline zone) increment for T-SPOT.TB but this did not 
change the associations.  
 
11. The provision of TB services is a function of local government clinics and 
staff and may explain the strong association shown between T-SPOT.TB 
conversion (OR=14.19) and employment by the local authority.  
 
12. Multivariate analysis using more stringent definitions of IGRA conversion 
showed QFT conversion to be associated with work in facilities that practiced 
separation / isolation of TB patients from other patients [OR 3.77 (95% CI 
1.03 – 13.73).  
 
13. For most of the occupational and environmental control measures, no 
demonstrable protective effect was demonstrated against conversion.  
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 14. There was no association between BCG vaccination and TST positivity in 
this study. The lack of a potentially confounding role for BCG on LTBI 
prevalence has been demonstrated in other studies and suggests that in 
communities vaccinated at birth BCG has little impact on subsequent TST 
response (Farhat et al., 2006). 
 
15. In this study there was very low uptake of repeat TST, but excellent 
uptake of the repeat IGRA assays suggesting that despite being relatively 
invasive, the ease of administration (one visit), and absence of side effects or 
clinical reactions rendered it a better tolerated serial screening tool in this 
population. 
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CHAPTER 7  
 
7.1 INTRODUCTION 
 
This prospective study was undertaken to evaluate the use of IGRAs for 
LTBI screening in HCWs in a high TB incidence settings, against a 
background of high HIV prevalence. It measured LTBI prevalence using both 
IGRA assays in a head-to-head comparison with TST, together with host and 
occupational and environmental factors associated with LTBI prevalence at 
baseline (Chapter 4). Analyses were carried out to measure test agreement 
and perform a direct comparison of test performance (sensitivity and 
specificity) using a latent class analysis model. In addition, factors associated 
with test discordance were studied (Chapter 5). At one year follow-up, the 
incidence of TB infection using all three test modalities was calculated. Risk 
factors associated with incidence of infection (conversion) were explored to 
identify potentially modifiable factors to limit LTBI risk in HCWs (Chapter 6). 
 
7.2 MAIN FINDINGS OF THE STUDY  
 
7.2.1 PREVALENCE AND DETERMINANTS OF LATENT 
TUBERCULOSIS INFECTION IN HEALTH CARE WORKERS 
 
Participation 
 
The study achieved a 67% participation rate (based on voluntary 
participation) with staff equally drawn from primary and secondary level 
facilities. Proportionately more staff from secondary facilities participated 
than those from primary facilities (72% vs. 63%). Reasons for this greater 
participation may be greater awareness among such staff of the hazards of 
TB as both secondary facilities were dedicated TB hospitals. By contrast, 
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primary facility staff provided a broad range of primary care services, some 
outside the facilities, resulting in increased mobility and time away from the 
facility. Staff employed at primary level facilities was also of younger age, 
predominantly female, Xhosa-speaking, had shorter duration of employment, 
were more likely to be HIV positive and to have had treatment for previous 
TB than secondary level staff. This is in keeping with a risk profile among 
primary level staff that is reflective of lower socio-economic status as well as 
increased TB risk. Socio-economic status has been shown to be strongly 
associated with TB in a study evaluating the social epidemiology of TB in 
South Africa (Harling, Ehrlich & Myer, 2008). Whilst a proxy measure for 
socio-economic status viz. parental employment (one or either parents 
employed versus no employment) during childhood was used, this did not 
show significant differences between the two groups. It is likely that this 
measure of socio-economic status was too remote to be strongly associated 
with current TB risk in this group of HCWs.  
 
Non-occupational factors influencing TB risk  
 
Past BCG coverage was very high in HCWs. This is to be expected as it is 
has been offered as part of the South African Department of Health’s 
Expanded Immunization Programme (EIP) since 1960 to children at birth, 
with reportedly 95% population coverage attained (Department of Health, 
South Africa, 2003). 
 
A high proportion of HCWs (13%) indicated that they had previously been 
treated for TB. This estimate represents a fourfold excess when compared to 
the South African adult population estimate (based on the 1998 
Demographic and Household survey) which reported 2.8% of a 
representative sample as having been diagnosed with tuberculosis disease 
in their lifetime (Harling, Ehrlich & Myer, 2008). TB risk is further increased 
by the high prevalence of smoking (22%) among HCWs in this study, which 
is similar to estimates from a general population study (26%). Although the 
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causal pathways are not clearly understood, smoking has been shown to be 
associated with increased risk for both TB infection and disease (Brunet et 
al., 2011; van Zyl Smit et al., 2010; Harling, Ehrlich & Myer, 2008; Bates et 
al., 2007). 
 
HIV prevalence 
 
HIV infection greatly increases the risk of TB disease by accelerating the 
progression to active TB in those who are latently infected. The HIV 
prevalence among HCWs in this study (11%) is lower than that of the 
population prevalence for adults aged 15 – 49 years in the Western Cape in 
2008 (16.9%) (Avert. South Africa HIV & AIDS statistics, 2014). The high 
percentage of HCWs who had undergone HIV testing is encouraging and 
suggests that the stigma in this population associated with HIV is waning and 
prevention efforts are bearing fruit, with large numbers willing to be tested 
and or willing to disclose the result of their tests. No other studies among 
HCWs from other high burden settings have evaluated TB risk in relation to 
HIV. The HIV prevalence estimate, however, means that one out of ten 
HCWs in this study with LTBI face an exceptionally high risk of progression 
from LTBI to active TB. Current recommendations for HCW surveillance in 
South Africa thus recommend the determination of HIV status as part of 
screening for TB at pre-placement screening (Department of Health, South 
Africa, 2014). 
 
Occupational exposure factors 
 
In this group of HCWs reported exposure to newly diagnosed TB patients (in 
the past three months) was high (76%), with 90% reporting daily contact with 
a suspected TB patient. This high background rate of exposure was not 
objectively verified, but is plausible given the high rates of TB in communities 
serviced by these facilities. HCWs displayed some awareness of the practice 
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of infection control measures (44 – 93%). However, more than a third had 
not had any training on protecting themselves or fellow patients against 
contracting TB, despite 58% of them perceiving themselves to be at high risk 
of infection. Farley et al (2012), in a review of infection control measures of 
South African hospitals providing treatment for drug-resistant tuberculosis, 
reported that annual infection control training was available in only 38% 
facilities, whilst written infection control plans were available in 54% facilities. 
Claassens et al (2013),in an audit of primary care, facilities reported that of 
facilities who had cases of TB among HCWs, only 20% had a written 
infection control plan in place, although 91% of HCWs at such facilities had 
been trained in infection control. Similar results have been shown for 
Russian HCWs employed at TB hospitals, who exhibited poor knowledge of 
infection control and understanding of their risk despite having an acceptable 
level of knowledge of TB disease and its treatment (Woith, Volchenkov & 
Larson, 2010). Training in infection control is therefore needed to reduce TB 
risk in HCWs in high burden settings. 
 
LTBI prevalence 
 
The LTBI prevalence as measured by TST, QFT-GIT and TSPOT.TB was 
84%, 65% and 60% respectively for the group. Surprisingly it was not 
significantly different between primary and secondary level staff. The 
prevalence of LTBI as measured by TST is higher than that reported in a 
review of LTBI in HCWs from LMICs (33 – 79%), and markedly higher than 
from a recent studies of South African HCWs in Johannesburg which 
reported a 57% prevalence (Joshi et al, 2006; van Rie et al., 2013). It is, 
however, similar to community based general population studies in the 
Western Cape, which reported LTBI prevalence of 81%-88 (Mahomed et al, 
2006;Wood et al., 2010; Middelkoop et al., 2008). Wood et al (2010) showed 
an increasing prevalence of latent TB infection with increasing age in a 
population of HIV negative individuals aged 5-40 years drawn from high TB 
prevalence areas, with 88% of adults 31-35 years of age testing positive on 
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TST. The prevalence of LTBI among HCWs in this study is therefore not 
indicative of greater TB infection risk than is found in community participants 
in the Western Cape. 
 
The lower LTBI prevalence estimated by using IGRAs is in keeping with 
studies among HCWs from low and intermediate incidence settings which 
have generally reported lower LTBI prevalence measured by IGRAs, 
primarily using QFT-GIT, than for TST (Zwerling et al., 2012). This has been 
ascribed to its greater specificity and less confounding by BCG vaccination. 
By accurately identifying those who are truly negative for LTBI, lesser 
numbers of HCWs have to be considered for IPT and follow-up than is the 
case with TST. This allows for more targeted IPT and has economic benefit 
as well as decreasing the morbidity associated with adverse effects due to 
IPT, in such settings. Studies using IGRAs among HCWs from high TB 
incidence settings have produced varied results. A study of Indian HCWs 
reported equivalent rates of LTBI using TST and QFT-GIT (41% and 40%, 
respectively), whilst a Vietnamese study showed a different prevalence of 
LTBI ( 47% for  QFT-GIT and 61% with TST) (Pai et al, 2005;Lien et al., 
2009). LTBI estimates using IGRAs in this study, approximate those 
produced by a community based South African study involving healthy 
adults, which performed a head-to-head comparison between TST and 
IGRAs (Mahomed et al., 2006). As with TST, LTBI prevalence as measured 
by IGRAs was similar in HCWs and the community. 
 
TB disease 
 
Despite a high proportion of individuals testing positive on preliminary 
screening for TB disease using symptom screen (26%) and chest x-ray (7%), 
only five new cases of tuberculosis was diagnosed at baseline. All cases 
detected by screening were diagnosed on sputum culture. Three cases were 
HIV positive, three had radiographic evidence of TB, three were positive on 
symptom screen and none were positive on microscopy. The use of only one 
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clinical test in this setting would have resulted in missing one or more cases 
of active TB. 
 
The new cases detected together with two co-prevalent cases already on 
treatment resulted in a TB disease prevalence of 7/505 or 14/1000. This is 
slightly higher than the national TB prevalence estimated at 4 – 13 cases / 
1000 for 2010 (World Health Organization, 2011). Notably all five new cases 
tested positive on TST, but not on IGRAs. Two HIV positive cases tested 
negative on QFT-GIT, with one case testing negative on both IGRAs. Using 
active TB as a proxy gold standard for LTBI, these findings suggest that in 
this study TST had superior sensitivity to both IGRAs and performed better in 
immunocompromised individuals at detecting LTBI than did IGRAs.  
 
 
Factors associated with LTBI prevalence stratified by test 
 
TST 
 
The lack of an association between BCG vaccination and a positive TST test 
in both univariate and multivariate analysis confirms that BCG does not 
confound TST response in this population. This finding has been replicated 
in HCW studies from high and intermediate incidence settings (India, 
Georgia and China) and in a local community based study, which showed no 
association between TST and BCG in subjects vaccinated in childhood 
(Mahomed et al, 2006; Pai et al, 2005; He et al., 2012; Mirtskhulava et al., 
2008). However the high prevalence of BCG vaccination (>90%) due to near 
universal coverage makes it difficult to adequately test this association.  
 
The stratified analyses to evaluate associations between LTBI and 
occupational factors revealed interesting differences between primary and 
secondary level HCWs. The negative association between TST and HIV 
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status is to be expected because of the known depressive impact of HIV on 
cellular immunity and resultant anergy. Duration of employment in healthcare 
has been shown to be associated with increased risk of TST positivity and is 
presumed to be indicative of “cumulative” exposure. This correlation has 
been previously established and was replicated in a recent South African 
study of LTBI risk among medical students and established HCWs showing a 
doubling of TST positivity in HCWs compared to medical students (van Rie et 
al., 2013; Zwerling et al., 2012). Studies among Russian HCWs have shown 
similar results, with clinical staff exhibiting a threefold greater risk of LTBI 
than medical students (Drobniewski et al., 2007). In the current study, these 
associations were, however, only demonstrated among staff at primary level 
facilities. 
 
QFT-GIT 
 
The negative association between BCG vaccination and a positive QFT-GIT 
test is surprising as most studies have shown no association between BCG 
and IGRA test outcomes. The lack of an association has in part been 
explained by the improved specificity of IGRAs when compared to TST in 
BCG vaccinated populations.  
 
Strong associations with QFT-GIT were shown for exposure to 
environmental tobacco smoke (ETS) (in primary level staff), which has not en 
reported previously. Whilst smoking has been shown to be associated with 
increased risk for TB in a meta-analysis the association was stronger for TB 
disease than LTBI (Bates et al., 2007; Pai et al., 2007). ETS exposure may 
be associated with increased TB risk, and is pertinent in countries where 
high population rates of smoking and TB prevail and with poor 
implementation of tobacco control policies. Co-exposure to TB contacts and 
smoking in public spaces may well contribute synergistically to TB risk.  
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A recent study evaluating the potential TB transmission risk among users of 
public transport reports an annual risk of 3.5 – 5% of TB infection among 
users of minibus taxis suggesting that settings characterized by  poor 
ventilation and high respiratory contact rates, may play an important role in 
sustaining tuberculosis transmission in South Africa (Andrews, Morrow & 
Wood, 2013; Uys et al, 2011). 
 
In this study, staff that performed sputum collection duties had a threefold 
increased risk of a positive QFT-GIT test. Sputum collection may result in the 
aerosolization and spread of tuberculous bacilli and is considered a high risk 
procedure for transmission of TB. Despite this known risk, a recent study of 
drug resistant TB facilities in South Africa has shown that of 24 facilities, only 
two facilities had an appropriate infrastructure for the safe collection of 
sputum (Farley et al., 2012). 
 
In secondary level health facilities training in infection control procedures 
were associated with a decreased risk of LTBI as measured by QFT and 
TST, suggesting a potential protective effect. This is consistent with findings 
from a South African study of drug resistant TB treatment facilities which has 
shown higher levels of  clinical training to be  associated with greater 
knowledge of infection control (P < 0.001), more appropriate attitudes (P < 
0.001) and less time spent with coughing patients (P < 0.001) (Farley et al., 
2012). 
 
T-SPOT.TB 
 
Several occupational factors were associated with having a positive T-
SPOT.TB test. The threefold increase in LTBI odds (as tested by T-
SPOT.TB)associated with home-based care is relevant as high burden 
settings struggle with providing adequate health care to TB patients. Existing 
hospital facilities in the Western Cape are overstretched. Many TB patients 
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are resistant to prolonged hospitalization, e.g. those who are drug-resistant, 
and removal from their communities, contributing to an increased rate of 
treatment default. This has resulted in the advocacy for, and establishment of 
treatment programmes which involve community-based care, even for those 
with drug resistant TB (Nardell & Dharmadhikari, 2010). 
 
Paradoxically, staff working in facilities that practised cough etiquette were 
also at increased risk of having a positive T-SPOT.TB test, as were primary 
level staff who worked at facilities providing disposable masks to infectious 
patients. The anomalous associations between increased occurrence of LTBI 
and the practice of infection control measures may arise because facilities 
with higher caseloads of TB and HIV positive patients are more likely to 
implement infection control practices. There may also have been a degree of 
reporting bias from such facilities as actual implementation of control 
measures were not verified in this study. Farley et al (2012), in a study of 
infection control, has shown inconsistency between data supplied by key 
informants and that from direct observation on infection control practices, in 
drug-resistant TB hospitals in South Africa.  
 
Speaking Xhosa as a home language is considered a proxy measure for 
indigenous African ethnicity and lower socio-economic status in the Western 
Cape. This is on account of a racialized society which has skewed 
employment and educational opportunities in the Western Cape for those of 
ethnic African origin. The association between African ethnicity and LTBI 
occurrence (as measured by T-SPOT.TB), was not replicated following 
stratified analysis, whilst all the other associations remained present but 
significant only for primary level staff. 
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Predictive models 
 
Models generated to best predict test outcome shows male gender to be a 
consistently positive predictor across all test outcomes, whilst increasing age 
showed a significantly positive, and BCG vaccination a significantly negative 
association with both IGRA outcomes. The predictive model for TST 
positivity in addition included being an African language speaker (proxy for 
lower socio-economic status and indigenous African ethnicity) and exposure 
to secondary smoke, a known association with LTBI which has been 
previously described (Bates et al., 2007). In this population male HCWs of 
indigenous African ethnicity with exposure to environmental tobacco smoke 
had the highest risk of having a positive TST.  
 
Surprisingly predictive models for IGRA positivity differed for QFT-GIT and T-
SPOT.TB. Increasing age and male gender were common positive 
predictors, whilst BCG vaccination was a negative predictor for testing 
positive on either IGRA. Other predictors such as the occupational tasks of 
sputum collection, home-based care, ETS exposure and the presence of 
infection control measures were variably associated with one or other of the 
IGRA tests. These differences are suggestive of innate differences in test 
properties between the IGRAs and cannot be easily explained.    
 
7.2.2 AGREEMENT BETWEEN IGRA ASSAYS AND TSTAND A 
COMPARISON OF TEST PERFORMANCE USING LATENT CLASS 
ANALYSIS 
 
Concordance 
 
In this study there was only fair agreement between TST and IGRAs as 
reflected in κ values of 0.28 for QFT–GIT and 0.25 for TSPOT.TB 
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respectively, whilst agreement between the two IGRA assays as expected 
was substantial with κ=0.65. This is consistent with agreement studies in 
HCWs from low and intermediate incidence settings and that of a community 
based study from South Africa (Zwerling et al., 2012;Mahomed et al., 2006). 
 
Inter-test agreement at follow-up testing one year after baseline was 
however improved for QFT-GIT and TST (fair to moderate) but only 
marginally so for T-SPOT.TB and TST. The improvement in agreement 
between QFT-GIT and TST is possibly an effect of boosting induced by 
earlier administration of TST, a phenomenon which has been previously 
described (van Zyl-Smit et al., 2009a; van Zyl-Smit et al., 2009b). 
 
In this study varying the TST cut off to greater than 10mm did not improve 
inter-test agreement at baseline. This is similar to findings of HCW studies in 
other high TB incidence settings (Lien et al., 2009; Pai et al., 2005). Findings 
from HCW studies in low and intermediate TB settings have, however, 
shown improvement in agreement when using higher TST cut-point (15 mm) 
(Zwerling et al., 2012). Varying the IGRA cut-points upwards (QFT-GIT≥0.70 
IU/L or using an 8 spot increment for T-SPOT.TB) to denote a positive test 
did not enhance agreement with TST≥15 mm, in the current study.  
 
Factors associated with discordant LTBI test results  
 
The predominant discordant response reported from HCW studies has been 
that of a TST positive/ IGRA negative pattern (Zwerling et al., 2012). In this 
study such a pattern of discordance (TST+ / IGRA -) ranged from 23% for 
QFT to 28% for T-SPOT.TB. Whilst a positive association was shown with 
BCG vaccination and this pattern of discordance for both IGRAs, this was not 
significant. This confirms the lack of significant BCG effect on TST positivity 
that has previously been demonstrated in this study. 
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Those with longer years spent in a healthcare environment were less likely to 
exhibit a pattern of TST- / QFT + discordance in this study, suggesting that 
participants with long duration of employment would tend to have concordant 
results. A TST - / QFT + discordance was the predominant pattern of 
discordance found in a recent study of Canadian HCWs(Zwerling et al., 
2012).The lack of an association between QFT positivity and recent TB 
exposure in this study is suggestive of a potentially high rate of false 
positives reflected in this discordant pattern. This raises the possibility that 
the initial high rate of QFT positives may indicate suboptimal specificity (high 
rate of false positives) that may lead to unnecessary use of IPT in HCWs 
who do not really require it.    
 
For T-SPOT.TB, a pattern of TST+/ IGRA - discordance was less likely in 
older HCWs and those engaged in home-care of TB patients. Risk factors 
associated with TB such as being HIV positive, having had previous 
treatment for TB, working in a facility that practiced isolation of TB patients 
from others as part of infection control and being symptom screen positive 
were strongly associated with TST-/ T-SPOT.TB + discordance. The 
markedly increased risk of a discordant test response in HIV-infected 
participants(OR=4.72) has been replicated in other studies in similar settings 
and suggests that T-SPOT.TB test performance is relatively unimpaired by 
moderate HIV infection (as reflected in a median CD4 count of 392/mm3)and 
potentially more sensitive than TST for detecting LTBI in HIV-infected 
participants (Rangaka et al., 2007a; Rangaka et al., 2007b). Whilst a meta- 
analysis by Cattamanchi et al (2011) did not show IGRAs to be consistently 
more sensitive than TST,T-SPOT.TB did exhibit higher sensitivity, and 
appeared to be less affected by immunosuppression than TST or QFT-GIT.  
 
The association between this pattern of discordance and known TB risk 
factors such as previous TB treatment or being symptom screen positive 
remains unexplained. Such unexplained discordance has been described in 
studies from both low and high TB incidence settings and it is postulated that 
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both the epidemiological context and the use of standard cut-offs may be 
contributory factors (Pai et al., 2006; Pai et al., 2007).For example persons 
with tuberculosis in high-incidence countries often have advanced disease 
and are likely to be infected with HIV or malnourished. Anergy due to 
advanced HIV-associated immune suppression may affect test performance 
of IGRAs and TST leading to discordant test responses. The unexpected 
association between the implementation of infection control measures 
(isolation of TB patients from others) and a TST negative T-SPOT.TB 
positive discordant pattern in this study is similarly unexplained.   
 
Latent class analysis modelling 
 
In the absence of a gold standard for LTBI, and the problems inherent in the 
use of surrogate measures for LTBI, the use of latent class analysis and a 
fixed effect model allowed a more direct comparison of test performance in 
this population (Dendukuri, Hadgu & Wang, 2009; Pai, 2008; Dendukuri & 
Joseph 2001).This technique showed TST to have excellent sensitivity (93%) 
in this study. This is superior to both IGRAs for which the sensitivity was 
shown to be 84% for QFT-GIT and 79% for T-SPOT.TB. These findings 
suggest that as a first line screening test TST is better at detecting LTBI than 
IGRAs in this population. IGRAs appear to be more specific at ruling out 
LTBI than TST, displaying excellent specificity ranging from 93 -96%, 
compared to TST with 55% specificity.  
 
This suggests that in high burden settings such as this, TST performance as 
a first line screening test is highly sensitive. The superior specificity of IGRAs 
and increased sensitivity in HIV positive individuals may potentially make 
them useful adjunct tests in the diagnosis of LTBI in this population.  
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 7.2.3 ANNUAL INCIDENCE OF TB INFECTION IN HEALTH CARE 
WORKERS AND FACTORS ASSOCIATED WITH INCREASED 
RISK OF TEST CONVERSION 
 
Participation and loss to follow-up 
 
A large number of participants were lost to follow up resulting in a 67% 
participation rate by the end of the study. The greater proportion (68/91) 
could not be traced, suggesting a mobile HCW workforce and high staff 
turnover in health care facilities that formed part of the study. Those staff 
who participated in follow-up were significantly different from those lost to 
follow-up. They were generally healthier (less likely to smoke or be HIV 
infected), of older age and longer duration of employment in healthcare. This 
healthy worker effect would result in a degree of attrition bias that could 
affect estimates of LTBI and active TB generated by this study. Such bias 
would usually have the effect of attenuating estimates of adverse outcomes 
such as TB disease. 
 
Serial screening with IGRAs better tolerated than with TST 
 
There was also very low uptake of repeat TST, but excellent uptake of  the 
repeat IGRA assays, suggesting that despite being relatively invasive, the 
ease of administration (one visit), and absence of side effects or clinical 
reactions rendered it a better tolerated serial screening tool in this population 
A possible reason for this is that TST administration resulted in some 
discomfort for participants with greater than 80% testing positive at baseline 
and the median size of the skin reaction being 18mm.  
 
 
206
Incidence of TB Infection as measured by test conversion 
 
TST 
 
The annual incidence of infection in this population was extraordinarily high 
at 38% (95% CI; 22% - 56%) using TST, but needs to be interpreted with 
caution in view of the relatively wide confidence intervals. A proportion of the 
conversions may also be attributable to boosting. This figure is much higher 
than demonstrated in two Indian studies among HCWs (Table 6.7) 
(Christopher et al., 2011; Pai et al., 2006). Reasons for this difference may 
be that both Indian studies were conducted on nursing students or a 
combination of nursing and medical students, who might be less exposed to 
TB bacilli in the occupational context than HCWs in formal employment. A 
recent study in South Africa similarly showed a large difference in LTBI 
prevalence between medical students and HCWs(van Rie et al., 2013). 
Whilst there are no comparable studies among South African adults, a recent 
study of infection among adolescents in a high HIV prevalence community in 
Cape Town, reported an annual incidence of infection of 11% (Middelkoop et 
al., 2008). The authors argue that social contact is likely to be at its peak 
during adolescence and that TB risk of infection is more likely to resemble 
that of adults in the community than that of childhood. Using this estimate as 
a proxy measure for adult community risk of infection, this suggests that 
HCWs have a threefold higher risk of becoming infected during a one year 
period than a community comparison group from a high burden setting.  
 
IGRAs 
 
Serial testing with IGRAs also produced high conversion rates of 22% in this 
study, for both assays. Two studies of HCWs in India have produced 
comparable IGRA conversion rates ranging from 11.6 %– 21% using QFT-
GIT (Zwerling et al., 2012). Conversion estimates among HCWs in low and 
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intermediate TB incidence settings have varied from 1.8% -14.4 % for IGRA 
assays, mainly using QFT-GIT.  
 
In this study, only a small number of reversions (1%) was demonstrated 
using serial TST. This is in contrast to IGRAs which showed a 7% and 16% 
reversion rate for QFT-GIT and T-SPOT.TB respectively. Reversion rates of 
a study conducted by Pai et al (2006) have varied from 7% among baseline 
concordant positives to 70% in those with TST-/ IGRA + discordance. Joshi 
et al (2009) as cited by Zwerling et al (2012) have similarly shown a 27% 
reversion rate after a 6 month interval and a 40% reversion rate after a 12 
month interval among Indian HCWs. 
 
Studies of HCWs in low and intermediate TB incidence settings have 
reported similar high reversion rates ranging from 40%-52.9%. High rates of 
reversions have recently been shown in a large US-based study of HCWs 
followed up for 18 months and tested at 6 month intervals. The authors 
conclude that most conversions among HCWs in low TB incidence settings 
appear to be false positives, and the frequency of conversion was six to nine 
times higher with IGRAs than with TST. They propose that repeat testing of 
apparent converters should be considered (Dorman et al., 2014). 
 
Another US based study by Slater et al (2013) has proposed that given the 
relative stability of TST conversions when compared to IGRAs, a QFT-GIT 
cut-off of 5.3 IU/ml or higher (manufacturer's cut-off is >/=0.35 IU/ml) would 
yield a conversion rate of 0.4%, which was equal to the known TST 
conversion rate for the study population . The authors suggest that the 
current manufacturer's definition of QFT conversion results in an inflated 
conversion rate that is incompatible with the low risk study setting and that a 
much higher QFT cut-off value was needed to define a true conversion. The 
high rate of non-reproducible conversions in a majority of converters 
suggested a high rate of false positive results (Slater et al., 2013).There is 
therefore considerable uncertainty as to what the best cut-point for 
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conversion should be when using IGRAs for serial screening (Zwerling et al., 
2013; van Zyl-Smit et al., 2009a). This is true for both high and low TB 
incidence settings.   
 
In this study, varying the conversion cut-points by using more stringent 
definitions resulted in a modest decrease in the conversion rates. The role of 
natural variability in test response and a possible boosting effect on IGRAs 
by TST are two factors that  may play a role in influencing the optimal cut-off 
that determines whether a conversion truly reflects a new infection or not. 
This renders the use of IGRAs problematic in the clinical setting. The 
existence of natural variability in IGRA test response is lent further credibility 
by the far higher rate of reversion than demonstrated for TST in this study (7-
16% vs. 1%).   
 
Factors associated with LTBI test conversion 
 
There were no factors consistently associated with test conversion for both 
the TST and IGRA assays in this study. There were also no consistent 
associations with test conversion for the two IGRA assays. The threefold 
increased risk for QFT-GIT conversion associated with counselling of TB 
patients was the reverse of the negative association with TST conversion. 
This anomalous result suggests that the test outcomes are not equivalent 
and may call into question any suggested substitution of TST with IGRAs in 
this population.   
 
The association between male gender and QFT-GIT conversion (OR=4.02) 
in this study has been replicated in a study of serial testing of HCWs in the 
USA (Belknap, 2010). Male gender was also a consistently positive predictor 
of LTBI test positivity at baseline in predictive models generated for all three 
tests (Chapter 4 results) as well as in univariate analysis for conversion 
(Chapter 6 appendix). Naidoo et al (2006) showed a 45% increased 
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incidence of TB disease in male HCWs compared to female HCWs in KZN. 
These findings would suggest that male HCWs were at higher risk of incident 
LTBI infection and TB disease in South Africa.   
 
The strong association between a baseline positive TST result and a later T-
SPOT.TB conversion points to possible suboptimal sensitivity of the 
T.SPOT.TB in this population. This was similarly reflected in latent class 
modelling, which showed T-SPOT.TB to be the least sensitive of the three 
tests for the diagnosis of LTBI in this population. Varying of the T-SPOT.TB 
cut-point in the analysis by using an eight spot increment (treating 5-7 spots 
increment as a borderline zone), did not change the associations in 
multivariate analysis. An alternative explanation of the association between a 
baseline positive TST and subsequent T-SPOT.TB conversion could be due 
to boosting of the subsequent T-SPOT. TB test response by TST 
administration at baseline, which has been previously described (Belknap et 
al., 2009). 
 
The strong association with employment sector deserves further scrutiny as 
the provision of TB services has traditionally been a function of local 
government clinics and staff. This is still the case in combined facilities(run 
by local and provincial government health department staff). It is therefore 
plausible that local government staff have greater exposure to infectious TB 
patients than others. This may explain the strong association shown between 
TSPOT.TB conversion (OR=14.19) and employment by the local authority, 
suggesting a causative role for occupational exposure in conversion. 
However, this estimate lacks precision as reflected in the wide confidence 
interval (95% CI 1.28 – 157.75). 
 
For most of the occupational and environmental control measures, no 
demonstrable protective effect was demonstrated against conversion. This is 
contrary to the known impact of infection control measures on TB infection 
and disease rates in HCWs. (Baussano et al., 2007; Blumberg et al., 
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1995).This lack of a protective effect may be ascribed to a reliance on 
reported implementation of such measures rather than objective measures 
quantifying the practice and implementation of such control measures, 
rendering this measure of exposure assessment highly inaccurate.  
 
In conclusion this study demonstrates a high prevalence of LTBI using 
different testing modalities in HCWs, which mirrors that of the surrounding 
community. TST has superior sensitivity for the detection of LTBI in this 
population, but poor specificity when compared to IGRAs. Whilst there was 
excellent uptake of IGRAs in repeat testing, sequential IGRA test responses 
were marked by high rates of reversion when compared to TST, possibly as 
a result of boosting and greater inter-test variability. The markedly higher 
annual incidence of infection in this study than HCWs and community 
participants from other high TB incidence settings (Table 6.7), is strongly 
suggestive of a causative role for occupational exposure. The role of specific 
occupational and environmental exposures in driving TB infection rates 
deserves further exploration as effective infection control measures in such 
settings may reduce this risk. 
 
7.3 RESEARCH AND POLICY IMPLICATIONS AND 
RECOMMENDATIONS 
 
This is the first prospective HCW study in Africa evaluating TST and both 
QFT-GIT and T-SPOT.TB in a head-to-head comparison, with a focus on the 
potential occupational and environmental risk factors associated with LTBI 
prevalence and incidence. As such, it adds to the body of evidence on the 
utility of such tests in HCWs employed in a high TB and HIV prevalence 
setting.   
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7.3.1 POLICY AND PROGRAMME IMPLICATIONS  
 
Participation 
 
The low participation rate and high loss to follow-up in this study despite the 
potential benefit of the study for HCWs and the efforts that went into 
encouraging participation in this study are limitations on potential screening 
programmes. Initiatives aimed at surveillance and delivery of occupational 
health programmes to HCWs need to address this resistance and consult 
widely on preferred models of service delivery to this population. Service 
provision models need to address ease of access, confidentiality and the 
promotion of employee occupational health and safety. This may positively 
influence the poor uptake and suboptimal participation in such programmes 
which would hamper efforts to manage the burden of TB infection and 
disease among HCWs. 
 
Optimal screening test for LTBI 
 
TST performance was unaffected by BCG vaccination and its sensitivity was 
superior to IGRAs in the diagnosis of LTBI in this population. TST test 
response was also very stable with a low rate of reversion when compared to 
IGRAs, supporting the inference that those who tested LTBI positive at 
baseline were correctly identified as such. This suggests that where LTBI 
screening is incorporated into occupational health programmes for HCWs, 
TST should remain the preferred method of screening in this population. This 
supports the recommendation in the most recent South African National TB 
Control Programme which for the first time advocates the regular screening 
for LTBI in HCWs using the TST (Department of Health, South Africa, 2014). 
This is aligned to the current WHO recommendation that discourages the 
use of IGRAs for LTBI screening in HCWs, in low and middle-income 
countries (World Health Organization, 2011). Specific recommendations are 
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that data are insufficient and there is  low quality evidence on the 
performance of IGRAs in low- and middle-income countries, typically those 
with a high TB and/or HIV burden;  IGRAs and the TST cannot accurately 
predict the risk of infected individuals developing active TB disease;  Neither 
IGRAs nor the TST should be used for the diagnosis of active TB disease;  
IGRAs are more costly and technically complex to do than the TST. Given 
comparable performance but increased cost, replacing the TST by IGRAs as 
a public health intervention in resource-constrained settings is not 
recommended. For TST screening to have value as a programmatic 
intervention, IPT will have to be provided for those considered at high risk of 
developing TB disease.   
 
On the other hand, from a logistical point of view, there was greater uptake of 
repeat IGRAs (99%) than of TST (44%), despite the ostensibly more invasive 
nature of these assays. This is an important consideration especially in 
populations where the logistics of TST administration may be too 
cumbersome to implement.  
 
Ideally the choice of LTBI diagnostic test should be informed by multiple 
factors inclusive of test performance, available resources such as trained 
personnel, risk profile of the population and the acceptability and uptake of 
the test by populations targeted to benefit from such screening.   
 
Screening and follow-up of those at risk of TB infection 
 
Screening for LTBI has been difficult in those most at risk of LTBI such as 
HIV-infected individuals, young children and silicotics, despite the proven 
benefit of IPT in such groups. Reasons for the poor uptake are many and will 
need to be addressed if LTBI screening for HCWs is to be implemented. 
Such an initiative will have to create awareness of the benefits of IPT and 
devote additional resources to such programmes.  
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 The current recommendation from the National Tuberculosis Management 
Guideline advocates six monthly surveillance of HCWs which should include 
medical history, TB symptom review, TST, physical assessment, chest x-ray 
and other appropriate tests (Department of Health, South Africa, 2014). 
Since recent infection is associated with a 5% risk of developing TB disease 
in the next two years, it would be important to identify those HCWs with 
recent infection. Additional risk factors such as positive HIV status should 
also be screened for, as it would greatly increase their risk of progression 
and should be considered in targeted preventive measures in the form of IPT 
and workplace infection control.   
 
Whilst the recommendation for medical surveillance is a logical step, it is 
unclear how this will be implemented given the current paucity of 
occupational health service provision to HCWs, the lack of occupational 
health expertise and the chronic underfunding of occupational health 
services that currently prevail in South Africa (Adams et al., 2012). This 
strategy if properly implemented could reduce the incidence of active TB in 
HCWs in South Africa.  
 
HIV screening 
 
Regular HIV screening should be strongly encouraged both at entry into 
employment and periodically among HCWs. In this study 60% of incident TB 
cases were HIV positive, whilst 11% of HCWs were HIV positive and 
therefore at high risk of progression to active TB. HIV screening should be 
accompanied by the provision of INH prophylaxis for at least 6 months to 
those who test positive for HIV. Whilst HIV testing is recommended as part of 
pre-placement screening, it is not included as part of periodic screening in 
the national guideline. This needs to be addressed as HCWs remain at risk 
of becoming infected with HIV and TB for the duration of their working lives.  
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 Differential risk between staff from primary and secondary level 
facilities 
 
The significant differences in the demographic profiles and TB risk profile 
between staff from primary and secondary level facilities were not reflected in 
LTBI prevalence, but did reflect in TB disease prevalence as all TB cases 
were found in the primary care level staff at both the baseline and follow-up 
phase of the study. At baseline, all new cases of TB disease were 
community HCWs underscoring the high risk of this category of HCWs, 
which has been established in a previous study by Kranzer et al (2010).  
 
This suggests that primary care staff are at greater risk of TB disease than 
secondary level staff in this setting. This is indicative of a high background 
community exposure to TB and HIV, lower socio-economic status as well as 
increased occupational exposure to TB. Primary level staff have much 
greater contact with undiagnosed infectious TB cases and primary level 
facilities are known to have poor implementation of infection control 
measures, contributing to their occupational exposure to TB (Naidoo, 
Seevnarain & Nordstrom, 2012).Greater focus on the protection of primary 
level staff is therefore recommended. This should include LTBI and HIV 
screening with targeted implementation of IPT.  
 
Potential role of training in infection control  
 
A significantly protective effect on prevalent TB infection of training was 
demonstrated in secondary level staff. Training in TB administrative controls 
would incorporate safe work practices and infection control procedures which 
may mitigate TB risk if effectively implemented. Training programmes on 
infection control should therefore be implemented especially in low-resource 
settings where expensive engineering controls may not be feasible. This is in 
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keeping with recommendations from the WHO(World Health Organization, 
2009). 
 
Potential role of exposure factors in LTBI occurrence 
 
The strong association between certain occupational tasks such as home-
based care and sputum collection with LTBI occurrence points to areas of 
occupational exposure that could be addressed by interventions. Given the 
shift to home-based care, HCWs and family members engaged in the 
provision of such care should be trained in the application of infection control 
measures in such settings. This would have the impact of limiting 
occupationally acquired TB among HCWs and limiting TB transmission to 
family members of infectious patients being cared for at home.  
 
Training in safe work procedures and the provision of appropriate 
infrastructure for sputum collection are additional interventions that are 
needed. The lack of infrastructure for the safe collection of sputum in 
facilities treating drug-resistant TB cases is cause for concern(Farley et al., 
2012). Whilst not objectively evaluated in this study, infrastructural 
challenges are likely to be worse at primary level facilities which perform a 
greater volume of diagnostic tests and service larger numbers of infectious 
patients.   
 
TB disease screening in HCWs  
 
Whilst screening for TB disease was not a primary focus of this study, the 
results point to a suboptimal yield if only one screening tool is utilized such 
as sputum microscopy. This is especially relevant in high TB incidence 
settings where WHO criteria (cough and smear positive for acid fast bacilli) 
have been shown to have suboptimal sensitivity (56%) in diagnosing TB 
disease in those at highest risk (HIV positive individuals) (Bassett et al., 
216
2010). Implementation of screening programmes for the detection of TB 
disease in HCWs needs to take this into consideration and will have to 
consider a combination of screening tests to improve case detection rates. In 
this study all of the individuals diagnosed with TB at baseline were smear-
negative, with all five cases testing positive on culture. This makes it 
imperative that all HCWs suspected of having TB have a sputum culture as 
part of their initial investigation, in accordance with the South African 
Department of Health’s National TB guideline recommendation (Department 
of Health, South Africa, 2014). 
 
Factors associated with conversion 
 
The positive association between employment category and conversion for 
both IGRAs supports an effect of occupational exposure. Whilst the 
association was only significant for T-SPOT.TB, it does suggest that 
individuals employed in the provision of TB diagnostic and treatment services 
(local government staff) were at greater risk of T.SPOT.TB conversion than 
those in other employment sectors.  
 
The strong association between a baseline TST and a sequential positive 
IGRA test response (conversion), which was significant for T- SPOT.TB only, 
points to a probable boosting effect of antecedent TST on subsequent IGRA 
testing. Screening programmes which utilize both TST and IGRAs need to 
consider the impact of boosting of IGRA responses by antecedent TST in the 
interpretation of serial test outcomes.  
 
There were contrary associations between occupational tasks such as 
“counselling of TB patients” and test outcomes as it was a positive predictor 
of QFT conversion (OR=3.04) and a negative predictor of TST conversion 
(OR=0.12). This points to the need to arrive at a better understanding of 
incident infection using more appropriate cut-points to denote conversion. It 
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also points to the need for appropriate tools to evaluate occupational 
exposures of HCWs, which have been validated in high TB incidence 
settings. 
 
There is global consensus that HCWs need to be better protected against 
the risk of occupational tuberculosis (WHO, UNAIDS & ILO, 2010).Several 
strategies have been proposed to address the problem of TB in HCWs. 
These include: the generation of reliable data on HCW TB burden and 
infection control practices; ongoing review of policies dealing with the 
management of TB in HCWs and the rapid identification of new TB cases 
both among HCWs and the patients they serve (Chai, Mattingly & Varma, 
2013). For such strategies to be effective, policy formulation and review 
should be informed by research and a strong evidence base.  
 
7.3.2 RESEARCH IMPLICATIONS 
 
Burden of disease among HCWs 
 
Findings generated from the study suggests that LTBI and TB prevalence is 
very high among HCWs and remarkably similar to that of the surrounding 
community, making it difficult to clearly differentiate between the role of 
occupational and community exposure in this setting. It could be argued 
though that HWCs would be expected to have a lower LTBI and TB disease 
prevalence than the general population as they are likely to have a higher 
average socio-economic status. The equivalent LTBI and TB rates may 
therefore point to occupational exposure as playing a role in the occurrence 
of LTBI and TB in HCWs. The generation of more accurate estimates of the 
incidence of LTBI and TB disease among HCWs will require universal 
surveillance programmes targeting all HCWs, with uniform implementation 
across the country. Regular medical surveillance of HCWs for LTBI and TB 
disease has been incorporated into the most recent National TB control 
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programme for South Africa in support of such a strategy (Department of 
Health, South Africa, 2014). 
 
Tools for infection control measurement  
 
Studies evaluating infection control practices have shown poor 
implementation of such measures at both primary and secondary level 
facilities in South Africa (Farley et al., 2012; Naidoo, Seevnarain & 
Nordstrom, 2012; Claassens et al., 2013). In this study, paradoxical 
associations were also found between the practice of certain infection control 
measures and incident TB infection in HCWs. Claassens et al (2013) have 
similarly  shown paradoxical associations between infection control 
measures and TB disease rates in HCWs. This has highlighted the need for 
the development of tools have been validated and tested locally for the 
monitoring and measurement of infection control practices. 
 
Role of TSPOT.TB in diagnosing LTBI in immunosuppressed 
individuals 
 
The greater sensitivity of T-SPOT.TB than the other tests in HIV positive 
individuals deserves further exploration. This is reflected in a strong 
association between TST-/ TSPOT.TB + discordance and HIV positive status 
in this study.  
 
The current South African Antiretroviral Treatment Guidelines requires LTBI 
screening by way of TST only for the initiation of IPT (Department of Health, 
South Africa, 2013). The WHO currently considers the evidence base for the 
use of TSPOT.TB in HIV positive individuals too limited to recommend its 
use for LTBI screening. Whilst a recent meta-analysis by Cattamanchi et al 
(2011) did not show IGRAs to be consistently more sensitive than TST, the 
T-SPOT.TB did exhibit higher sensitivity, and appeared to be less affected by 
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immunosuppression than TST or QFT-GIT. Whilst the overall differences 
were considered to be too small and inconclusive, in advocating for the use 
of T-SPOT-TB in place of TST it is suggested that the choice of diagnostic 
test for LTBI screening should take into consideration resources and logistic 
demands as well as country-specific guidelines. Arriving at a more accurate 
diagnosis of LTBI in high risk individuals with HIV positive status, who may 
face additional risk from occupational exposure to TB, would be an important 
strategy in the targeted implementation of IPT (Cattamanchi et al., 2011). 
 
Reproducibility of assay results in serial testing 
 
IGRA assays in this study were characterized by high rates of conversion 
and reversion. Whilst TST had a higher conversion rate than IGRAs, much 
higher reversion rates were demonstrated for IGRAs than for TST. Since 
similar findings have been generated in studies from low and intermediate 
TB incidence settings, the degree of variability must in part be “intrinsic to 
these assays, and independent of exposure” (Pai, 2012: 1367).Pai suggests 
that some of this variability may be related to “pre-analytic delays, 
procedures such as test-tube shaking and test re-test variations.” The use of 
a binary definition would also invariably result in conversion and reversion 
rates that are not in keeping with the risk profile of the population. Pai(2012: 
1367) therefore advocates the consideration of additional factors such as the 
“risk profile of the HCW, TST results when available and history of contact, 
before making decisions about preventative therapy”. In addition he 
proposes a re-evaluation of the strategy of annual screening of all HCWs in 
low and intermediate incidence settings, calling for a more targeted approach 
to LTBI screening.  
 
In summary, risk profiling of high risk individuals, taking into consideration 
clinical risk factors and exposures, should inform targeted screening for LTBI 
and IPT. This strategy requires an improved understanding of host and 
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occupational risk factors associated with LTBI and TB disease risk, in high 
incidence TB settings.  
 
7.5  LIMITATIONS 
 
A limitation of the study is that of selection bias on account of a reliance on 
voluntary participation at both the baseline and follow-up phase of the study. 
Clinical staff at potentially greater risk of occupational TB infection (nurses 
and physicians) was underrepresented, probably as a result of high 
workloads and limited time to participate in the study during work hours.  
Whilst care was taken to not discourage participation on account of HIV 
testing being included as part of the protocol, there is still considerable 
stigma associated with the diagnosis and disclosure of HIV status that may 
have resulted in non-participation, by those most at risk of TB disease. 
 
Loss to follow up was a significant problem with only 67% of participants 
from the original cohort being available for follow-up testing. The decreased 
participation reflects in part the mobility and high staff turnover especially 
amongst the non-governmental sector (NGO) sector. Since all cases of TB 
disease at the baseline phase of the study emanated from staff working in 
this sector, this is suggestive of greater susceptibility of this group. Kranzer 
has similarly shown much higher rates of TB among community health care 
workers than the general population (Kranzer et al., 2010). TB programmes 
rely heavily on the use of community health care workers to support large 
treatment and adherence programmes, to achieve success in managing the 
epidemic. Surveillance programmes aimed at HCWs need to take account of 
the increased risk of TB faced by community health care workers, the 
mobility of this population and promote their inclusion in such programmes. 
 
Other reasons for non-participation may have been a perceived lack of 
benefit from participating especially amongst those who tested LTBI negative 
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at baseline as well as time constraints on attending the screening 
programme which occurred during work hours. Whilst the impact of attrition 
bias is not known, those who participated in the follow-up phase of the study 
were older, less likely to be HIV positive, and had longer years of service, 
pointing to a possible ‘healthy worker effect’. This may have had the effect of 
underestimating adverse outcomes such as incident TB disease which is 
greatly influenced by HIV status. 
 
Since the study setting was one of the highest TB incidence areas in the 
country, the findings may not be generalizable to all HCWs in South African 
or occupational settings where the community incidence of TB may be  lower 
and occupational exposure less than is the case in this study. A recent study 
of HCWs conducted in Johannesburg reported considerably lower LTBI 
prevalence among HCWs as measured by both TST and IGRA assay than 
this study (van Rie et al., 2013). 
 
The reliance on self-reported measures of exposure and infection control 
measures also rendered it difficult to arrive at accurate measures of such 
exposure and their relationship with LTBI. Ideally these exposures should be 
verified by more objective assessment using tools that are validated for use 
in high burden settings. Such tools are, however, lacking and area problem 
highlighted in a recent study that evaluated the relationship between infection 
control and TB risk of staff working in health care facilities in South Africa 
(Farley et al., 2012). 
 
The cross-sectional study design used to evaluate factors associated with 
LTBI prevalence makes it difficult to arrive at a true understanding of 
potential causes underlying LTBI prevalence in this population, as both 
exposure and outcomes are measured concurrently. Longitudinal studies 
that evaluate risk factors associated with new TB infection in LTBI negative 
individuals would provide clearer answers. In assessing occupational 
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exposures, tools will have to be developed which are adapted to and 
validated for use in local settings.   
 
Conventional binary cut-points were used in the agreement analysis between 
IGRA and TST outcomes. Emerging evidence from large serial screening 
activity in low and intermediate incidence settings, suggests that these cut-
points may be inappropriate for reflecting true IGRA conversion (Slater et al., 
2013; Fong et al., 2012). A recent study conducted among HCWs in India 
suggests this is likely to be true for high incidence settings as well (Zwerling 
et al., 2013). 
 
In this study, the use of cut-points for test positivity was based on the 
manufacturer’s instructions and software provided for assay analysis at the 
time that the study was conducted. For T-SPOT.TB this represented a 6 spot 
increment. Later recommendations, based on emerging evidence from 
studies performed, advised that a 5-7 spot increments be treated as a grey 
zone, and that an 8 spot or greater increment be considered a positive test. 
Whilst the original criterion of a 6 spot increment was used in our study, the 
revised cut point was taken into consideration in the multivariate analysis, but 
did not lead to a significant difference in results. Current evidence suggests 
that further revision of cut points is required which may be considerably 
higher than those currently recommended (Slater et al., 2013). 
 
7.6 CONCLUSION 
 
The high LTBI prevalence and incidence rates among HCWS in this study, 
coupled with high HIV infection prevalence and occupational exposure, 
places them at high risk of progression to TB disease. The high rate of TB 
disease and HIV infection among primary level staff, specifically in the NGO 
sector, highlights their increased risk in comparison to other HCWs.  
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Strategies are needed from a program and policy perspective to address this 
risk. These should focus on the establishment of occupational health 
programmes aimed at protecting HCWs from contracting TB and 
implementation of workplace infection control. The regular surveillance of 
HCWs for TB infection and disease, as currently advocated by the 
Department of Health, presents an opportunity to start dealing with the 
problem of TB in HCWs. Whilst more research is needed to inform on the 
optimal screening strategies for LTBI and TB disease, this should not delay 
the implementation to programmes to address and manage TB risk in HCWs.  
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UCT STUDY FOR THE EVALUATION OF IMMUNODIAGNOSTIC TESTS
 FOR  TB INFECTION AND DETERMINANTS OF TB INFECTION IN  
HEALTH CARE WORKERS OF THE W.CAPE PROVINCE OF SOUTH AFRICA 
ENGLISH QUESTIONNAIRE
Card 1
Survey Number ________________________ 1-4
A. IDENTIFICATION DATA
1. Surname ____________________________________
2. First name/s ____________________________________
3. Address ____________________________________
____________________________________
____________________________________
____________________________________
4. Residential area ____________________________________ 5-7
5. Contact Telephone numbers 
home ___________________________________
work ___________________________________
mobile ___________________________________
6. Contact e-mail ___________________________________
7. Staff number ____________________________________
8. Date of birth: Day_____Month______Year____ 8-13
9. Where were you born?
Town/District              ________________________________ 14-16
10. Gender: Male                   (1) 17
Female               (2)
11. Home Language: English                (1) 18
Afrikaans             (2)
Xhosa                  (3)
Other                   (4)
12. Did your parents work when you were a child?
Yes                     (1) 19
No                      (2)
Do not know       (3)        
 1
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12.1 What type of work did they do?
Mother's Occupation ____________________________________ 20-22
Father's occupation     ____________________________________ 23-25
13. Interviewer's initials   ______________________ 26-27
14. Date of interview:
 Day____Month_________Year______ 28-33
15 Health Facility: ____________________________ 34-35
16. Type of facility
Primary Care clinic                 (1) 36
Community Health Centre      (2)
Secondary hospital                  (3)
TB hospital                              (4)
B.MEDICAL HISTORY
BCG vaccination
1. Have you ever received a BCG vaccination against TB 
which is an injection in the left arm or shoulder which may
 leave a scar (usually given at birth)
Yes                 (1) 37
No                   (2)
Do not know    (3)
1.1 Do you have a vaccination scar to show?
(examine L deltoid area for scar).
Consistent with BCG scar       (1) 38
Inconsistent with BCG scar     (2)
No scar visible                         (3)
Other illness
2. Do you have any other condition or disease which requires 
medical treatment?
Yes                  (1) 39
No                   (2)
2.1 If yes, could you please specify what the  2
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condition/s  is/are?
__________________________________ 40-41
__________________________________ 42-43
3. Have you ever been diagnosed with Diabetes?
Yes                  (1) 44
No                   (2)
3.1   Are you on any treatment for diabetes?
Yes                  (1) 45
No                   (2)
Crowding
4.1   How many people are in the household?
______________________________ 46-47
4.2   How many bedrooms are in the home?
______________________________ 48-49
HIV infection
5. Have you ever been tested for HIV?
Yes                  (1) 50
No                   (2)
Do not know    (3)
If YES, go on to Question 5.1
If NO, skip to Question 6
5.1 Would you be willing to share the result with us?
Yes                  (1) 51
No                   (2)
If YES, go on to Question 5.2
If NO, skip to Question 6
5.2 What was the result of your HIV test?
Positive            (1) 52
Negative           (2)          
6. Would you be willing to have an HIV test now as part of 
a confidential  voluntary, testing programme which  3
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form part of this study?
Yes                  (1) 53
No                    (2)
If YES, go on to Question 6.1
If NO, skip to Question 7
6.1 Do you wish to be given the result of your HIV test?
Yes                  (1) 54
No                   (2)
Previous screening for TB
7. Have you ever been tested for TB by a health professional 
as part of routine screening i.e. without having symptoms of 
TB
Yes                     (1) 55
No                       (2)
Do not know        (3) 
8.1. Was this done by means of  a Tuberculin skin test
(such as a Mantoux/ Heaf / Tine / PPD test)
Yes                  (1) 56
No                   (2)
If YES, go on to Question 8.1.1
If NO, skip to Question 8.2
8.1.1. When was this skin test done?
Month ______  Year _____ 57-60
8.1.2 Were you advised against having any future skin tests 
for TB because of a bad reaction to the test ? 
Yes                    (1) 61
No                     (2)
8.2  Were you ever examined for TB by having a chest x-ray
Yes                  (1) 62
No                   (2)
8.2.1. When was this CXR done?
 4
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Month ______  Year _____ 63-66
8.3. Were you ever tested for TB by means of a symptom 
questionnaire as part of routine screening?
Yes                  (1) 67
No                   (2)
8.3.1. When was this questionnaire done?
Month ______  Year _____ 68-71
8.4 Was your sputum ever tested for TB?
Yes                  (1) 72
No                   (2)
8.4.1 When was this done?
Month ______  Year _____ 73-76
C. SMOKING HISTORY
1. Have you ever smoked cigarettes or tobacco?
Card 2
Yes                  (1) 1
No                   (2)
                                 If YES, go to question 1.1 
                                 If NO, skip to question 3
1.1. Have you ever smoked tobacco (cigarettes or pipe) for 
as long as a year?
‘YES’ means at least 20 packs of cigarettes or 360 grams of tobacco
 in a lifetime  or at least one cigarette per day for one year
Yes                  (1) 2
No                   (2)
If YES, go on to Question 1.2
If NO, skip to Question 1.3
1.2 How old were you when you started smoking?
__________ years old 3-4  5
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1.3 Do you now smoke?
‘YES’ means smoking tobacco in the last month or more
Yes                  (1) 5
No                   (2)
If YES, go on to Question 1.4.1
If NO, skip to Question 2
1.4 1-2. How much do you now smoke on average?
1.4.1 Number of cigarettes per day ________ 6-7
1.4.2 Pipe tobacco in grams/week ________ 8-10
2. Have you stopped smoking completely?
Yes                  (1) 11
No                   (2)
If YES, go on to Question 2.1
If NO, skip to Question 2.2
2.1 How old were you when you stopped smoking 
completely?
__________ years old 12-13
2.2 How many years in total did you smoke 
cigarettes? (Do not include the years you stopped before 
you started again)  
__________ years 14-15
2.3 On average of the entire time you smoked, 
how much did you smoke?
2.3.1 Number of cigarettes per day _______ 16-17
2.3.2 Pipe tobacco in grams/week  _______ 18-20
2.4 Do you or did you inhale the smoke?
Yes                  (1) 21
No                   (2)
3. Have you been regularly exposed to tobacco smoke
 from other people smoking cigarettes or pipe in the last 
 6
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12 months?
‘Regularly’ means on most days or nights
Yes                  (1) 22
No                   (2)
D. ALCOHOLISM SCREEN
1.   Have you ever drunk alcohol?
Yes                 (1) 23
No                  (2)
2   Do you drink alcohol now?
Yes                  (1) 24
No                   (2)
                           If yes, go to question 2.1
                           If no, go to section E 
2.1  Have you felt the need to cut down your drinking?
Yes                  (1) 25
No                   (2)
2.2 Have you felt annoyed by criticism of your drinking?
Yes                  (1) 26
No                   (2)
2.3 Have you had guilty feelings about drinking?
Yes                  (1) 27
No                   (2)
2.4 Have you taken a drink as a morning eye opener?
Yes                  (1) 28
No                   (2)
E. TB SYMPTOM SCREEN
Current TB symptoms 
 7
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1. Have you ever received treatment for TB?
Yes                  (1) 29
No                   (2)
                           If yes, go to question 1.2
                           If no, go to question 2 
1.2 When did you receive treatment for TB?
Month ______  Year _____ 30-33
1.3 For how long did you receive treatment for TB?
Months _______________ 34-35
2. Are you currently receiving treatment for TB?
Yes                  (1) 36
No                    (2)
3. Do you have a cough at the moment ?
Yes                  (1) 37
No                    (2)
If YES, go on to Question 3.1
If NO, skip to Question 4
3.1 Have you been coughing for more than 2 weeks?
Yes                  (1) 38
No                   (2)
4. Have you coughed up blood in the last month?
Yes                  (1) 39
No                   (2)
5. Have you suffered from weight loss without trying to lose
 weight? 
Yes                  (1) 40
 8
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No                   (2)
6. Do you experience night sweats currently i.e excessive 
sweating that drenches your nightclothes / bedding ?
Yes                  (1) 41
No                   (2)
7. Have you had a fever lasting more than two weeks recently?
Yes                  (1) 42
No                   (2)
8. Have you had chest pain lasting more than 2 weeks 
recently? 
Yes                  (1) 43
No                   (2)
F. EXPOSURE FACTORS
General occupational factors
1. What is your current job title? 
____________________________ 44-45
2. How long have you been employed in this position?
Years __________ 46-47
months __________ 48-49
3. Which department/ section are you working in? 
____________________________ 50-51
4. How long have you been employed in a healthcare
 environment?
Years __________ 52-53
months __________ 54-55
5. Do you have a professional health qualification?
Yes                  (1) 56
No                   (2)
 9
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If YES, go on to Question 5.1
If NO, skip to Question 6
5.1 If yes , when did you obtain your qualification?
Month ______  Year _____ 57-60
5.2 Could you please specify what your qualification is?
____________________________ 61-62
6. In your judgement how often do you come into contact with 
suspected TB patients during the course of your work?
a) Every day ______ 63
b) Less than 2 times a week ______
c) At least once a month ______
d) Less than once a month ______
e) Never                 ______
7. Are you during the course of your work involved in 
any of the following procedures?
7.1 Clerking or interviewing of suspected / known TB  
patients?
Yes                  (1) 64
No                   (2)
7.2 Counselling of suspected/known TB patients
Yes                  (1) 65
No                   (2)
7.3 Examination of suspected /knownTB patients?
Yes                  (1) 66
No                   (2)
7.4 Taking of sputum from suspected/known TB patients
Yes                  (1) 67
No                   (2)
7.5 General nursing care of suspected/known TB patients?
Yes                  (1) 68
No                   (2)  10
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7.6 Home-based care of TB patients?
Yes                  (1) 69
No                   (2)
7.7 Bronchoscopic procedures on suspected /known TB 
patients
Yes                  (1) 70
No                   (2)
7.8 Other exposure not mentioned above
Please specify              ____________________________ 71-72
Facility exposure factors
8. To your knowledge does the facility have an infection 
control policy to decrease the risk of TB infection?
Yes                  (1) 73
No                   (2)
Do not know    (3)
9. To your knowledge are control measures in place within 
the facility to decrease  TB risk to the staff such as:
9.1 Ventilation measures (natural or mechanical)?
Yes                  (1) 74
No                   (2)
Natural ventilation refers to the opening of windows and doors to allow 
for adequate ciruclation of air
Mechanical ventilation refers to the use of (1) propeller fans and / or     
(2) exhaust ventilation to allow for adequate circulation of air
9.2 Ultra-violet lights?
Yes                  (1) 75
No                   (2)
9.3 Teaching of cough etiquette to patients? 
Yes                  (1) 76
No                   (2)
 11
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Cough etiquette/ hygiene means to instruct coughing patients to cover
 their nose and mouth when coughing or sneezing and if possible to use
  facemasks or tissues to assist them in covering their mouths 
9.4 Early triage of potentially infectious patients through   
early separating of TB patients from others in the facility?
Yes                  (1) 77
No                   (2)
9.5 Separating TB patients from other patients in the 
different clinic areas?
Yes                  (1) 78
No                   (2)
9.6 On site TB diagnostic services such as sputum 
microscopy and/or x-rays
Yes                  (1) 79
No                   (2)
9.7 Provision of disposable surgical masks to infectious 
patients to wear?
Yes                  (1) 80
No                   (2)
9.8 Supply of special (N95) (non-surgical) masks for staff  
to wear to protect against TB? (show picture of mask)
Card 3
Yes                  (1) 1
No                   (2)
 12
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Recent exposure and contact score for TB
10. To your knowledge have you recently (in the last 3 months) 
had contact with a newly-diagnosed person with TB?
Yes                  (1) 2
No                   (2)
11. Did the contact occur at work , home or elsewhere?
Home                 (1) 3
Work                  (2)
Other                 (3)
11.1 If elsewhere, please specify where
_________________________________ 4-5
If home /other, go on to Question 12
If work, skip to Question 13
Household/other contact exposure score
12.1 What is your relationship to the TB case
______________________________ 6
12.2 Infectivity of TB case
a) Sputum test result not known 0 7
b) Sputum-negative TB 2
c) Sputum positive TB 4
12.3 Type of exposure to TB case (proximity)
a) No known exposure 0 8
b)Lives and sleeps in different house 1
c) Lives and sleeps in same house 2
d) Sleeps in same room 3
12.4 Duration (hours) per day contact with TB case
a) No known contact 0 9
b) 0 - 3 hours 1
c) 4 - 7 hours 2
d) 8 - 11 hours 3
e) ≥ 12 hours 4
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Occupational contact exposure score
13.1 Which of the following best describes your
 relationship with the TB patients?
a) Provider of  non-clinical service 1 10
b) Provider direct clinical care 2
c) Both 3
Non-clinical service includes administrative duties, clerking of 
patients, transport of patients, cleaning of facility.   
Clinical care includes examination of patients, general nursing care, 
radiography, taking of sputum, blood and urine specimens for
 investigations and dispensing of TB medication 
13.2 Type of exposure to TB patients (proximity)
a) No direct exposure but works in facility treating TB 1 11
patients 
b) No direct exposure but works in a department treating 2
TB patients 
c) Direct exposure in same room providing 3
non-clinical service
d) Direct exposure in same room providing clinical care 4
13.3 Average duration (hours) per day contact with TB cases
a) 0 - 3 hours 1 12
b) 4 - 7 hours 2
c) 8 - 11 hours 3
d)≥12 hours 4
G. HEALTH AND SAFETY EDUCATION AND TRAINING
14. In your view the probability of getting infected by TB  
patients in your workplace is?
a) low 1 13
b)moderate 2
c)high 3
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15. How much training have you had on how
to protect yourself when working with TB patients?
a) no training 1 14
b) some training 2
c) extensive training 3
16. How much training have you received  in infection control 
practices to minimize the risk of transmission of infection 
from  a TB case to other patients?
a) no training 1 15
b) some training 2
c) extensive training 3
17. Are you provided with personal protective equipment 
e.g. masks during high risk procedures? 
Yes                  (1) 16
No                   (2)
18. Do you have any concerns and/or recommendations 
regarding your risk of acquiring TB as a result of your work?
________________________________________________________ 17-18
________________________________________________________
________________________________________________________ 19-20
_________________________________________________________
________________________________________________________ 21-22
_________________________________________________________
________________________________________________________ 23-24
 15
249
APPENDIX 2 
250
FOLLOW-UP PHASE OF UCT STUDY FOR THE EVALUATION OF 
 IMMUNODIAGNOSTIC TESTS FOR  TB INFECTION AND DETERMINANTS OF 
TB INFECTION IN  HEALTH CARE WORKERS OF THE W.CAPE PROVINCE 
OF SOUTH AFRICA 
ENGLISH QUESTIONNAIRE
Card 1
Survey Number ________________________ 1-4
A. IDENTIFICATION DATA
1. Surname ____________________________________
2. First name/s ____________________________________
3. Address ____________________________________
____________________________________
____________________________________
____________________________________
4. Residential area ____________________________________ 5-7
5. Contact Telephone numbers 
home ___________________________________
work ___________________________________
mobile ___________________________________
6. Contact e-mail ___________________________________
7. Staff number ____________________________________
8. Date of birth: Day_____Month______Year____ 8-13
9. Interviewer's initials   ______________________ 14-15
10. Date of interview:
 Day____Month_________Year______ 16-21
11 Health Facility: ____________________________ 22-23
 1
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B. SMOKING HISTORY
1. Have you ever smoked cigarettes or tobacco?
Yes                  (1) 24
No                   (2)
                                 If YES, go to question 1.1 
                                 If NO, skip to Section C
1.1 Do you now smoke?
Yes                  (1) 25
No                   (2)
If YES, go on to Question 1. 2
If NO, skip to Question 2
1.2 1-2. How much do you now smoke on average?
(Answer one or the other option provided)
1.2.1 Number of cigarettes per day ___________ 26-27
1.2.2 Pipe tobacco in grams/week ___________ 28-30
2. How many years in total did you smoke or have you smoked 
cigarettes? (Do not include any years you stopped before 
you started again)  
__________ years 31-32
C. EXPOSURE FACTORS
General occupational factors
1. What is your current job title? 
______________________________________________ 33-34
2. How long have you been employed in this position?
Years __________ 35-36
months __________ 37-38
3. Which department/ section are you working in? 
______________________________________________________ 39-40
 2
252
4. Who is you employer ? currently?
Provincial Health Dept 1 41
City of Cape Town 2
NGO (Specify which) 3
Other (Specify which) 4
____________________________________
D. TB SYMPTOM SCREEN
Current TB symptoms 
1. Have you been diagnosed with TB since we last screened you?
Yes                  (1) 42
No                   (2)
                           If yes, go to question 1.2
                           If no, go to question 2 
1.2 Have you received treatment for TB since we last screened 
you?
Month ______  Year _____ 43-46
1.3 For how long have you received treatment for TB?
Months _______________ 47-48
2. Are you currently receiving treatment for TB?
Yes                  (1) 49
No                    (2)
3. Do you have a cough at the moment ?
Yes                  (1) 50
No                    (2)
If YES, go on to Question 3.1
If NO, skip to Question 4
3.1 Have you been coughing for more than 2 weeks?
Yes                  (1) 51
No                   (2)
 3
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4. Have you coughed up blood in the last month?
Yes                  (1) 52
No                   (2)
5. Have you suffered from weight loss without trying to lose
 weight? 
Yes                  (1) 53
No                   (2)
6. Do you experience night sweats currently i.e excessive 
sweating that drenches your nightclothes / bedding ?
Yes                  (1) 54
No                   (2)
7. Have you had a fever lasting more than two weeks recently?
Yes                  (1) 55
No                   (2)
8. Have you had chest pain lasting more than 2 weeks 
recently? 
Yes                  (1) 56
No                   (2)
E. HIV infection
1. Have you ever been tested for HIV?
Yes                  (1) 57
No                   (2)
Do not know    (3)
If YES, go on to Question 2.1 
If NO, skip to Question 3
2.1 Would you be willing to share the result with us?
Yes                  (1) 58
No                   (2)
If YES, go on to Question 2.2
If NO, skip to Question 3
 4
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2.2 What was the result of your HIV test?
Positive            (1) 59
Negative           (2)          
3. Would you be willing to have an HIV test now as part of 
a confidential  voluntary, testing programme which
form part of this study?
Yes                  (1) 60
No                    (2)
If YES, go on to Question 3.1
If NO, skip to Section F
3.1 Do you wish to be given the result of your HIV test?
Yes                  (1) 61
No                   (2)
F. Health Services for TB and HIV
1. Did the researchers or study staff refer you for TB and /or 
HIV  health care services after your initial screening ?
Yes                  (1) 62
No                   (2)
If YES, go on to Question 1.1
If NO, skip to Question 2
1.1 Where did you attend for TB / HIV care ?
1. Place of employment 63
2. Other clinic/ healthcare facility
3. Private Care
4. Did not attend
1.2 Did you find it easy to access such services?
Yes                  (1) 64
No                   (2)
We are interested in your opinion:
 5
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2. How do you think TB and HIV health services should  be 
provided to staff ?
1. At public sector clinics as for patients 65
2. Occupational health clinics specially provided 
for staff (and funded by employers)
3. Referred to private medical care
4. Other: Specify ________________________
3. Would you use Occupational Health services provided 
at your site of employment for TB and HIV care for yourself? 
Yes                  (1) 66
No                   (2)
If NO, go on to Question 3.1
3.1 If No, please provide reason
__________________________________________________________________ 67
___________________________________________________________________
 6
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 UCT STUDY FOR THE EVALUATION OF IMMUNODIAGNOSTIC TESTS 
FOR TB INFECTION AND THE DETERMINANTS OF TB INFECTION IN 
HEALTH CARE WORKERS OF THE WESTERN CAPE PROVINCE  
OF SOUTH AFRICA – 2009  
 
ENGLISH CONSENT FORM  
 
1. Title of research project 
 
An evaluation of immunodiagnostic tests for tuberculosis infection and   
determinants of TB infection in healthcare workers of the Western Cape of South Africa 
 
2. Purpose of the research 
 
The University of Cape Town is conducting this important study on TB infection and its determinants 
in health care workers. This study is going to be done by researchers who are independent of the 
Provincial Dept of Health and the City of Cape Town. We will be studying healthcare workers in 
public sector health facilities that serve communities with a high prevalence of TB and HIV infection. 
It is hoped that this study will provide greater insight into the utility of newer immunodiagnostic test 
for detecting latent TB infection (LTBI), the burden of LTBI and TB amongst health care workers and 
the exposure factors that increases TB risk in this population.  Study findings may also be used to 
inform the need for improved risk control measures and surveillance systems to be implemented in 
order to reduce the incidence of tuberculosis among health care workers. 
 
3. Description of the research project 
  
 If you agree to participate you will be asked to complete the following tests during working time: 
  
a) Complete a questionnaire 
A member of our study team will interview you in privacy to complete the questionnaire. You will be 
asked questions about TB symptoms, current and previous employment history, risk factors related 
to potential TB exposure ( questions will cover environmental, occupational and personal factors). 
 
b) Examination 
If BCG vaccinated or you are uncertain of having received such vaccination you will be required to 
show the interviewer the site of vaccination (usually upper left arm) 
 
c) Chest radiograph 
A postero-anterior chest x-ray will be taken to evaluate your lungs for signs of TB disease. The X-ray 
will be read by doctors from UCT.  
   
d) Tuberculin skin test 
A tuberculin skin test will be done to see whether you react to TB antigen.  A nurse will inject a small 
amount (0.1ml) of tuberculin into the skin of your forearm. The reaction will be read and measured 
48-72 hours later using a ball point pen to mark the diameter of the induration (reaction) and a ruler 
to measure it with. 
 
e) Blood tests 
A 3ml volume of venous blood will be collected from all subjects by a nurse into the three tubes (1ml 
per tube) and will be sent to a laboratory to check for an immune response to TB infection 
(Quantiferon Gold in tube test). The blood samples will be stored and may be tested to look for the 
presence of other biological substances (biomarkers) associated with TB at a later stage. 
Two ten ml blood will also be collected in heparinized tubes for the T SPOT TB test which will be 
sent to the laboratory for analysis.  
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f) HIV test 
You will be asked to provide blood for an HIV test. This will be obtained from a fingerprick sample 
taken by a trained nurse and member of the research team. You will be asked whether you wish to 
be given your result. If you do wish to have your result, you will be provided with counseling and 
appropriate referral for further care depending on your test result. Your test result will be kept 
confidential and disclosed only to you. You have the right to refuse the HIV test but still enroll into the 
study.   
 
g) Confidentiality of information collected 
 
Your name will not appear in any reports on this study. The records of skin tests, blood tests, and x-
rays will be kept completely confidential and will be seen only by members of the study team. 
 
5. Risks and discomforts of the research 
 
a) From the blood tests. You will feel a single needle stick when the blood is taken. Sometimes a 
small bruise may occur from the needle stick, but this is minor and will heal quickly.  The total 
amount of blood taken is quite small and your body will quickly replace it.  
 
b) Tuberculin skin test 
You may experience redness, swelling and/or ulceration at the site of the tuberculin skin. Very 
rarely an allergic reactions to the tuberculin skin test may occur. In the event of such a reaction a 
trained nurse will be present to provide you with treatment for the allergic reaction. It will also be 
arranged with the facility to have a doctor located nearby and ready to help if necessary. 
 
    c) From the chest x-ray 
     You will be exposed to a small amount of radiation during taking of the x-ray. However this  
     represents a negligible exposure and has not been associated with increased risk of illness due  
     to radiation. 
 
d) From the questionnaire  
      There are no risks associated with the questionnaire and all information will be treated as  
                confidential.  
 
6. Expected benefits to you and to others 
  
You will be given a written copy of all your test results along with an explanation of what they mean, 
unless you tell us that you do not wish to receive this.  You may wish to show these to your doctor if 
you are having any problems.  These tests will help determine if you have latent TB or active TB.  
What we learn from this study will help us to know whether the new TB test may be used for 
detecting latent TB among healthcare workers and what are the environmental and occupational 
factors associated with increased TB risk. Preventative programme can then address these factors  
to reduce health care workers’ risk of contracting TB. 
 
7. Costs to you resulting from participation in the study 
 
The study is offered at no cost to you.  In the event of an abnormal test result requiring further 
investigation or management you will be referred to a facility of your choice for further investigation 
and care 
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8. Contact person.   
 
You may contact one of the following persons for answers to further questions about the research, 
your rights, or any injury you may feel is related to the study.   
 
University of Cape Town Researchers: 
 
Dr. Shahieda Adams, Telephone No. (021) 406-6665 
                                    Mobile              083 2857665     
 
University of Cape Town Research Ethics Committee: 
 
Contact person (ethics administrator)  406-6492 
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 UCT STUDY FOR THE EVALUATION OF IMMUNODIAGNOSTIC TESTS 
FOR TB INFECTION AND THE DETERMINANTS OF TB INFECTION IN 
HEALTH CARE WORKERS OF THE WESTERN CAPE PROVINCE  
OF SOUTH AFRICA – 2009  
 
ENGLISH CONSENT FORM  
 
 
STUDY NO. ______________ 
 
 
 
9. Consent of the participant 
  
I have read the information given above, or it has been read to me.  I understand the meaning of this 
information, Dr./Mr./Ms. ________________________________________________________ 
has offered to answer any questions concerning the study.  By signing this form, I hereby consent to 
participate in the study.  I also understand that I am free to withdraw from the study at any time 
without penalty. 
 
10. Documentation of the consent 
  
 One copy of this signed document will be kept together with our research records for 
 this study. A copy of the information sheet about the study will be given to you to keep. 
 
 
 __________________________________  _____________________________ 
 Printed name of participant    Signature, Mark, or Thumb Print  
 
 
__________________________________  ______________________________ 
 Interviewer’s name (Print)    Signature 
 
 
 DATE: ____________________ 
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 UCT STUDY FOR THE EVALUATION OF IMMUNODIAGNOSTIC TESTS 
FOR TB INFECTION AND THE DETERMINANTS OF TB INFECTION IN 
HEALTH CARE WORKERS OF THE WESTERN CAPE PROVINCE  
OF SOUTH AFRICA – 2010[FOLLOW-UP]  
 
ENGLISH CONSENT FORM  
 
1. Title of research project 
 
An evaluation of immunodiagnostic tests for tuberculosis infection and    
determinants of TB infection in healthcare workers of the Western Cape of South Africa 
 
2. Purpose of the research 
 
The University of Cape Town is conducting this important study on TB infection and its determinants 
in health care workers. This study is going to be done by researchers who are independent of the 
Provincial Dept of Health and the City of Cape Town. We will be studying healthcare workers in 
public sector health facilities that serve communities with a high prevalence of TB and HIV infection. 
It is hoped that this study will provide greater insight into the utility of newer immunodiagnostic test 
for detecting latent TB infection (LTBI), the burden of LTBI and TB amongst health care workers and 
the exposure factors that increases TB risk in this population.  Study findings may also be used to 
inform the need for improved risk control measures and surveillance systems to be implemented in 
order to reduce the incidence of tuberculosis among health care workers. 
 
3. Description of the research project 
  
 If you agree to participate you will be asked to complete the following tests during working time: 
  
a) Complete a questionnaire 
A member of our study team will interview you in privacy to complete the questionnaire. You will be 
asked questions about TB symptoms, employment history, risk factors related to potential TB 
exposure and questions related to health service access. 
 
 
b) Chest radiograph 
A postero-anterior chest x-ray will be taken to evaluate your lungs for signs of TB disease. The X-ray 
will be read by doctors from UCT.  
   
c) Tuberculin skin test 
A tuberculin skin test will be done to see whether you react to TB antigen.  A nurse will inject a small 
amount (0.1ml) of tuberculin into the skin of your forearm. The reaction will be read and measured 
48-72 hours later using a ball point pen to mark the diameter of the induration (reaction) and a ruler 
to measure it with. 
 
d) Blood tests 
A 3ml volume of venous blood will be collected from all subjects by a nurse into the three tubes (1ml 
per tube) and will be sent to a laboratory to check for an immune response to TB infection 
(Quantiferon Gold in tube test). The blood samples will be stored and may be tested to look for the 
presence of other biological substances (biomarkers) associated with TB at a later stage. 
Two ten ml blood samples will also be collected in heparinized tubes for the T SPOT TB test which 
will be sent to the laboratory for analysis.  
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 e) HIV test 
You will be asked to provide blood for an HIV test. This will be obtained from a fingerprick sample 
taken by a trained nurse and member of the research team. You will be asked whether you wish to 
be given your result. If you do wish to have your result, you will be provided with counseling and 
appropriate referral for further care depending on your test result. Your test result will be kept 
confidential and disclosed only to you. You have the right to refuse the HIV test but still enroll into the 
study.   
 
f) Confidentiality of information collected 
 
Your name will not appear in any reports on this study. The records of skin tests, blood tests, and x-
rays will be kept completely confidential and will be seen only by members of the study team. 
 
5. Risks and discomforts of the research 
 
a) From the blood tests. You will feel a single needle stick when the blood is taken. Sometimes a 
small bruise may occur from the needle stick, but this is minor and will heal quickly.  The total 
amount of blood taken is quite small and your body will quickly replace it.  
 
b) Tuberculin skin test 
You may experience redness, swelling and/or ulceration at the site of the tuberculin skin. Very 
rarely an allergic reactions to the tuberculin skin test may occur. In the event of such a reaction a 
trained nurse will be present to provide you with treatment for the allergic reaction. It will also be 
arranged with the facility to have a doctor located nearby and ready to help if necessary. 
 
    c) From the chest x-ray 
     You will be exposed to a small amount of radiation during taking of the x-ray. However this  
     represents a negligible exposure and has not been associated with increased risk of illness due  
     to radiation. 
 
d) From the questionnaire  
      There are no risks associated with the questionnaire and all information will be treated as  
                confidential.  
 
6. Expected benefits to you and to others 
  
You will be given a written copy of all your test results along with an explanation of what they mean, 
unless you tell us that you do not wish to receive this.  You may wish to show these to your doctor if 
you are having any problems.  These tests will help determine if you have latent TB or active TB.  
What we learn from this study will help us to know whether the new TB test may be used for 
detecting latent TB among healthcare workers and what are the factors associated with increased 
TB risk. Preventitive programme can then address these factors to reduce health care workers’ risk 
of contracting TB. 
 
7. Costs to you resulting from participation in the study 
 
The study is offered at no cost to you.  In the event of an abnormal test result requiring further 
investigation or management you will be referred to a facility of your choice for further investigation 
and care 
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8. Contact person.   
 
You may contact one of the following persons for answers to further questions about the research, 
your rights, or any injury you may feel is related to the study.   
 
University of Cape Town Researchers: 
 
Dr. Shahieda Adams, Telephone No. (021) 406-6665 
                                    Mobile              083 2857665     
 
University of Cape Town Research Ethics Committee: 
 
Contact person (ethics administrator)  406-6492 
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 UCT STUDY FOR THE EVALUATION OF IMMUNODIAGNOSTIC TESTS 
FOR TB INFECTION AND THE DETERMINANTS OF TB INFECTION IN 
HEALTH CARE WORKERS OF THE WESTERN CAPE PROVINCE  
OF SOUTH AFRICA – 2010 FOLLOW-UP 
 
ENGLISH CONSENT FORM  
 
 
STUDY NO. ______________ 
 
 
 
9. Consent of the participant 
  
I have read the information given above, or it has been read to me.  I understand the meaning of this 
information, Dr./Mr./Ms. ________________________________________________________ 
has offered to answer any questions concerning the study.  By signing this form, I hereby consent to 
participate in the study.  I also understand that I am free to withdraw from the study at any time 
without penalty. 
 
10. Documentation of the consent 
  
 One copy of this signed document will be kept together with our research records for 
 this study. A copy of the information sheet about the study will be given to you to keep. 
 
 
 __________________________________  _____________________________ 
 Printed name of participant    Signature, Mark, or Thumb Print  
 
 
__________________________________  ______________________________ 
 Interviewer’s name (Print)    Signature 
 
 
 DATE: ____________________ 
266
APPENDIX 5 
267
 UNIVERSITY OF CAPE TOWN 
 
 
 
 
 
 
UCT STUDY FOR THE EVALUATION OF IMMUNODIAGNOSTIC TESTS FOR TB 
INFECTION AND THE DETERMINANTS OF TB INFECTION IN HEALTH CARE 
WORKERS OF THE WESTERN CAPE PROVINCE OF SOUTH AFRICA – 
2009/2010  
 
 
MEDICAL REPORT 
 
Date :_______________________ 
 
Name :__________________________________________________________________________ 
 
This is the report of the medical examination and tests conducted on you by medical 
staff from the University of Cape Town, as part of the research on TB infection in 
healthcare workers 
 
1. Questionnaire result 
 
 
 Questionnaire completed       Questionnaire not completed 
        
 
Symptom screen suggestive of Active TB:  
     
   Yes 
 
   No 
 
 
2. Chest radiograph result 
 
 
 Test not done  Normal      Abnormal  
 
 
 
 
 
 
OCCUPATIONAL AND ENVIRONMENTAL HEALTH RESEARCH UNIT 
____________________________________ 
School of Public Health & Family Medicine 
Faculty of Health Sciences 
Anzio Road 
Observatory 7925 
SOUTH AFRICA 
Telephone: (27 21) 406 6665 
Fax: (27 21) 406 6163 
e-mail: shahieda.adams@uct.ac.za 
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 If Abnormal specify:  
     
   Signs of inactive TB 
 
 
   Signs of active TB 
 
    
                                 Signs of other pathology 
 
 
3.  Tuberculin skin test results 
 
 
              Test not done   Negative   Positive 
 
       
      If Positive specify:            Mildly positive (≤ 5mm induration) 
     
   Moderately positive (≤10mm induration) 
 
   Markedly positive (≤15mm induration) 
 
   Ulcerating 
 
 
3. OVERALL COMMENTS 
 
(Please note that the tick in the box applies to you) 
 
The results indicate that you have no evidence of latent or active TB infection  
 
 
The results indicate that you may have latent TB infection. The current 
policy is not to offer treatment for TB infection to health care workers. 
However you are advised to seek medical care should you suffer from any 
symptoms suggestive of active TB such as cough >2 weeks, night sweats, loss 
of weight or haemoptysis.  
 
The results indicate that you may have active tuberculosis. You will be 
referred for sputum microscopy and culture. 
 
 
The results indicate that you are at high risk for TB disease and will require 
referral for further care and management 
 
 
 
Please do not hesitate to contact Dr S Adams (Telephone: 083 2857665) should you 
have any queries or require more detailed results of the investigations done on you. 
 
 
Yours faithfully, 
 
 
 
__________________ 
Dr S Adams 
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           UNIVERSITY OF CAPE TOWN 
 
 
 
UCT STUDY FOR THE EVALUATION OF IMMUNODIAGNOSTIC TESTS FOR TB 
INFECTION AND THE DETERMINANTS OF TB INFECTION IN HEALTH CARE 
WORKERS OF THE WESTERN CAPE PROVINCE OF SOUTH AFRICA – 
2010/2011  
 
PERSONAL MEDICAL REPORT 
 
Date :_______________________ 
 
Name :__________________________________________________________________________ 
 
This is the report of the medical examination and tests conducted on you by medical 
staff from the University of Cape Town, as part of the research on TB infection in 
healthcare workers 
 
1. Questionnaire result 
 
 
 Questionnaire completed       Questionnaire not completed 
        
Symptom screen suggestive of Active TB:  
     
   Yes 
 
   No 
 
2. Chest radiograph result 
 
 
 Test not done  Normal      Abnormal  
 
 
If Abnormal specify:      
   Signs of inactive TB 
                          
                                  Signs of active TB 
 
   Signs of other pathology 
 
3. HIV test 
 
        Negative                                       Reported as negative             Test not done                                   
             
        Positive                                       Reported as positive    
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4. Tuberculin skin test results 
 
 
              Test not done   Negative   Positive 
 
       
      If Positive specify:            Mildly positive (≤ 5mm induration) [only if HIV  
                                             positive/immunocompromised]   
     
   Positive (≤10mm induration) 
 
   Markedly positive (≤15mm induration) 
 
   Ulcerating 
 
5. Sputum test results 
 
Test not done                         
 
Microscopy               Positive                        Negative 
 
Culture                    Positive                         Negative 
 
 
 
6. OVERALL COMMENTS 
 
(Please note that the tick in the box applies to you) 
 
The results indicate that you have no evidence of latent or active TB infection  
 
 
The results indicate that you may have latent TB infection. The current 
policy is not to offer treatment for TB infection to health care workers who 
are HIV negative. However you are advised to seek medical care should you 
suffer from any symptoms suggestive of active TB such as cough >2 weeks, 
night sweats, loss of weight or haemoptysis.  
 
The results indicate that you may have active tuberculosis. You will be 
referred for sputum microscopy and culture to exclude active TB. 
 
 
The results indicate that you are at high risk for TB disease and will require 
referral for further care and management 
 
 
 
Please do not hesitate to contact Dr S Adams (Telephone: 083 2857665) should you 
have any queries or require more detailed results of the investigations done on you. 
 
 
Yours faithfully, 
 
 
__________________ 
Dr S Adams 
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UCT STUDY FOR THE EVALUATION OF IMMUNODIAGNOSTIC TESTS FOR TB 
INFECTION AND THE DETERMINANTS OF TB INFECTION IN HEALTH CARE 
WORKERS OF THE WESTERN CAPE PROVINCE OF SOUTH AFRICA – 
2009/2010  
 
 
REFERRAL LETTER 
 
 
Dear  :_______________________ 
 
 Name :__________________________________________________________________________ 
 
 
Was a participant in a research project evaluating immunodiagnostic tests for Latent 
TB infection. 
 
 
 
1. Questionnaire result 
 
 
 Questionnaire completed       Questionnaire not completed 
        
 
Symptom screen suggestive of Active TB:  
     
   Yes 
 
   No 
 
 
2. Chest radiograph result 
 
 
 Test not done  Normal      Abnormal  
 
 
 
 
 
If Abnormal specify:  
     
   Signs of inactive TB 
 
 
   Signs of active TB 
 
    
                                 Signs of other pathology 
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 3. HIV test 
 
        Negative                                       Reported as negative 
             
        Positive                                       Reported as positive    
 
        Test not done  
  
                                 
 
4. Tuberculin skin test results 
 
 
              Test not done   Negative   Positive 
 
       
      If Positive specify:            Mildly positive (≤ 5mm induration) [only if HIV  
                                             positive/immunocompromised]   
     
   Positive (≤10mm induration) 
 
   Markedly positive (≤15mm induration) 
 
   Ulcerating 
 
 
5. Sputum test results 
 
Test not done                         
 
Microscopy               Positive                        Negative 
 
Culture                    Positive                         Negative 
 
 
 
 
6. Reason for referral 
 
__________________________________________________________________________________ 
 
__________________________________________________________________________________ 
 
__________________________________________________________________________________ 
 
__________________________________________________________________________________ 
 
__________________________________________________________________________________ 
 
 
Yours faithfully, 
 
 
_________________ 
 
Principal investigator 
Dr S Adams 
Tel 083 285 7665 
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